Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),0.6822499956785927,2.068391385363607,0.0,0.030066938014907806,0.028,16/29,18.01%,GRIA4;GRID2;CHRNA1;GABRA2;GRIK5;GRIK2;GABRB3;GRID1;GRIK1;GABRA5;CHRNB1;GLRA3;GABRG1;GABRB1;GABRG3;GABRG2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.8102363895074459,2.0184854082898522,0.004319654427645789,0.04459929138877991,0.079,3/13,1.29%,BMP6;BMP2;BMP5
prerank,BMP receptor binding (GO:0070700),0.8102371895106932,1.9875490036715864,0.004282655246252677,0.04977748626912514,0.128,3/12,1.29%,BMP6;BMP2;BMP5
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6627159573675062,1.9874147261940918,0.0,0.03733311470184386,0.128,15/28,18.01%,GRID2;CHRNA1;GABRA2;CHRNB4;GRIK5;GRIK2;GRID1;GRIK1;GABRA5;CHRNA4;CHRNA7;CHRNB1;GABRG1;GABRG3;GABRG2
prerank,vinculin binding (GO:0017166),-0.8268337763573053,-1.987179109517207,0.0,0.04491017964071856,0.039,6/11,6.61%,UTRN;SORBS3;DMD;PXN;CTNNA1;ACTN1
prerank,cadherin binding (GO:0045296),-0.4253884482103509,-1.9714751582315304,0.0,0.02944111776447106,0.05,139/315,25.06%,DOCK9;PTPRB;PKP4;COBLL1;MRTFB;ITGA6;AHNAK;BSG;STXBP6;CDH1;BAIAP2L1;NOTCH3;PROM1;TMOD3;PTPRJ;ESYT2;SPTBN1;WASF2;FNBP1L;RPL6;RACK1;BMPR2;KDR;F11R;FXYD5;CTNNA1;EEF2;EHD4;IQGAP1;CLIC1;TJP2;PLCB3;CD2AP;DAB2IP;TRIM25;ANXA1;HSP90AB1;EPS8L2;PDLIM1;MPRIP;ARHGAP1;TES;SHTN1;PAICS;HSPA8;RPL14;ANXA2;ATXN2L;CAST;PTPRM;LRRFIP1;EZR;CDH4;CHMP2B;PKM;RPL23A;PFKP;GIPC1;RPL34;HCFC1;RPL29;EEF1D;USP8;JUP;UBAP2;NOP56;SPTAN1;CTNNA3;PFN1;ADD1;VCL;LDHA;TRPC4;ZC3H15;RAB11B;HSPA5;CDH6;SH3GLB2;STK38;DBNL;YWHAZ;LASP1;ACVR1;DBN1;PLIN3;RPL15;EPN2;SLC3A2;TAGLN2;ABI1;RAB1A;EPHA2;HNRNPK;RPL24;EGFR;TXNDC9;HSPA1A;PCBP1;CCS;IST1;BZW2;RPS26;TBC1D2;PPFIBP1;STAT1;GIGYF2;EIF5;GLOD4;EHD1;SERBP1;RANGAP1;PACSIN2;CAPG;CTTN;CDH5;TJP1;SFN;PTPRO;PPP1CA;ARHGAP18;BZW1;NCK1;CCT8;STX5;ANLN;YWHAB;DNAJB1;CNN3;LRRC59;RPL7A;RDX;NUMB;RSL1D1;PTPN1;ENO1;CIP2A;EVPL;EIF4H;FSCN1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.7700211761034395,1.9568610625259852,0.0,0.04991111710474696,0.204,4/15,4.45%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.7050845644854807,1.9537311472591077,0.002188183807439825,0.044432252844252645,0.214,12/19,18.01%,GRID2;CHRNA1;GABRA2;GRIK5;GRIK2;GRID1;GRIK1;GABRA5;CHRNB1;GABRG1;GABRG3;GABRG2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.778702387008655,1.9311553548094844,0.0041928721174004195,0.05254555357843413,0.287,4/13,4.45%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,ligand-gated ion channel activity (GO:0015276),0.6376131664306176,1.9226792924679985,0.0,0.05086323680855238,0.311,14/30,15.63%,GRIA4;GRID2;GRIN3A;CHRNB4;GRIK5;GRIK2;GRID1;GRIK1;GRIA3;CHRNA4;GRIN2A;CHRNB1;GRIA1;GABRB1
prerank,ligand-gated channel activity (GO:0022834),0.6435582782683347,1.9217455606489366,0.0,0.0453231250817314,0.312,14/29,15.63%,GRIA4;GRID2;GRIN3A;CHRNB4;GRIK5;GRIK2;GRID1;GRIK1;GRIA3;CHRNA4;GRIN2A;CHRNB1;GRIA1;GABRB1
prerank,glutamate receptor activity (GO:0008066),0.6976896377438343,1.9212965550127339,0.0042643923240938165,0.04079081257355826,0.312,9/19,14.82%,GRIA4;GRID2;GRIK5;GRIK2;GRM1;GRID1;GRIK1;GRM4;GRIA1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.5287884535623842,-1.9024873707639647,0.0,0.05056553559547571,0.127,35/57,27.14%,COX4I1;NDUFV2;COX6B1;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;UQCRQ;COX15;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFS3;NDUFB9;CYBRD1;NDUFS6;NDUFC1;UQCR11;NDUFA4;COX10;NDUFA3;UQCRH;NDUFA10;NDUFB10;NDUFA4L2;COX8A;NDUFB3;NDUFA1;COX4I2;NDUFA7;CYB561D2;NDUFA8
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.7037910477578295,1.8906044337573409,0.003968253968253968,0.05530494356075467,0.414,5/18,5.60%,ALDH1A1;ALDH1A2;AKR1B1;ALDH18A1;ALDH6A1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.7193646823839621,1.8473153876671202,0.002232142857142857,0.07992794355629658,0.561,2/14,0.06%,SLC7A11;SLC1A3
prerank,protein phosphatase 1 binding (GO:0008157),-0.6435140541322023,-1.8330099466454222,0.0018656716417910447,0.10329341317365269,0.302,11/21,23.73%,PPP1R3B;PPP1R16B;SHOC2;KCNQ1;SH3RF2;PHACTR4;PPP1R3F;PPP1R3C;PPP1R16A;PPP1R3E;SMTNL2
prerank,phospholipid transfer activity (GO:0120014),-0.6343217195008651,-1.814920318588191,0.0036429872495446266,0.10738522954091817,0.376,8/21,13.88%,PITPNC1;CERT1;PLTP;TNFAIP8L3;PITPNA;PITPNM2;PRELID2;PITPNM1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.6776054348047481,1.8129197557381231,0.004210526315789474,0.10007995082105028,0.701,8/17,12.09%,EPHA7;EPHA3;EPHA6;EFNA3;EPHB1;EPHA8;EPHA5;EPHA1
prerank,ephrin receptor activity (GO:0005003),0.6776054348047481,1.8129197557381231,0.004210526315789474,0.10007995082105028,0.701,8/17,12.09%,EPHA7;EPHA3;EPHA6;EFNA3;EPHB1;EPHA8;EPHA5;EPHA1
prerank,amino acid:sodium symporter activity (GO:0005283),0.7582815797304201,1.8055412781807711,0.008316008316008316,0.10042357296979208,0.724,6/11,9.85%,SLC1A3;SLC6A12;SLC6A13;SLC38A1;SLC6A11;SLC6A1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6608015864355324,-1.798514935352458,0.0036968576709796672,0.11210911510312709,0.441,6/18,4.77%,STXBP6;BAIAP2L1;TMOD3;ANXA1;PDLIM1;ANXA2
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.5587577991345615,-1.7968844784983475,0.003738317757009346,0.08595309381237524,0.448,23/34,27.14%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFS3;NDUFB9;NDUFS6;NDUFC1;NDUFA4;NDUFA3;NDUFA10;NDUFB10;NDUFB3;NDUFA1;NDUFA7;NDUFA8
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.5587577991345615,-1.7968844784983475,0.003738317757009346,0.08595309381237524,0.448,23/34,27.14%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFS3;NDUFB9;NDUFS6;NDUFC1;NDUFA4;NDUFA3;NDUFA10;NDUFB10;NDUFB3;NDUFA1;NDUFA7;NDUFA8
prerank,double-stranded RNA binding (GO:0003725),-0.4861092880421872,-1.7954955904408976,0.0,0.07728986471501442,0.449,23/70,15.96%,VIM;MBNL1;STRBP;IFIH1;TFRC;HSP90AB1;ADAR;MSN;LRRFIP1;ACTN1;TLR3;DUS2;RC3H1;DHX9;DHX15;HSPD1;DHX58;ILF2;TUBB4B;SLC3A2;FMR1;EIF4A1;OAS2
prerank,lipase activator activity (GO:0060229),0.7668200924858144,1.7947890635493957,0.004098360655737705,0.10629915377353864,0.768,3/10,2.31%,ARHGAP6;APOH;PDPK1
prerank,voltage-gated calcium channel activity (GO:0005245),0.5621972081325979,1.7939448716883404,0.008368200836820083,0.10087162930099462,0.77,9/37,8.28%,CACNA2D3;CACNA1E;CACNA2D1;CACNA1I;CACNG4;CACNB1;CACNA1G;CACNB4;CACNB2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.6366588464429453,1.7797693353376138,0.008695652173913044,0.11063519599189224,0.815,8/21,13.54%,CHRNA1;P2RX4;CHRNB4;GLRB;GRIK2;CHRNA4;CHRNA7;CHRNB1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.6114019240029386,1.7388719440356917,0.017204301075268817,0.1559788345790919,0.915,8/21,14.82%,CHRNA1;CHRNB4;GRM1;CHRNA4;CHRFAM7A;CHRNA7;CHRNB1;GRIA1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.7104075322879262,-1.7133680669749394,0.0055248618784530384,0.18932135728542915,0.812,6/11,18.92%,MAP3K5;MAP3K1;MAP3K20;TAOK2;EGFR;MAP3K6
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.7252493354484746,1.7076132338477585,0.01276595744680851,0.19222795704197726,0.946,5/10,9.85%,SLC6A12;SLC6A13;SLC10A1;SLC6A11;SLC6A1
prerank,rRNA binding (GO:0019843),-0.5082321052903431,-1.6782018469550952,0.010968921389396709,0.25557974959172564,0.911,21/42,22.89%,RPS14;RPS9;RPS3;RPL11;RPL23;RPS5;CAVIN1;RPS13;PTCD3;ERI1;RPL12;CIRBP;PPAN;ERAL1;EMG1;MRPL16;MRPS18C;RPL5;MRPS18A;MRPS6;MRPL11
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.722670346611007,-1.676143401330802,0.0018181818181818182,0.23819028609447773,0.916,4/10,1.30%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1
prerank,GABA-A receptor activity (GO:0004890),0.6285655068698626,1.676075259602733,0.010548523206751054,0.23604932606624446,0.982,9/18,18.01%,GABRA2;GABRR3;GABRB3;GABRR2;GABRA5;GABRG1;GABRB1;GABRG3;GABRG2
prerank,CARD domain binding (GO:0050700),-0.648775180133577,-1.6734040671920556,0.015209125475285171,0.22700752341470906,0.921,11/14,30.30%,NOD1;CARD14;CARD19;MAVS;NOD2;CASP1;BCL10;CARD10;CARD16;CARD11;IRGM
prerank,acetylcholine receptor activity (GO:0015464),0.5833086028078556,1.6713116407931405,0.017857142857142856,0.23525101198330897,0.982,8/22,13.54%,CHRNA1;CHRNB4;CHRM2;CHRM3;CHRNA4;CHRFAM7A;CHRNA7;CHRNB1
prerank,GABA receptor activity (GO:0016917),0.5956656502678801,1.653934225595987,0.01818181818181818,0.25870639274566326,0.991,10/21,19.37%,GABRA2;GABRR3;GABRB3;GABRR2;GABRA5;GABRG1;GABRB1;GABRG3;GABRG2;GPR156
prerank,hexosaminidase activity (GO:0015929),0.6810984017152144,1.6534219957937737,0.035164835164835165,0.24897095061788932,0.991,3/12,1.38%,CEMIP;HYAL3;SPAM1
prerank,poly-purine tract binding (GO:0070717),0.5565763290890088,1.6482372354017787,0.021235521235521235,0.2487938897606905,0.991,6/27,6.61%,RBMS3;ATXN1;RBMS1;DAZAP1;PABPC1L;KHDRBS1
prerank,calcium:sodium antiporter activity (GO:0005432),0.7139311910004561,1.6455893897055458,0.02522935779816514,0.24373493470290009,0.992,5/10,9.95%,SLC24A3;SLC8A1;SLC24A5;SLC24A4;SLC24A2
prerank,MHC class II protein complex binding (GO:0023026),-0.6888218025758623,-1.6451388968811422,0.007827788649706457,0.2786569717707442,0.966,8/11,20.21%,HSP90AB1;HSPA8;CD81;PKM;ATP1B1;CD74;HSP90AA1;ANXA11
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.4774138731152775,1.6422841413212261,0.00641025641025641,0.24020142703020791,0.992,21/53,16.45%,SLC7A11;SLC1A3;SLC7A2;SLC6A9;SLC43A1;SLC36A2;SLC38A1;SLC7A9;SLC25A13;SLC1A5;SLC38A3;CTNS;SLC38A9;SLC25A15;SLC38A6;OCA2;SLC1A2;SLC7A3;SLC1A7;SLC3A1;SLC25A18
prerank,protein phosphatase binding (GO:0019903),-0.4034989319510438,-1.6376950670782928,0.0,0.2795076513639388,0.977,44/117,19.81%,MAP3K5;ITGA1;CTTNBP2NL;PXN;RACK1;FOXO1;IQGAP1;PPP1R3B;PTK2;PPP1R16B;DAB2IP;SHOC2;CDKN1B;MFHAS1;KCNQ1;AP3B1;SH3RF2;JUP;FLT4;STRN4;VRK3;PHACTR4;PPP1R3F;VCP;PPP3CB;FBXL2;ERBB2;PPP1R3C;STRN3;MET;EGFR;STRN;ANAPC7;PIK3R2;IGBP1;BAD;JAK3;CDC27;GTF2F1;PPP6R3;BOD1;PPP1R16A;CDH5;SNX3
prerank,ligand-gated anion channel activity (GO:0099095),0.6131900060838326,1.6246079078522857,0.02197802197802198,0.26544810990304324,0.997,9/17,18.01%,GABRA2;GLRB;GABRB3;GABRA5;GLRA3;GABRG1;GABRB1;GABRG3;GABRG2
prerank,poly-pyrimidine tract binding (GO:0008187),0.5738053472969994,1.6200181677256396,0.02301255230125523,0.26479641272439497,0.997,7/23,10.46%,RBMS3;ATXN1;RBMS1;DAZAP1;PABPC1L;KHDRBS1;PNPT1
prerank,receptor ligand activity (GO:0048018),0.37171314436493197,1.6181065688145677,0.0,0.2594108596508435,0.997,24/245,5.97%,GREM2;IGF1;BMP6;EPHA7;WNT4;IL34;BMP2;PTN;AREG;SEMA5A;NRG3;BMP5;GPHB5;NRG1;GDNF;VEGFB;SEMA3A;ARTN;TGFA;SEMA3D;IL4;FAM3D;TAFA2;TAFA5
prerank,"DNA binding, bending (GO:0008301)",-0.6170305153750976,-1.6131750472005886,0.016042780748663103,0.33171157684630737,0.99,5/14,16.79%,LEF1;FOXD1;HHEX;TOP2A;SAP30L
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.66968526366611,1.606338356584378,0.03160270880361174,0.2719926338918488,0.998,5/11,13.54%,CHRNA1;CHRNB4;CHRNA4;CHRNA7;CHRNB1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.6650066775674335,-1.6007736196577653,0.023172905525846704,0.3491252788540566,0.994,3/11,9.82%,SGMS1;SGMS2;PIGF
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4503156471764391,1.5998489144751884,0.015444015444015444,0.27699166646233814,0.998,25/60,12.09%,EPHA7;DDR2;NTRK3;FGFR2;PDGFRA;KIT;EPHA3;EPHA6;DDR1;AXL;PDGFRB;EPHB1;ROR1;RYK;ERBB3;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;FGFR1;EPHA1
prerank,poly(U) RNA binding (GO:0008266),0.587299616210803,1.5957286130604966,0.03205128205128205,0.2765550884482328,0.998,7/20,10.46%,RBMS3;ATXN1;RBMS1;DAZAP1;PABPC1L;KHDRBS1;PNPT1
prerank,phospholipase activator activity (GO:0016004),0.6784675469247017,1.5899503320267154,0.035196687370600416,0.279681478319064,0.999,2/10,2.31%,ARHGAP6;PDPK1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.6389225070859863,1.5877518610047219,0.05200945626477541,0.27567086882811187,0.999,7/12,17.60%,B3GALT1;B3GALNT1;B3GNT7;B3GALT2;B3GALT5;B3GNT6;B4GAT1
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.6168699679559352,-1.58319454807955,0.028622540250447227,0.3849523175870482,0.999,6/13,22.35%,KCNQ1;EZR;PRKAR2B;PRKAR2A;SOX9;CSK
prerank,tropomyosin binding (GO:0005523),-0.584880385229496,-1.5787114932437742,0.027522935779816515,0.3770354028784536,0.999,5/16,10.23%,NEBL;TMOD3;LMOD1;TMOD1;S100A6
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.4968718609183191,-1.5776474428694882,0.015810276679841896,0.36117764471057884,0.999,11/34,11.31%,CYTH3;PARD3;ARAP3;IQGAP1;FERMT2;ARAP2;HIP1R;JPH2;AKT1;MAPKAP1;KIF16B
prerank,outward rectifier potassium channel activity (GO:0015271),0.6378519614155155,1.5763595796576098,0.03695652173913044,0.28791877125016346,0.999,4/11,9.00%,KCNK2;KCNT2;KCND2;KCND1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.44946988843002367,1.5708671974024184,0.020242914979757085,0.29091794079289174,1.0,26/60,12.09%,EPHA7;NRP1;DDR2;NTRK3;FGFR2;PDGFRA;KIT;EPHA3;EPHA6;DDR1;AXL;PDGFRB;EPHB1;ROR1;RYK;ERBB3;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;FGFR1;EPHA1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.6106151787162877,1.5707315286103285,0.024070021881838075,0.2836841976213582,1.0,2/15,2.52%,PLA2G5;PLA2G4A
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.475607976043131,-1.56802854202024,0.011516314779270634,0.3709248170326015,0.999,10/42,4.84%,BSG;ESAM;STXBP6;BAIAP2L1;TMOD3;ANXA1;PDLIM1;JAM3;ANXA2;ROBO4
prerank,low-density lipoprotein particle binding (GO:0030169),-0.5896986660914133,-1.5656320162335213,0.03125,0.36145890038105605,1.0,5/16,4.17%,THBS1;PLTP;SCARB1;SCARF1;STAB1
prerank,sodium channel activity (GO:0005272),0.47925329085933654,1.5629836758375664,0.026970954356846474,0.28959343973503937,1.0,9/37,7.77%,SCN7A;GRIK5;GRIK2;SCN3A;CACNA1I;ASIC2;CACNA1G;SCN2A;GRIK1
prerank,Wnt-activated receptor activity (GO:0042813),-0.5937636333559028,-1.5625657858336013,0.04220183486238532,0.3553762041135121,1.0,6/15,8.66%,LRP5;FZD6;FZD4;PKD1;FZD7;FZD3
prerank,phosphatidylinositol binding (GO:0035091),-0.4069859358762636,-1.562070958622253,0.00408997955010225,0.34169161676646703,1.0,26/91,15.51%,PITPNC1;ITPR2;MCF2L;ESYT2;PARD3;SCARB1;SNX11;DENND1A;TNFAIP8L3;ITPR3;BCAS3;EEA1;HIP1R;DENND1B;PITPNA;MREG;AIDA;HIP1;PITPNM2;RPH3A;FCHO2;MITD1;PITPNM1;PHF12;ESYT3;MTM1
prerank,ligand-gated cation channel activity (GO:0099094),0.4224818006676593,1.5613309990147053,0.01603206412825651,0.2855106322332287,1.0,26/75,18.11%,GRIA4;CHRNA1;GRIN3A;P2RX4;CHRNB4;CCDC51;GRIK5;GRIK2;TRPM5;KCNJ16;ASIC2;KCNJ3;GRIK1;KCNJ5;GRIA3;CHRNA4;KCNJ14;CHRNA7;GRIN2A;CHRNB1;KCNJ6;GRIA1;KCNJ9;KCNN1;GRIN2B;ASIC4
prerank,FAD binding (GO:0071949),0.5308936337949387,1.5550031901661816,0.03696098562628337,0.29006039551617563,1.0,8/24,11.20%,MICAL3;KDM1B;CYB5R2;PRODH;KMO;CRY1;DDO;MICAL1
prerank,neurexin family protein binding (GO:0042043),0.6572832945957134,1.5521216315257929,0.05518763796909492,0.28885736878607854,1.0,5/10,8.00%,SYTL5;NLGN2;NLGN3;SYTL2;NLGN1
prerank,insulin-like growth factor receptor binding (GO:0005159),0.6390510923104438,1.5502969617534443,0.042505592841163314,0.2854727572144115,1.0,2/12,0.26%,IGF1;PIK3R1
prerank,insulin-like growth factor binding (GO:0005520),-0.599134018454836,-1.5494261705443002,0.023391812865497075,0.3647904191616766,1.0,8/15,7.95%,IGF1R;ITGA6;IGFBP6;ITGB4;IGFBP5;IGF2R;IGFBP3;INSR
prerank,disordered domain specific binding (GO:0097718),-0.519274844428081,-1.5490558558961176,0.036968576709796676,0.35110548134500236,1.0,10/23,16.64%,FN1;HSP90AB1;CALM1;GAPDH;RB1;TEAD2;CALM3;FKBP8;HSP90AA1;HSPA1A
prerank,acylglycerol lipase activity (GO:0047372),-0.6262533317755249,-1.5395891912923183,0.03723404255319149,0.36497375619132105,1.0,3/11,13.52%,ABHD2;MGLL;FAAH
prerank,protein phosphatase activator activity (GO:0072542),-0.6151886751989196,-1.5367732700920305,0.03225806451612903,0.3591745081266039,1.0,6/13,18.18%,CALM1;IGFBP3;PPP2R5A;PHACTR4;CALM3;PPP2R5E
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.6168476172753028,1.5366165187801983,0.053691275167785234,0.3045416373176647,1.0,7/13,18.01%,GABRA2;GLRB;GABRA5;GLRA3;GABRG1;GABRG3;GABRG2
prerank,phosphate ion binding (GO:0042301),-0.65531950111685,-1.531098959249073,0.05163511187607573,0.3638240759859591,1.0,5/10,19.33%,PDE2A;ADSS2;RPH3A;RELA;ADSS1
prerank,phospholipase binding (GO:0043274),0.6181867161816021,1.5216798059059795,0.06666666666666667,0.32601469530534843,1.0,3/13,5.78%,ARHGAP6;PDPK1;PRKN
prerank,actin monomer binding (GO:0003785),-0.5217868038014299,-1.5202494620535962,0.03207547169811321,0.3830339321357285,1.0,7/22,11.76%,TMSB4X;NOS3;COBL;PFN1;TMSB10;ABL2;PRKCE
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.5730081635267807,-1.5198720245051651,0.038391224862888484,0.37228768269911783,1.0,7/17,9.79%,PITPNC1;ATP10A;PLTP;ATP8B1;PITPNA;ABCG1;PITPNM2
prerank,aspartic-type peptidase activity (GO:0070001),-0.6437266448325575,-1.5166215949897435,0.043557168784029036,0.3697916666666667,1.0,3/10,9.18%,BACE2;BACE1;CTSD
prerank,phosphatidylglycerol binding (GO:1901611),-0.5998271970804053,-1.5154849899476979,0.060714285714285714,0.36133793020020566,1.0,3/13,6.44%,PITPNC1;PLTP;PITPNA
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5532947430118587,1.5149859299932213,0.0635593220338983,0.3315206730687226,1.0,9/17,18.02%,GRIA4;GRIN3A;GRIK5;GRIK2;GRIK1;GRIA3;GRIN2A;GRIA1;GRIN2B
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.6319740623880338,1.514247994598338,0.04504504504504504,0.3257891340367103,1.0,7/12,18.01%,GABRA2;GABRB3;GABRA5;GABRG1;GABRB1;GABRG3;GABRG2
prerank,histone methyltransferase binding (GO:1990226),-0.6377671560885837,-1.5132717647677465,0.02962962962962963,0.3566103087941763,1.0,5/11,14.11%,HSP90AB1;CBX1;PRDM4;NOP56;LCOR
prerank,poly(A) binding (GO:0008143),0.5435881164143621,1.5114626051618132,0.05304518664047151,0.3242635745635543,1.0,4/21,6.61%,RBMS3;RBMS1;PABPC1L;KHDRBS1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.6291019734125471,-1.5086470620750634,0.054249547920433995,0.3593384659252923,1.0,5/11,5.05%,ATP10A;ATP8A1;ATP8B1;ATP11C;ATP11A
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.36118544525661445,-1.50503995069386,0.001976284584980237,0.3585329341317366,1.0,51/147,20.37%,DOCK9;RAPGEF5;CYTH3;PLCE1;FGD5;ARHGEF28;RAP1A;DOCK1;RIN3;RASGRF2;RAPGEF1;ARHGEF15;RGL1;DENND1A;EPS8L2;DOCK4;FGD6;DENND1B;SPATA13;BCR;NUCB1;EEF1D;DENND3;DENND6A;ITSN1;HERC2;EEF1B2;PREX1;ABR;DENND2C;ARHGEF5;LAMTOR2;ARHGEF18;MADD;RGL2;DENND5B;HPS1;RAPGEF3;EIF2B3;CYTH2;ARHGEF17;ECT2;ARHGEF4;ARHGEF2;ARHGEF6;RASGRP4;FGD2;RAPGEF2;CYTH4;RAB3GAP2;RINL
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.6025008105002055,1.503808895331528,0.08639308855291576,0.3323317067117157,1.0,3/11,8.59%,SLC22A4;SLC22A3;SLC25A47
prerank,BMP binding (GO:0036122),0.6197322483359525,1.499684240620642,0.07311827956989247,0.33370292271479013,1.0,1/11,0.03%,GREM2
prerank,calcium channel activity (GO:0005262),0.401266382612929,1.4909438605490895,0.024,0.3449640718390141,1.0,16/84,9.95%,CACNA2D3;SLC24A3;CACNA1E;SLC24A5;CACNA2D1;P2RX4;TRPM1;ORAI2;CACNA1I;TRPM5;CACNG4;CACNB1;CACNB4;CACNB2;SLC24A4;SLC24A2
prerank,chemorepellent activity (GO:0045499),0.5043558646383862,1.4907315778736547,0.056842105263157895,0.3388890840487974,1.0,6/25,5.02%,EPHA7;SEMA5A;NRG3;NRG1;SEMA3A;SEMA3D
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.5934110152543377,-1.4906755374016516,0.05758157389635317,0.3892755030479581,1.0,7/13,23.69%,SH3BP4;ARHGDIA;ARHGDIB;GDI1;GDI2;EIF5;CCDC88A
prerank,SH3 domain binding (GO:0017124),-0.41421979668546033,-1.4846351588247388,0.017928286852589643,0.39670658682634724,1.0,21/62,19.88%,AFAP1L1;SHANK3;AFAP1L2;WASF2;ARHGAP27;CD2AP;DAB2IP;ADAM15;CRK;ABI3;GPX1;SGIP1;RUFY1;ABI1;PTPN12;SYNJ1;RAD9A;CABYR;SHANK1;DNM2;WIPF1
prerank,metalloendopeptidase activity (GO:0004222),0.4003820232043376,1.481151167324294,0.025341130604288498,0.35149952441579013,1.0,9/76,5.60%,ADAMTS6;ADAMTS12;ADAM33;ADAMTS10;TRABD2B;ADAMTS5;MMP16;OMA1;MMP11
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5768985650028741,1.4811402569820264,0.0824295010845987,0.34499027396364584,1.0,5/15,14.29%,P2RY13;P2RX4;GPR171;P2RY1;GPR34
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5575466750731062,-1.4748644032352458,0.062264150943396226,0.415220840370541,1.0,4/15,7.05%,SLC26A7;SLC26A2;SLC39A8;SLC4A8
prerank,LRR domain binding (GO:0030275),0.5981704593688035,1.4732546700896207,0.08641975308641975,0.3548080909625878,1.0,3/14,4.35%,ROBO1;PAWR;PMF1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.4486098895998244,-1.4728455998947783,0.04296875,0.41090319361277444,1.0,15/37,18.64%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1;SLC22A8;COX4I1;COX6B1;UQCRQ;COX15;SLC22A6;UQCR11;NDUFA4;COX10;SLCO4A1;UQCRH
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.3262588638198122,-1.4723390668416698,0.0,0.40221995034321595,1.0,89/269,21.17%,ACTG1;FZD6;NFKBIA;NLK;GPI;FOXO1;FZD4;SMAD7;MAP1LC3B;HSP90AB1;RPL11;RPL23;UBB;MFHAS1;HSPA8;PRR5L;PPARGC1A;RALB;MID1;UBC;RPS27A;SMAD6;GABARAP;PRKAR2B;USP7;CASP8;TNFRSF1B;RIPK1;TRIB2;CUL4A;UBE2L6;CCDC50;CAMLG;CKB;DNAJA1;RB1;VCL;TRIM28;OTUB1;ARRDC1;ATP6V0C;ERLIN2;TRIB1;HERC2;DDRGK1;UCHL1;HSPD1;VCP;BAG5;HSPA5;UBXN1;NDUFS2;YWHAZ;FAF2;TRAF1;ITCH;SLF1;SUMO3;MAP1LC3A;RBX1;CCT2;RNF20;TSG101;UBE2G1;RAD18;LAPTM4B;EGFR;CDKN1A;PRKAR2A;HSP90AA1;HSPA1A;RELA;HSPA9;STAT1;SKI;AMBRA1;ELOB;CUL1;CASC3;CDK5RAP3;LAPTM5;RPL5;TMBIM6;UBE2B;LTBR;FZD5;SMAD2;RRAGA;HSPA1B
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.6265155053116965,-1.4722986055557112,0.05128205128205128,0.3926908088584735,1.0,3/11,9.47%,PPP1R1A;PABIR1;PPP1R8
prerank,ubiquitin protein ligase binding (GO:0031625),-0.3286377617710051,-1.470202760263256,0.0,0.38908230051524856,1.0,84/254,21.17%,ACTG1;FZD6;NFKBIA;NLK;GPI;FOXO1;FZD4;SMAD7;MAP1LC3B;HSP90AB1;RPL11;RPL23;UBB;MFHAS1;HSPA8;PRR5L;PPARGC1A;RALB;MID1;UBC;RPS27A;SMAD6;GABARAP;PRKAR2B;USP7;CASP8;TNFRSF1B;RIPK1;TRIB2;CUL4A;UBE2L6;CCDC50;CAMLG;CKB;DNAJA1;RB1;VCL;TRIM28;OTUB1;ARRDC1;ATP6V0C;ERLIN2;TRIB1;HERC2;UCHL1;HSPD1;VCP;BAG5;HSPA5;UBXN1;NDUFS2;YWHAZ;FAF2;TRAF1;SLF1;MAP1LC3A;RBX1;CCT2;RNF20;TSG101;UBE2G1;RAD18;LAPTM4B;EGFR;CDKN1A;PRKAR2A;HSP90AA1;HSPA1A;RELA;HSPA9;SKI;AMBRA1;ELOB;CUL1;CASC3;LAPTM5;RPL5;TMBIM6;UBE2B;LTBR;FZD5;SMAD2;RRAGA;HSPA1B
prerank,sulfuric ester hydrolase activity (GO:0008484),0.599639740963689,1.4688759965554392,0.10690423162583519,0.3567227431625848,1.0,4/12,5.87%,SULF1;SULF2;GNS;GALNS
prerank,organic cation transmembrane transporter activity (GO:0015101),0.5580527037982854,1.4669934928163115,0.07608695652173914,0.3541744634118643,1.0,4/16,9.48%,SLC22A4;SLC22A3;SLC25A42;SLC44A1
prerank,lipoprotein particle binding (GO:0071813),-0.5165761091650279,-1.4641687577731557,0.0616822429906542,0.3963663581927055,1.0,5/20,4.17%,THBS1;PLTP;SCARB1;SCARF1;STAB1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5411159683483162,1.4622319467387066,0.0649895178197065,0.3575719243347628,1.0,5/18,9.33%,LTBP1;TGFBR3;TGFBR3L;TGFBR1;BMPR1A
prerank,CoA-ligase activity (GO:0016405),0.5705004921095135,1.4618187229949746,0.10022271714922049,0.3523607317758377,1.0,2/14,4.49%,ACSS3;ACSL1
prerank,insulin-like growth factor I binding (GO:0031994),-0.582034387296223,-1.460849074432524,0.06542056074766354,0.3969616322909736,1.0,7/13,7.95%,IGF1R;ITGA6;IGFBP6;ITGB4;IGFBP5;IGFBP3;INSR
prerank,leak channel activity (GO:0022840),0.5362561189064681,1.4598758083239936,0.08085106382978724,0.3498622315123578,1.0,2/18,0.54%,KCNK2;NALCN
prerank,voltage-gated sodium channel activity (GO:0005248),0.5013678833114693,1.4528847193297094,0.06315789473684211,0.35741867189961996,1.0,6/22,7.60%,SCN7A;SCN3B;SCN3A;CACNA1I;CACNA1G;SCN2A
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.613888308140142,-1.4507660923864787,0.08181818181818182,0.41469235442159164,1.0,2/10,4.10%,MECOM;PRDM16
prerank,translation elongation factor activity (GO:0003746),-0.5748817263087566,-1.4500669850281613,0.0749063670411985,0.40758907716481924,1.0,5/14,12.23%,EEF1A1;EEF2;EEFSEC;EEF1B2;TSFM
prerank,gated channel activity (GO:0022836),-0.5728567905866191,-1.4488095291861782,0.05426356589147287,0.40229956753160345,1.0,6/14,17.68%,PIEZO2;PIEZO1;TMC6;PACC1;TMEM266;TMEM63B
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5140177159875837,1.4465400796198509,0.07415730337078652,0.352534848224794,1.0,7/22,12.80%,HTR7;CHRM2;HRH1;CHRM3;HRH2;HTR4;HTR5A
prerank,serotonin receptor activity (GO:0099589),0.5140177159875837,1.4465400796198509,0.07415730337078652,0.352534848224794,1.0,7/22,12.80%,HTR7;CHRM2;HRH1;CHRM3;HRH2;HTR4;HTR5A
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5140177159875837,1.4465400796198509,0.07415730337078652,0.352534848224794,1.0,7/22,12.80%,HTR7;CHRM2;HRH1;CHRM3;HRH2;HTR4;HTR5A
prerank,actin binding (GO:0003779),-0.3404566837190002,-1.445854895262041,0.004210526315789474,0.402440017923337,1.0,41/170,12.94%,UTRN;ABLIM1;TMSB4X;MYRIP;SYNE1;SORBS1;NOS3;DMD;PARVB;COBL;EPS8;ACTN4;FXYD5;PTK2;FERMT2;EPS8L2;PDLIM1;SSH2;MICAL2;KLHL2;EZR;CAP1;FLII;GIPC1;PFN1;TMOD1;TMSB10;ADD1;VCL;SPEF1;PHACTR4;TRPV4;SYNPO;ABL2;FHDC1;MAEA;PRKCE;MLPH;DBNL;BCL7B;DBN1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5814246710539355,-1.4424364414706379,0.06946983546617916,0.4030139720558882,1.0,9/12,31.57%,ISCA2;FXN;SDHB;ISCA1;CIAPIN1;AOX1;CISD3;XDH;CISD1
prerank,chloride transmembrane transporter activity (GO:0015108),-0.534280137247978,-1.437027474672576,0.07649253731343283,0.40959257954678874,1.0,4/16,7.05%,SLC26A7;SLC26A2;SLC1A1;SLC4A8
prerank,nuclear receptor coactivator activity (GO:0030374),-0.40759372712624087,-1.4366389442395242,0.03294573643410853,0.4026754183939813,1.0,20/52,22.43%,ACTN4;ETS1;PPARGC1B;PPARGC1A;DCAF6;TACC1;ACTN1;MED24;ENY2;ZMIZ2;FGF2;SS18;KDM1A;CCAR2;USP22;MED14;SRA1;HELZ2;SFR1;RBM14
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5954234885679736,-1.4353164716949809,0.0748663101604278,0.3988249915263812,1.0,6/11,10.83%,ITPR2;TRPC3;ITPR3;TRPC6;RPH3A;TRPC4
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.6197916944539472,-1.4277894195870362,0.07564575645756458,0.4116766467065868,1.0,5/10,18.12%,CXADR;JUP;DSG2;DSP;CD200
prerank,retinoid binding (GO:0005501),0.4989628689509161,1.4265831242832898,0.09533898305084745,0.38556607794912034,1.0,3/22,3.74%,ALDH1A2;NR2F2;ABCA4
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.4623943384427739,-1.4253753904890847,0.06679764243614932,0.41099618943930327,1.0,5/27,5.21%,SLC26A7;SLC26A2;SLC22A8;ANO1;SLC39A8
prerank,MHC class I protein binding (GO:0042288),-0.5663033729867167,-1.4216755199090279,0.08260105448154657,0.41324493869404044,1.0,7/13,29.30%,ATP5F1A;TAPBP;ATP5F1B;TUBB4B;TAP2;LILRB1;DERL1
prerank,phosphatidic acid binding (GO:0070300),-0.5150923605189728,-1.4111704480328686,0.07034220532319392,0.43423678957873724,1.0,8/19,19.77%,PITPNC1;PLTP;JPH2;MAPKAP1;PITPNM1;OPA1;PACSIN2;RAPGEF2
prerank,anion transmembrane transporter activity (GO:0008509),-0.578374713374294,-1.4088615543416805,0.10412926391382406,0.43275517929657925,1.0,5/12,13.52%,ABCG2;SLCO2B1;SLC39A8;SLC4A2;SLC22A6
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.4445959270852321,-1.4059412012513226,0.06641366223908918,0.4333705470415102,1.0,4/31,2.13%,SLC12A7;SLC12A2;KCNK5;ABCC9
prerank,phospholipase inhibitor activity (GO:0004859),-0.5991029271341328,-1.4020653025346608,0.07942238267148015,0.43675981370592154,1.0,3/10,7.45%,ANXA1;ANXA2;ANXA4
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.5723618244127581,1.3963815322872155,0.11038961038961038,0.44354807700880916,1.0,5/12,9.33%,LTBP1;TGFBR3;TGFBR3L;TGFBR1;BMPR1A
prerank,nucleotidyltransferase activity (GO:0016779),0.5085018323672906,1.3949495652901096,0.08296943231441048,0.44006927833859344,1.0,11/19,26.24%,TUT4;CRPPA;PAPSS1;YRDC;PNPT1;PAPSS2;TENT4A;MTPAP;TENT2;REV1;TENT4B
prerank,RNA binding (GO:0003723),-0.2703513918282561,-1.393092990135815,0.0,0.4539282091554596,1.0,437/1321,26.82%,MSI2;TMSB4X;AHNAK;SORBS2;SYNE1;EEF1A1;DDX5;TPT1;SPTBN1;RPS16;RPL41;RPS14;NOVA2;VIM;RPL6;RPL26;RPL19;MBNL1;STRBP;RPS11;RACK1;RPSA;IFIH1;RPS12;ACTN4;RPS23;RPL13;CTNNA1;RPS25;EEF2;RPS15;RPL28;TFRC;NOP14;RPL30;RPS21;RPS4X;RPS27;RPL10;LARP1B;RPL27A;RPS9;RPS3;LBR;RPL37A;RPL38;HNRNPA2B1;RPL39;TRIM25;HSP90AB1;MAP3K20;KMT2C;HNRNPLL;FAU;RPL18A;RPL11;RBM20;ADAR;DHX32;CNBP;MAP4;RPS8;RPL32;RPS10;RPS28;RPL17;RPL23;DDX17;QKI;RPS15A;PPARGC1B;TES;MSN;HSPA8;RPL14;PPIA;RPS5;ANXA2;CAVIN1;SARS1;PPARGC1A;RPL21;ATXN2L;UBC;RPS27A;CAST;RPS24;EIF4G3;EIF5B;PEBP1;RPL18;RPS13;DIAPH1;LRRFIP1;RPS19;PRPF8;RPL35;SRSF5;MTREX;SRSF2;DDX55;RPL27;LTA4H;ATP5F1A;EZR;ACAA2;PTCD3;PCDHGA9;SNRPC;SNRPA;PTBP3;PKM;N4BP1;RPL23A;ACTN1;RBFOX2;ZNF326;HSPB1;RPL34;PRKDC;ISY1;ANP32A;RPL29;CMSS1;SRPK1;SAFB;FAM120A;TLR3;RPL8;ERI1;DUS2;PSMA6;RC3H1;ISG20L2;RPL35A;RPL31;HDGF;THUMPD1;UBAP2;DDX41;YBX3;NOP56;RPS18;SRSF6;NCL;TNS1;TRMT9B;RPL22L1;PFN1;DHX9;YY1;CARS1;ADD1;DHX15;NMD3;PCBP4;NOP2;RBM22;FUS;SNRPD3;RBM47;TRIM28;IFIT1;PPP1R8;MRPL28;RPS20;TDRD7;ACO1;ZC3H8;JMJD6;RPL13A;RPL12;UTP14A;U2AF1;SFPQ;EIF3D;HSPD1;RPS27L;LUC7L2;VCP;CAPRIN1;PES1;DHX37;ZC3H15;LARP4B;PELP1;HNRNPDL;SEC63;DHX58;ILF2;CIRBP;ZC3H18;RPL10A;TUBB4B;NELFE;EIF3I;ZC3H11A;RCC2;FAM133B;RPL36;FNDC3A;YTHDF2;PDAP1;RPS7;MRPL43;TSFM;FAM98A;STAU1;RPS6;YWHAZ;DKC1;SARS2;RPL3;NUDT4;RNPS1;TRIM56;RBMS2;RPL15;MRPL32;MRPL14;SAMHD1;PPAN;NUFIP2;RBM42;RBM6;SRSF4;MAGOH;BTF3;S100A16;SLC3A2;FMR1;RPP38;SEC61B;TRMT10C;PURG;DHX40;DDX23;URB1;CHTOP;ERAL1;MRPS30;PEF1;SRF;RBM45;TOP2A;GDI2;RPL22;DYNC1LI1;EIF4A1;HMGN2;FARS2;RBM4B;MTHFSD;ALYREF;PNO1;HNRNPK;PSMC1;RPL24;RPUSD4;YWHAG;TASOR;SF3A3;OAS2;DSP;EMG1;EFTUD2;MRPL16;DDX39B;LGALS1;AGFG1;NQO1;DDX51;HSP90AA1;SRP19;HSPA1A;FASTKD3;PPIG;MRM3;NOSIP;CDK13;HNRNPA1;PCBP1;ANKRD17;DDX20;LSM14A;CCT3;DUSP14;MCRS1;RPS26;GTF2F1;HSPA9;HSD17B10;KDM1A;DCP1B;SNRPG;ASCC3;CCAR2;PPIL4;GIGYF2;SCAF11;EIF5;DUSP11;EXD1;PHF5A;PNN;DNM1;SERBP1;MRPL54;CASC3;LSM2;RANGAP1;LSM1;LSM14B;RPL7;EDF1;RPL5;TRIP6;RPP21;PTCD2;PUM2;HSPE1;SRRM2;RBM19;PRPF40A;SPATS2;RBM7;ZC3H7A;CPSF4;ANXA11;NSA2;PSMA1;PDIA4;NOL7;CHERP;HELZ2;FKBP4;STIP1;MKI67;CPNE3;MEPCE;SMG7;YTHDF1;LSM3;TRMT6;SRP68;MEX3D;EIF4A2;HSPA1B;DDX10;UTP4;UBA1;DDX49;ZCCHC7;AARS2;EIF1;ZCCHC3;DDX39A;TBRG4;PYM1;PWP2;BZW1;LSM7;KIF1C;PHF6;FDPS;RTCB;API5;LSM10;MRPL13;RBM14;EIF4G1;TUFM;PEG10;NOM1;PPIB;MRPL11;KCTD12;NME1;SYNCRIP;ABT1;NCBP2;TBL3;LRRC59;RPL7A;RDX;SMG1;DDX47;CCDC137;RSL1D1;REPIN1;PTPN1;ENO1;EIF4B;EIF4E;MRPS24;ANXA7;MRPL21;TSR1;CSTF2T;PABPC1;NSUN5;EIF4H;UTP15;WDR6;RPF2;ADAT1;SF3A1;FSCN1;SNRPB;RPP25L;CEBPZ;MRPL42;GANAB;MRPL2;RBPMS2;RO60;PRRC2A;CLNS1A;ACIN1;TXN;MYH9;FTSJ3;NUP42;RAD51AP1;KNOP1;YWHAE;PDCD11;NOCT;DHX57;PSIP1;FAM50A;GOLGB1;SF3A2;PARK7;TUBA1B;TSNAX;HNRNPR
prerank,cytochrome-c oxidase activity (GO:0004129),-0.5245172577276687,-1.3888116465572025,0.10566037735849057,0.4578584765951967,1.0,11/15,36.29%,COX4I1;COX6B1;COX15;NDUFA4;COX10;NDUFA4L2;COX8A;COX4I2;COX7A2L;COX5B;COX6A1
prerank,steroid hydroxylase activity (GO:0008395),0.5268713069869727,1.3879814683960687,0.10993657505285412,0.4492943815913969,1.0,4/16,10.00%,CYP7B1;CYP27A1;CYP2A6;CYP46A1
prerank,E-box binding (GO:0070888),0.4486505689978413,1.3879362702083344,0.09129511677282377,0.4428264440871953,1.0,7/34,10.97%,TCF4;ZEB1;MITF;HES3;ATOH8;GATA3;AHR
prerank,semaphorin receptor activity (GO:0017154),0.5822386380412288,1.3877511631404411,0.13846153846153847,0.43687260935661043,1.0,2/11,0.31%,PLXNA2;NRP1
prerank,GTP binding (GO:0005525),-0.3274409002213609,-1.3870785846512719,0.014256619144602852,0.45523239235814084,1.0,53/172,23.74%,RAP1A;EEF1A1;RHOJ;RAP1B;RASL12;TGM2;GBP5;GCH1;TUBA1A;RAB27A;MFHAS1;RAC1;RALB;ADSS2;REM1;GBP7;KRAS;ATL3;ARF5;INSR;RIT1;RHOT1;ATL2;RHOB;RAB8A;RHOT2;RAB11B;TUBB4B;TUBD1;RAB4A;RAB7A;ARL4A;ARHGEF5;HRAS;ARL6;DYNC1LI1;RRAGD;AGAP2;ARL2;ADSS1;DNM2;ARL8B;RAB32;RND2;RRAGA;TUBE1;TUBA4A;ARL4C;NRAS;NMUR2;NME1;RRAGC;ARL3
prerank,myosin binding (GO:0017022),-0.39223685509443634,-1.3856675666706388,0.05783582089552239,0.4522673403193612,1.0,15/55,15.17%,SHROOM4;MYRIP;DMD;RAB11A;TRAK1;MYOC;TRAK2;GIPC1;RAB6B;LMTK2;RAB8A;RAB11B;MLPH;MYBPC1;SHROOM1
prerank,acid-thiol ligase activity (GO:0016878),0.548071932506913,1.385519561194336,0.15034168564920272,0.4356459347493356,1.0,2/13,4.49%,ACSS3;ACSL1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.5403736961380745,-1.3826170932508632,0.11490125673249552,0.4535390756947643,1.0,6/14,13.25%,MINDY2;MINDY1;USP7;OTUD5;USP9X;USP15
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.5917340165527,1.3802016411407159,0.10888888888888888,0.4415942322152478,1.0,5/10,18.01%,GABRA2;GABRA5;GABRG1;GABRG3;GABRG2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5631842624432752,-1.3797326900446678,0.10638297872340426,0.45431863545636003,1.0,10/12,23.69%,VEGFC;DAB2IP;VEGFA;VEGFD;GREM1;PGF;CDH5;ITGB3;CADM4;CCDC88A
prerank,solute:anion antiporter activity (GO:0140323),0.5434882028228306,1.3791798148820713,0.13195876288659794,0.4374396251283071,1.0,2/14,5.51%,SLC7A11;SLC26A1
prerank,MHC protein binding (GO:0042287),-0.49418245271663935,-1.375541329703807,0.08414872798434442,0.4589328805076414,1.0,7/20,17.81%,CD81;ATP5F1A;TAPBP;ATP5F1B;CD74;TUBB4B;TAP2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.568405401197133,-1.3752860948136203,0.10694183864915573,0.45304978278736646,1.0,6/11,24.64%,DAB2IP;MAP3K11;STK38;TCF3;PPEF2;TRAF6
prerank,single-stranded DNA binding (GO:0003697),0.35899994080074293,1.3737799026911397,0.04251012145748988,0.443202918738668,1.0,24/93,14.56%,RBMS1;DMC1;MCM3;STN1;JCHAIN;RNF138;TOP1;SETMAR;TOP3A;RAD51B;FUBP1;SWSAP1;RADX;BLM;POLR2G;RPA2;MCM2;MCM9;NUP35;MCM8;PMS2;SSBP2;MAPT;RPA1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.4808675170659417,-1.371504969979692,0.1104868913857678,0.45631924556683734,1.0,4/23,3.46%,PLCE1;EDNRA;PLCG2;PLCB3
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.5187517038820636,1.3713203896320068,0.15450643776824036,0.4422646135739505,1.0,7/15,18.33%,SLC1A3;SLC25A13;SLC1A5;SLC1A2;SLC1A7;SLC25A18;SLC38A7
prerank,nucleosomal DNA binding (GO:0031492),-0.47112013910706135,-1.3712436248673647,0.0936936936936937,0.45039920159680635,1.0,12/21,31.40%,ACTB;H3-3A;MTA2;MBD3;SMARCA4;GATAD2B;RBBP4;CHD4;RCC1;SMARCC1;SMARCD2;HNRNPC
prerank,store-operated calcium channel activity (GO:0015279),-0.584657906431217,-1.3639989432643949,0.10849909584086799,0.46438109696100754,1.0,5/10,10.83%,TRPC3;STIM2;TRPC6;ORAI1;TRPC4
prerank,protein kinase binding (GO:0019901),-0.28450727153288047,-1.3557683445202058,0.0,0.4803171434907962,1.0,120/479,17.24%,UTRN;SLC12A7;CAV1;ACTB;FRMD5;SLC12A2;EEF1A1;PTPRJ;ESR1;CCND3;PLCG2;RACK1;BMPR2;CAVIN2;CAV2;DCTN2;EEF2;IQGAP1;WNK1;TFRC;PTK2;TJP2;CSPG4;FOXO3;RPS3;DAB2IP;FERMT2;GCH1;MAP3K1;CALM1;RICTOR;CDKN1B;MAPKAPK3;ADCY4;HDAC7;HDAC9;MSN;ADAM10;NEDD9;NBEA;RAC1;KCNQ1;ADIPOR1;PKD1;LYST;LIMS1;PEBP1;CRK;RPS19;ACTA2;EZR;CAVIN3;IKBKB;RARA;PRKAR2B;SHC1;ATF4;CEP192;HSPB1;NR3C1;GATA6;RGCC;TRIB2;LRBA;MAP3K11;TRIM14;WARS1;MAP3K2;INKA2;TRIB1;RELB;RHOB;EMP2;DCTN1;MAPKAP1;TRPV4;PPP1CB;TAOK2;BAG5;TIRAP;VRK1;MTCP1;GRK5;BCL2L1;STK38;RCC2;MAVS;DUSP3;SRCIN1;RPS7;RPS6;YWHAZ;CALM3;FBXW5;ACVR1;HINT1;ACE;TRIM68;CEP68;TRIM5;SPAG9;TOP2A;PRKAG1;SIKE1;AP2A1;NOD2;PTPN6;UFL1;YWHAG;DSP;CCNK;CDKN1A;RAD9A;PRKAR2A;JAK2;HSP90AA1;BAD;NSF;TCF3;RELA
prerank,amino acid transmembrane transporter activity (GO:0015171),0.4114405597535541,1.3539228599732767,0.08281573498964803,0.47427957267814,1.0,13/47,13.10%,SLC7A11;SLC7A2;SLC43A1;SLC6A13;SLC22A4;SLC36A2;SLC38A1;SLC7A9;SLC6A1;SLC1A5;SLC38A3;SLC38A9;SLC38A6
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3946041948265274,-1.347877774827884,0.06794055201698514,0.4959806414568124,1.0,11/48,10.59%,PIEZO2;SLC12A7;SLC12A2;TRPM7;ABCC9;TRPM6;PIEZO1;TMEM165;TRPC6;TRPV4;SLC39A1
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.3845040960276165,-1.3467644228053883,0.06792452830188679,0.4925014835194476,1.0,10/51,7.68%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1;SLC22A8;SLC7A5;SLC5A6;SLC25A3;MFSD2A;CLCN3
prerank,ligand-gated calcium channel activity (GO:0099604),0.49269080185643327,1.3456036259478263,0.12738853503184713,0.48699328390812796,1.0,6/19,13.33%,ITPR1;P2RX4;TRPM5;TRPA1;RASA3;GRIN2A
prerank,mRNA 5'-UTR binding (GO:0048027),-0.4518678605347634,-1.3432624911411977,0.11678832116788321,0.49610113107119097,1.0,10/24,24.36%,RPL41;RPS14;RPL26;RPS13;NCL;RPS7;FMR1;RPL5;SYNCRIP;RSL1D1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5684669530798451,1.341870960899482,0.15348837209302327,0.4894614828213175,1.0,5/10,13.01%,PRDM9;SETMAR;NSD1;NSD3;SETD5
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5456127731280935,-1.339648791084761,0.11487758945386065,0.4991595755856707,1.0,3/12,8.43%,PIEZO2;PIEZO1;TMC6
prerank,guanyl ribonucleotide binding (GO:0032561),-0.3098934118980373,-1.3393741068177187,0.02385685884691849,0.4933509604168287,1.0,59/196,23.74%,RAP1A;EEF1A1;RHOJ;PDE5A;RAP1B;RASL12;TGM2;GBP5;GCH1;TUBA1A;RAB8B;RAB27A;PDE2A;MFHAS1;RAC1;RALB;ADSS2;RAB18;REM1;MIEF1;GBP7;KRAS;ATL3;ARF5;INSR;RIT1;RHOT1;ATL2;RHOB;RAB8A;RHOT2;RAB11B;TUBB4B;TUBD1;RAB4A;RAB7A;ARL4A;ARHGEF5;HRAS;ARL6;DYNC1LI1;RRAGD;AGAP2;ARL2;ADSS1;DNM2;RAPGEF2;ARL8B;RAB32;RND2;RRAGA;TUBE1;TUBA4A;ARL4C;NRAS;NMUR2;NME1;RRAGC;ARL3
prerank,metallopeptidase activity (GO:0008237),0.3393317559927383,1.338076619061913,0.04961832061068702,0.49180376332739073,1.0,22/113,14.15%,ADAMTS6;ADAMTS12;PAPPA;ADAM33;ADAMTS10;TRABD2B;ADAMTS5;MMP16;OMA1;ADAM12;MMP11;ANPEP;ADAM21;CHMP1A;ECE2;EEF1AKMT4-ECE2;ADAMTS9;THOP1;ADAMTSL4;ADAM2;NRDC;METAP1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.5554608706144926,1.3349997835153329,0.15349887133182843,0.4921832474132013,1.0,3/11,8.23%,ITPR1;TRPA1;RASA3
prerank,nucleotide diphosphatase activity (GO:0004551),0.5202543427011262,1.334176865125578,0.16589861751152074,0.4880742538831495,1.0,1/14,0.19%,ENPP1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.5332069040223321,-1.3319316092007907,0.16730038022813687,0.5072931060955014,1.0,7/12,22.90%,PIK3R6;IPMK;PIK3C2A;PIK3R3;PIK3CA;PIK3C2B;PIK3CG
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4047355190623297,1.3265296734817005,0.10208816705336426,0.499661176011157,1.0,15/46,17.60%,B3GALT1;B3GALNT1;MGAT4C;B3GNT7;B3GLCT;MGAT3;PIGP;EXTL1;B3GALT2;B3GALT5;MGAT2;MGAT5B;EXTL2;B3GNT6;B4GAT1
prerank,ion channel inhibitor activity (GO:0008200),-0.4094902059848853,-1.3257612716271958,0.11023622047244094,0.5182798959043937,1.0,8/35,6.19%,NEDD4L;RACK1;WNK1;MCUB;CAMK2D;CALM1;FKBP1A;STX1A
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.45805203031844377,1.324027172537711,0.13140311804008908,0.49971492482286933,1.0,6/24,6.93%,CAMK1D;PHKA1;MAPKAPK5;CAMK4;DAPK1;CAMK2B
prerank,ribosomal small subunit binding (GO:0043024),-0.49079150128381177,-1.3239514013667677,0.13503649635036497,0.5171032934131737,1.0,12/17,40.85%,PTCD3;ERAL1;EIF1;NME1;EIF4B;EIF4H;NPM1;MTIF2;CPEB2;UNG;PIM1;EIF1B
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5379079110362616,1.3210485221706472,0.17592592592592593,0.5002446468853332,1.0,7/12,22.51%,TENT5A;PAPOLB;TENT5B;PAPOLA;TENT4A;MTPAP;TENT2
prerank,GTPase activator activity (GO:0005096),-0.2883659146766061,-1.3202300187264948,0.002150537634408602,0.5215371725684433,1.0,77/313,15.32%,ARHGAP31;DOCK9;RAPGEF5;CYTH3;CHN2;PLCE1;FGD5;RGS3;ARHGEF28;RAP1A;ARHGAP42;RGS5;RASGRP3;DOCK1;SIPA1L1;RIN3;ASAP2;OPHN1;RASGRF2;ARAP3;STARD13;SGSM2;RALGAPA2;STARD8;IQGAP1;TBC1D8;ARHGAP17;RAPGEF1;ARHGAP27;ARHGAP26;ARHGEF15;RGL1;GRTP1;DENND1A;EPS8L2;ARHGAP1;DOCK4;CHN1;ARHGAP25;TBC1D1;FGD6;TBC1D12;DENND1B;SPATA13;BCR;NUCB1;EEF1D;TBC1D22A;DENND3;RGS6;RALGAPB;SIPA1;DENND6A;ITSN1;HERC2;WNT11;ADAP1;GMIP;SIPA1L3;EEF1B2;PREX1;ABR;DENND2C;NF1;ARHGEF5;TBC1D9B;TBCK;PGAM5;LAMTOR2;ARHGEF18;RANBP2;MADD;RGL2;DENND5B;HPS1;RAP1GDS1;RAPGEF3
prerank,growth factor activity (GO:0008083),0.3557862620752258,1.3196286644933541,0.08757637474541752,0.49770804727344053,1.0,13/74,10.27%,PTN;AREG;NRG3;NRG1;GDNF;VEGFB;ARTN;TGFA;IL4;THPO;IGF2;CXCL1;CNTF
prerank,GTPase activity (GO:0003924),-0.30613924797210085,-1.3164377816752535,0.025052192066805846,0.5255708096003116,1.0,58/192,23.55%,DNM3;RAP1A;EEF1A1;RHOJ;RAP1B;RASL12;RAB11A;EEF2;GBP5;GCH1;RAB8B;GNB2;RAB27A;RAC1;RALB;ARHGDIB;RAB18;GBP7;KRAS;ATL3;HBS1L;RIT1;RAB6B;GPN3;RHOT1;ATL2;RHOB;RAB8A;RHOT2;RAB11B;ENTPD7;RAB24;RAB4A;RAB7A;HRAS;GNB1;GNG5;RAB1A;RRAGD;OPA1;EFTUD2;AGAP2;ARL2;DNM1;NKIRAS2;GNG11;DNM2;ARL8B;GNA11;RAB32;RND2;RRAGA;RAB23;NRAS;GNGT2;RAP1GAP;RRAGC;RAB43
prerank,potassium ion antiporter activity (GO:0022821),0.5039917489643247,1.315262955498943,0.15466101694915255,0.5012438259531782,1.0,5/15,9.95%,SLC24A3;SLC24A5;SLC9A7;SLC24A4;SLC24A2
prerank,sialyltransferase activity (GO:0008373),-0.4696876034834546,-1.3137108355602143,0.1323251417769376,0.5267657456171994,1.0,6/20,6.25%,ST3GAL6;ST3GAL4;ST6GALNAC3;ST8SIA4;ST6GAL1;ST8SIA6
prerank,5'-nucleotidase activity (GO:0008253),-0.5171036112978717,-1.3125644243371504,0.16822429906542055,0.5237738808098089,1.0,5/13,15.53%,NT5E;NT5C;NT5DC3;NT5C1A;NT5C3B
prerank,cation:chloride symporter activity (GO:0015377),-0.5600760549307648,-1.311638846472278,0.17570093457943925,0.5201361981918516,1.0,2/10,0.94%,SLC12A7;SLC12A2
prerank,phosphatase binding (GO:0019902),-0.32633940233565684,-1.31127572239335,0.05496828752642706,0.5150745021584737,1.0,36/105,20.62%,MAP3K5;ITGA1;PXN;RACK1;MAPK3;IQGAP1;WNK1;PTK2;SHOC2;CDKN1B;AP3B1;SH3RF2;CEP192;CTSC;JUP;FLT4;CHCHD3;VRK3;PPP1R3F;VCP;FBXL2;ERBB2;PPP1R3C;MET;EGFR;ANAPC7;PIK3R2;BAD;JAK3;CDC27;GTF2F1;TSC2;PPP6R3;CDH5;SNX3;SMAD2
prerank,NAD binding (GO:0051287),0.4368122497980892,1.3078776130661183,0.1279826464208243,0.5125894536058765,1.0,6/26,15.10%,ALDH1A1;CRYL1;SIRT2;HPGD;GRHPR;SIRT6
prerank,peptidase activator activity (GO:0016504),-0.4507378201190634,-1.3075167932102572,0.13610586011342155,0.5194553421891849,1.0,8/22,16.59%,CAV1;MAL;PSENEN;PCOLCE2;VCP;PSMD14;APH1A;VSIR
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.4420565522939102,1.305616502873071,0.14906832298136646,0.5120604545788902,1.0,8/25,11.20%,MICAL3;CYP27B1;CYP27A1;POR;MSMO1;KMO;CYP46A1;MICAL1
prerank,death domain binding (GO:0070513),-0.5442245443270022,-1.305316222509069,0.15837937384898712,0.5194043730720378,1.0,6/11,11.39%,RACK1;DAPL1;CRADD;RIPK1;BAX;BCL2L1
prerank,adenylate cyclase binding (GO:0008179),0.5593026256696986,1.30335064895406,0.16331096196868009,0.5116446923997514,1.0,2/10,1.34%,ADCY2;ADCY5
prerank,kinase binding (GO:0019900),-0.27594288075771184,-1.303045871474139,0.0066815144766146995,0.5194330440243109,1.0,103/434,16.14%,UTRN;SLC12A7;CAV1;ACTB;FRMD5;SLC12A2;EEF1A1;TTC28;PTPRJ;ESR1;CCND3;TAX1BP1;PLCG2;CAV2;DCTN2;EEF2;IQGAP1;WNK1;TFRC;PTK2;CSPG4;FOXO3;RPS3;DAB2IP;FERMT2;MAP3K1;HSP90AB1;CALM1;RICTOR;CDKN1B;HDAC7;MSN;ADAM10;NBEA;RAC1;HTT;ADIPOR1;PKD1;MYOM1;LYST;CHP1;LIMS1;PEBP1;CRK;RPS19;ACTA2;PIK3IP1;STX1A;IKBKB;SHC1;ATF4;PDE8A;CEP192;HSPB1;NR3C1;GATA6;RGCC;PPP2R5A;LRBA;RB1;TRIM14;WARS1;FAS;MAP3K2;INKA2;RELB;RHOB;EMP2;DCTN1;MAPKAP1;TRPV4;PPP1CB;TOLLIP;BAG5;VRK1;MTCP1;BCL2L1;RCC2;MAVS;DUSP3;SRCIN1;RPS7;RPS6;YWHAZ;CALM3;FBXW5;TRIM68;CEP68;TRIM5;PRKAG1;SIKE1;AP2A1;BCAR3;CAB39;NOD2;LAPTM4B;PTPN6;UFL1;MYOM2;EGFR;CCNK;CDKN1A;RAD9A
prerank,lipase activity (GO:0016298),-0.3887936120507941,-1.3026619970626212,0.09560229445506692,0.5149146152140164,1.0,17/43,35.96%,ABHD2;MGLL;PNPLA2;PITPNM3;FAAH;LYPLA1;DAGLB;LCAT;PLA1A;LDAH;LIPH;ABHD6;SMPD2;LIPE;PLB1;DDHD1;ABHD16A
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3918556137598919,-1.3004586125182256,0.12209302325581395,0.5153429404926411,1.0,15/35,22.35%,PTK2B;PEAK1;BMX;PTK2;STYK1;ABL2;CLK1;FRK;SYK;YES1;HCK;SLA;TXK;BTK;CSK
prerank,sodium:proton antiporter activity (GO:0015385),-0.542009435025983,-1.299596372304386,0.15671641791044777,0.5121496138158466,1.0,2/11,1.78%,SLC9A2;SLC9B2
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4967641463381981,-1.2972722951611828,0.1450676982591876,0.5131457515077372,1.0,2/14,1.05%,SLC26A7;SLC26A2
prerank,calcium activated cation channel activity (GO:0005227),-0.47953363508904373,-1.2960104307650044,0.1412639405204461,0.5108824903384719,1.0,2/17,1.38%,ANO6;ANO1
prerank,ion channel activity (GO:0005216),0.35022656752945924,1.2956000122399491,0.09542743538767395,0.5243673989799921,1.0,23/80,15.96%,NALCN;GRIA4;GRID2;CHRNA1;GRIN3A;TRPM1;TRPM3;CHRNB4;GRIK5;GRIK2;UNC80;TRPM5;GRID1;GRIK1;GRIA3;CHRNA4;CALHM6;CHRNA7;GRIN2A;CHRNB1;GRIA1;GABRB1;TRPC1
prerank,glycine binding (GO:0016594),0.5504260507692817,1.2953591907957018,0.19205298013245034,0.519199850512375,1.0,3/11,4.38%,GRIN3A;GLDC;GLRB
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.4215790745491525,-1.2942055122622667,0.16165413533834586,0.5101901460237419,1.0,14/29,27.03%,CDKN1B;PRKAR2B;HSPB1;INKA2;CIB1;YWHAG;CDKN1A;PRKAR2A;CDKN2C;SFN;CIT;PKIG;CDKN2B;RPTOR
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.3294947136773484,-1.2929511540918954,0.08183632734530938,0.508285512308716,1.0,36/100,24.73%,CYTH3;CERT1;PARD3;ARAP3;SNX11;IQGAP1;DENND1A;DAB2IP;FERMT2;ARAP2;HIP1R;DENND1B;ZFYVE26;TECPR1;JPH2;AKT1;HIP1;MAPKAP1;RPH3A;KIF16B;TTPAL;LAPTM4B;PHLDA3;SAP30L;GAB2;PLEKHF1;SNX3;WIPI2;BTK;RUBCNL;VEPH1;RUBCN;PLEKHA4;GOLPH3;ANXA8;GOLPH3L
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.48206574610508773,-1.2928290073808348,0.14563106796116504,0.4983095034420954,1.0,7/16,20.61%,PTPRB;PTPRG;PTPRM;PTPN6;PTPRK;PTPRO;PTPRU
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.48206574610508773,-1.2928290073808348,0.14563106796116504,0.4983095034420954,1.0,7/16,20.61%,PTPRB;PTPRG;PTPRM;PTPN6;PTPRK;PTPRO;PTPRU
prerank,nucleotidase activity (GO:0008252),-0.49246209151039855,-1.2928218561266067,0.1575984990619137,0.4932760741143975,1.0,5/15,15.53%,NT5E;NT5C;NT5DC3;NT5C1A;NT5C3B
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.2739183788316627,-1.2922534849209943,0.006564551422319475,0.48989021956087825,1.0,130/431,23.39%,CDK6;MAP3K5;RAP1A;RPS6KA5;EEF1A1;RHOJ;MAP4K3;RAP1B;RASL12;TGM2;PEAK1;NLK;WNK1;ATP1A1;SMC4;GBP5;GCH1;TUBA1A;HSP90AB1;MAP3K20;RAB27A;PI4K2A;MFHAS1;HSPA8;ATP5F1D;RAC1;RALB;ADSS2;MINK1;REM1;MTREX;ATP5F1A;ACLY;GBP7;PRPS2;PFKP;IDE;SRPK1;KRAS;ATL3;PSMA6;ARF5;INSR;DYRK2;NDUFA13;RIT1;DHX9;HACL1;AKT1;CARS1;CDC42BPB;RHOT1;ATL2;ABCG1;LMTK2;TRIB1;RHOB;RAB8A;KCNJ8;RHOT2;PRPS1;PRPS1L1;RAB11B;HSPA5;STK38;TUBB4B;PPP5C;TUBD1;RAB4A;STK36;RAB7A;SARS2;PNKP;ARL4A;ACVR1;ARHGEF5;ABCA2;RRM1;TBCK;HRAS;TARS1;ARL6;HSPA4;CAD;UHMK1;NUAK2;CARS2;PRKAG1;DYNC1LI1;STK38L;STK26;PGK1;RRAGD;OAS2;UBA2;HSP90AA1;MYO1F;HSPA1A;MLKL;AGAP2;HSPA9;TAP2;ARL2;MAP3K6;N4BP2;BMPR1B;ADSS1;SNRK;DNM2;ARL8B;RAB32;RND2;MTHFS;RRAGA;HSPA1B;BTK;TUBE1;PYGL;AARS2;TUBA4A;ARL4C;PFKL;NRAS;EIF4G1;NMUR2;BCKDK;MKNK2;NME1;SIK1;RRAGC
prerank,MAP-kinase scaffold activity (GO:0005078),0.5447652044409393,1.2916433383850894,0.17371937639198218,0.5228379069157555,1.0,3/11,7.80%,KSR1;SH3RF1;MAPK8IP2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5334979759516041,1.2909175354019007,0.18303571428571427,0.5188217193016869,1.0,2/12,4.15%,PIK3R1;STAP1
prerank,transforming growth factor beta binding (GO:0050431),0.4489175819643027,1.2883503440559405,0.15301724137931033,0.5191877824950126,1.0,5/23,7.55%,LTBP1;TGFBR3;TGFBR3L;LRRC32;TGFBR1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4841018780604964,1.2857580536410014,0.17684210526315788,0.5197571351510396,1.0,8/16,19.09%,SLC13A3;SLC25A10;SLC25A13;SLC1A5;SLC25A30;SLC25A18;SLC38A7;SLC13A5
prerank,protein tyrosine kinase activity (GO:0004713),0.3312385336312827,1.2831143419475273,0.09741550695825049,0.5203355061114653,1.0,31/108,12.66%,EPHA7;DDR2;NTRK3;FGFR2;PDGFRA;KIT;EPHA3;TNK2;EPHA6;DDR1;LYN;AXL;PDGFRB;BAZ1B;EPHB1;ROR1;RYK;ERBB3;FGFR4;EPHA8;ERBB4;EPHA5;TEC;ALK;MUSK;MST1R;MERTK;FGFR1;WEE2;EPHA1;ITK
prerank,UDP-galactosyltransferase activity (GO:0035250),0.5417707499961588,1.281823721872919,0.18287037037037038,0.518008913188111,1.0,6/10,22.24%,B3GALT1;B3GALT2;B3GALT5;B4GALT7;B4GALT6;B3GALT6
prerank,voltage-gated cation channel activity (GO:0022843),0.33624961114027724,1.2804128750211858,0.10040160642570281,0.515780936001313,1.0,24/97,18.45%,CACNA2D3;CACNA1E;GRIN3A;CACNA2D1;CACNA1I;KCND2;CACNG4;CACNB1;CACNB4;CACNB2;KCND1;KCNMA1;GRIN2A;KCNS3;KCNH7;KCNQ4;KCNG2;KCNS1;HVCN1;KCNG4;KCNC2;GRIN2B;KCNH1;KCNH5
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.4973741432368378,-1.2768856815110214,0.1906474820143885,0.5253453489061481,1.0,7/14,32.53%,CAPN2;CAPN15;CAPN5;CAPN10;CAPN6;CAPN3;CAPN11
prerank,anion:anion antiporter activity (GO:0015301),-0.459119318575188,-1.2714809627361807,0.17375231053604437,0.5343822159602364,1.0,2/17,1.05%,SLC26A7;SLC26A2
prerank,cAMP response element binding (GO:0035497),0.5343248704120218,1.2696163914029697,0.20484581497797358,0.5359912569694592,1.0,4/10,17.28%,CREB5;CREB3L1;ATF2;ATF7
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.41171513612020216,-1.2685729177794387,0.15900383141762453,0.5373815475844428,1.0,8/26,10.32%,ABCG2;SLC6A6;SLC16A6;SLC16A9;SLC5A6;SLC16A13;SLC16A4;SLC16A1
prerank,ubiquitin protein ligase activity (GO:0061630),0.29507182923539665,1.2680100676956896,0.060669456066945605,0.5343696670262849,1.0,50/228,16.84%,RNF220;SH3RF3;HECW2;PDZRN3;MYCBP2;PELI2;CBLB;RNF24;TRIM38;RNF145;DTX4;SH3RF1;MDM2;ZNRF3;TRIP12;RNF43;RNF2;RNF138;RNF149;PRKN;HECW1;UBE2O;SMURF2;DTX1;ASB2;RNF181;TRIM27;KCMF1;MGRN1;TOPORS;RNF26;UBR3;SIAH2;PPIL2;RNF217;GID4;RNFT2;RNF122;ARIH2;TRIM63;BIRC2;FBXO44;ASB1;RNF34;MEX3C;UBE3C;NEDD4;LRSAM1;TRIM35;HLTF
prerank,DNA replication origin binding (GO:0003688),0.4410132790379565,1.2678669657197992,0.17647058823529413,0.5293765706994396,1.0,10/23,22.61%,MCM3;ORC4;MCM2;MCM9;MCM8;ORC1;ORC3;ORC5;MCMDC2;MCM7
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4488801152484069,1.2676098450146553,0.15217391304347827,0.5248154553111947,1.0,5/22,14.95%,RBMS3;CPEB3;KHSRP;CPEB1;RBM24
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5251831346159724,-1.2674759234928283,0.19019607843137254,0.5351220635651773,1.0,6/12,21.61%,ENTPD1;ENTPD7;ENTPD6;ENTPD2;CANT1;NUDT18
prerank,protein homodimerization activity (GO:0042803),-0.25938080057115537,-1.2668711382377833,0.0022988505747126436,0.5315369261477046,1.0,143/589,18.30%,ABCG2;PECAM1;MAP3K5;NADK2;B2M;SYNE1;ANO1;DPP4;ZHX3;RASIP1;RACK1;NOD1;ACTN4;F11R;CAV2;TPD52;TFRC;TBX1;PAXX;MID2;FZD4;STK10;TPD52L1;MGLL;GBP5;SLIT2;DAB2IP;IRAK2;GCH1;CAMK2D;HSP90AB1;FAP;CUBN;TGFB2;PDE2A;ADAM10;ST6GAL1;ZBTB16;SARS1;MID1;MYOM1;EEA1;LRRFIP1;BHLHE40;HIP1R;S100B;VEGFA;USF2;NRBP1;PSAP;SNRPC;IKBKB;PRPS2;ACTN1;CEP57;HSPB1;TOX3;IDE;TBC1D22A;JUP;RIPK1;FLT4;STARD3NL;FBXO4;STK25;PDGFC;AKT1;MAP3K11;ADD1;PDGFA;BAX;GSTA4;PRMT8;TRIM14;WARS1;HHEX;FOXP2;ABCG1;TRPC6;S100A10;HIP1;ATG7;SFPQ;S100A6;PON3;CARNMT1;PRPS1;PRPS1L1;BCL2L1;S100A13;GSTM2;BAK1;HES1;GRHL1;CSF1R;ACVR1;TMEM266;QTRT2;NAA60;HSPB8;S100A1;TRIM68;MLX;PHB2;S100A16;FMR1;RAB11FIP3;APOE;BNIP3L;CASQ2;LDB1;TSG101;TRIM5;MFSD1;SRF;GSTM1;INHBB;TOP2A;NPR3;SMAD4;ALDH1A3;SOX6;GOLGA5;STK26;SNF8;ATP5IF1;JAML;IMPA2;GALM;HSP90AA1;GREM1;SP1;MAP3K9;TCF3;QTRT1;RELA;RABEP1;NR6A1;CRYAB;CHUK;STAT1;ECT2;TSC2
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2945853498774709,1.2667946182299787,0.06694560669456066,0.5215008229478914,1.0,52/232,16.84%,RNF220;SH3RF3;HECW2;PDZRN3;MYCBP2;PELI2;CBLB;RNF24;TRIM38;RNF145;DTX4;SH3RF1;MDM2;ZNRF3;TRIP12;RNF43;RNF2;RNF138;RNF149;PRKN;HECW1;UBE2O;SMURF2;DTX1;ASB2;RNF181;TRIM27;KCMF1;MGRN1;TOPORS;RNF26;UBR3;SIAH2;PPIL2;RNF217;GID4;RNFT2;RNF122;ARIH2;TRIM63;BIRC2;PIAS1;FBXO44;ASB1;RNF34;PIAS2;MEX3C;UBE3C;NEDD4;LRSAM1;TRIM35;HLTF
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.5127321745538943,-1.2654759035730803,0.18773234200743494,0.530316725040485,1.0,2/12,1.78%,SLC9A2;SLC9B2
prerank,cytokine activity (GO:0005125),0.3211475824958048,1.2645276372570218,0.07905138339920949,0.5216324640413285,1.0,16/131,10.27%,BMP6;WNT4;IL34;BMP2;BMP5;NRG1;IL4;FAM3D;CXCL16;PPBP;SCG2;IL18;AIMP1;CCL25;CXCL1;CNTF
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.4473241938668402,1.2631805651751835,0.1945031712473573,0.5196712296138541,1.0,7/21,11.12%,PDE1A;PDE7B;PDE1C;PDE3A;PDE3B;PDE11A;PDE4B
prerank,phosphotyrosine residue binding (GO:0001784),-0.38308707199406594,-1.262040772784344,0.16666666666666666,0.5338575186076445,1.0,16/37,19.21%,PLCG2;SHE;SHB;CRK;SHC1;PFN1;ABL2;SHF;PIK3R3;SYK;BCAR3;PTPN6;PIK3R2;YES1;HCK;RASA1
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.4162080494389714,-1.2612166828741034,0.16356877323420074,0.5309750868633104,1.0,6/27,7.05%,ITPR2;SLC12A2;SLC9B2;TMEM165;ATP2A3;SLC4A8
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.4902687091913612,1.260715453867698,0.19599109131403117,0.5200918425742245,1.0,14/14,51.02%,DHRS3;RDH11;AKR1A1;ADH1A;RDH12;SDR16C5;RDH5;ADH7;ADH4;SDR9C7;HSD17B6;RDH16;RDH10;DHRS9
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5428435423644374,-1.2593145425833867,0.17922606924643583,0.5308923437528612,1.0,5/10,23.84%,ANKRD13A;IDE;USP15;LAPTM5;FAN1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.4952995098850931,1.2586720793072892,0.19239373601789708,0.5198863948845617,1.0,5/14,7.52%,TIMP3;RECK;SPOCK3;COL4A3;TIMP4
prerank,NAD+ binding (GO:0070403),0.5059254409920062,1.2576093021328445,0.1925601750547046,0.5172070133712567,1.0,7/12,24.28%,CRYL1;SIRT2;HPGD;SIRT6;SIRT3;ZC3HAV1;SIRT1
prerank,deoxyribonuclease activity (GO:0004536),-0.492363324604019,-1.2555491758188753,0.16939890710382513,0.5360188713482127,1.0,6/14,28.09%,RPS3;ERCC4;DNASE1L2;NME1;DFFB;MRE11
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5122703741306467,1.254094697780057,0.25054466230936817,0.520369507650059,1.0,5/11,21.08%,AKR1B1;AKR1B10;RDH13;RDH11;AKR1A1
prerank,death receptor binding (GO:0005123),-0.4773348244492097,-1.2478589385534138,0.19525547445255476,0.5510240779701857,1.0,4/15,14.55%,DAB2IP;NGF;RIPK1;MADD
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.4798617975828556,1.2471659357833735,0.2288888888888889,0.5308727910232176,1.0,4/15,8.73%,CCR6;ACKR2;ACKR4;CCR9
prerank,protein phosphatase 2A binding (GO:0051721),-0.42531885142257286,-1.2465815079393936,0.177007299270073,0.5493922868548616,1.0,11/23,21.64%,CTTNBP2NL;FOXO1;DAB2IP;MFHAS1;STRN4;STRN3;STRN;IGBP1;BOD1;SMG7;ARPP19
prerank,epidermal growth factor receptor binding (GO:0005154),0.4278598644994083,1.245980429478083,0.18526315789473685,0.5285460713263282,1.0,5/25,12.84%,AREG;TNK2;TGFA;ERBB4;BTC
prerank,calcium ion binding (GO:0005509),0.2769138371012546,1.245243274699524,0.044859813084112146,0.5253928963301435,1.0,50/323,11.95%,ENPP1;ADGRV1;FBN1;CLEC3B;PAM;PLSCR2;FBLN1;SLC8A1;SCUBE1;LRP1;KCNIP4;PLA2G5;NRXN1;CDH8;ITPR1;ANXA10;PLA2G4A;DCHS1;CDH18;TNNC1;ATP2A2;AMY1C;AMY1B;AMY1A;MAN1C1;ASTN2;CDH11;ASPH;CDH19;CDH20;CDH7;SYT1;LOXL2;MICU3;SLC25A13;OTOF;SCIN;S100A7A;CDK5R1;C2CD5;MCTP2;CDH10;MEX3B;NAALADL1;EML1;CDHR3;SYT13;BAIAP3;HSP90B1;GCA
prerank,retinoic acid binding (GO:0001972),0.5112108312089934,1.2444768539736615,0.22717149220489977,0.5224995237157032,1.0,1/12,1.09%,NR2F2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.48971303956337653,-1.2388292664031733,0.21042830540037244,0.5651263843993429,1.0,2/13,1.78%,SLC9A2;SLC9B2
prerank,transcription coactivator binding (GO:0001223),0.4452990314712954,1.2376480062989779,0.23110151187904968,0.5329496635677562,1.0,3/20,2.72%,RORA;AR;SMAD3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.4537571844580164,-1.2365061136451512,0.2122905027932961,0.5664110375739748,1.0,5/17,16.30%,LBR;DECR1;DHCR24;TM7SF2;MECR
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.5392730623704525,-1.2364534789289938,0.19622641509433963,0.5616332552286731,1.0,4/10,19.41%,SHANK3;SHISA7;NSF;SHANK1
prerank,estrogen receptor binding (GO:0030331),-0.39700922190253946,-1.236347118782246,0.16984732824427481,0.5571099180948448,1.0,14/32,27.84%,LEF1;ESR1;PPARGC1B;TACC1;NRIP1;WBP2;PHB2;LCOR;STRN;SRARP;DCAF1;PPID;TAF10;CTNNB1
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.3212838762532081,-1.2359236207614623,0.1218568665377176,0.5535424876742241,1.0,19/78,13.29%,CAPN2;CTSZ;USP1;USP46;CTSO;CASP7;USP7;CTSC;CASP8;USP8;CAPN15;CTSF;UCHL1;USP5;CAPN5;USP9X;CTSB;USP15;CAPN10
prerank,protein kinase regulator activity (GO:0019887),-0.31372285426879565,-1.234824232539989,0.11,0.5518031733143882,1.0,32/95,28.12%,RPLP1;CCND3;CCNY;WNK1;CDKN1B;TAOK3;PRKAR2B;RGCC;DUS2;CSNK2B;CCNG2;TRIB1;WNT11;KIDINS220;MADD;PRKAG1;CAB39;CCNF;CCNK;CDKN1A;PRKAR2A;AGAP2;CCND1;TPX2;NCK1;YWHAB;CDKN1C;SPDYA;RPTOR;NPM1;SPRY4;PPP1R1B
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.41582258319144216,1.2308822903277745,0.20507399577167018,0.5434446532740888,1.0,13/25,24.28%,PARP16;SIRT2;PARP11;PARP3;TIPARP;SIRT6;PARP4;PARP1;PARP8;SIRT3;ZC3HAV1;TNKS;SIRT1
prerank,GDP binding (GO:0019003),-0.3374204914815539,-1.229250192457861,0.14666666666666667,0.5622368707962226,1.0,17/63,15.88%,RAP1A;RAP1B;RASL12;RAB8B;RAB27A;RALB;RAB18;MIEF1;KRAS;RIT1;RAB8A;RAB11B;RAB4A;RAB7A;HRAS;DYNC1LI1;RRAGD
prerank,sulfotransferase activity (GO:0008146),0.4013732222245805,1.2265292353170536,0.20359281437125748,0.5484451411811258,1.0,8/33,10.62%,CHST8;GAL3ST3;GAL3ST2;UST;TPST1;SULT6B1;HS2ST1;CHST1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.32654309415147464,-1.2261987615837777,0.12962962962962962,0.5653359946773121,1.0,19/74,19.00%,NADK2;DGKH;HK1;RFK;FAM20A;PKM;IPMK;HYKK;NMRK1;CHKA;PIK3C2A;SPHK2;PIK3CA;DGKZ;PIK3C2B;TRPT1;POMK;FAM20B;NADK
prerank,nuclear receptor binding (GO:0016922),-0.30200798944452084,-1.224054234657045,0.10472279260780287,0.5660414707774534,1.0,32/111,19.85%,LEF1;FOXP1;ESR1;DDX5;ACTN4;JMJD1C;NCOR1;ZBTB7A;TACC2;PPARGC1B;NR4A2;BCAS3;PPARGC1A;TACC1;KDM3A;NRIP1;JUP;MED24;ARID1A;WBP2;TRIM68;PHB2;LCOR;SMARCA4;GAS2L1;STRN;YWHAH;KDM1A;STAT1;MED14;TRIP6;SRARP
prerank,metallocarboxypeptidase activity (GO:0004181),0.41423098946117626,1.2220859563336643,0.19383259911894274,0.5539940405236845,1.0,6/26,5.83%,AGBL4;CPZ;AEBP1;CPA6;PEPD;CPXM1
prerank,beta-tubulin binding (GO:0048487),0.39804494558741266,1.2203001094327957,0.17817371937639198,0.5535713988869014,1.0,7/31,9.52%,GJB6;EML4;UXT;DLEC1;PACRG;IFT74;CDK5R1
prerank,acetylation-dependent protein binding (GO:0140033),-0.4304588212424594,-1.2192459450249362,0.21212121212121213,0.5697629131979942,1.0,6/20,9.29%,MLLT3;BRD3;BRD9;DPF2;BRD4;ZMYND8
prerank,lysine-acetylated histone binding (GO:0070577),-0.4304588212424594,-1.2192459450249362,0.21212121212121213,0.5697629131979942,1.0,6/20,9.29%,MLLT3;BRD3;BRD9;DPF2;BRD4;ZMYND8
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.4245890891405458,1.2191218240586845,0.232409381663113,0.5517662120752577,1.0,7/23,11.12%,PDE1A;PDE7B;PDE1C;PDE3A;PDE3B;PDE11A;PDE4B
prerank,frizzled binding (GO:0005109),0.3840831920362686,1.217043657856036,0.19760479041916168,0.55186194340918,1.0,6/34,9.45%,WNT4;SFRP1;ZNRF3;RNF43;RYK;DVL3
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.3612478413044016,-1.2153174366630861,0.20040080160320642,0.5758483033932136,1.0,17/42,19.23%,PLCG2;SHE;SHB;CRK;SHC1;PFN1;ABL2;SHF;PIK3R3;SYK;BCAR3;PTPN6;PIK3R2;YES1;HCK;RASA1;PIN1
prerank,endopeptidase inhibitor activity (GO:0004866),0.3249895587447597,1.213704793630836,0.14315352697095435,0.5547722794387039,1.0,12/82,8.51%,TIMP3;SERPINE2;AHSG;SERPINI2;RECK;SERPINF1;SPOCK3;SERPINE1;UBE2O;COL4A3;TIMP4;PSMF1
prerank,protein serine/threonine kinase activity (GO:0004674),-0.2601715359419267,-1.2106346361787799,0.05011389521640091,0.5842554890219561,1.0,81/334,17.16%,PRKCH;CDK6;MAP3K5;RPS6KA5;TGFBR2;MAP4K3;PTK2B;BMPR2;LIMK2;HIPK1;NLK;MAPK3;WNK1;STK10;NEK7;RPS6KA3;IRAK2;CAMK2D;MAP3K1;MAP3K20;MAPKAPK3;FAM20A;TRIO;PRKCZ;CSNK1G2;MINK1;PRKD3;NRBP1;TAOK3;IKBKB;CSNK1G3;BRD4;BCR;PRKDC;MAP3K8;SRPK1;RIPK1;DYRK2;PLK2;AKT1;MAP3K11;CDC42BPB;STK32B;MAP3K2;PIM3;CSNK2B;LMTK2;VRK3;TAOK2;CAMK1;CDK4;RPS6KB2;VRK1;ULK3;GRK5;STK38;PRKCE;PKN3;HTATIP2;CLK1;SYK;STK36;ACVR1;RPS6KA2;FASTK;CDKL4;CDK10;UHMK1;NUAK2;LIMK1;STK35;STK38L;NEK3;NUAK1;EGFR;CCNK;MAST4;CSNK2A1;CSNK2A2;CDK13;MAP3K9
prerank,voltage-gated chloride channel activity (GO:0005247),-0.5179862415700471,-1.207882261768447,0.2536231884057971,0.5871114913031081,1.0,3/10,7.68%,ANO6;ANO1;CLCN3
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.46858775704810063,-1.20775507114778,0.2281021897810219,0.5827243151492292,1.0,8/14,23.74%,ACO1;ISCA2;ETFDH;RSAD2;CIAO3;NFU1;SDHB;ACO2
prerank,GTPase binding (GO:0051020),-0.2801661637507418,-1.2074730858644955,0.08695652173913043,0.5789358782435129,1.0,50/194,19.21%,PLCE1;FGD5;CAV1;EXOC4;SPTBN1;FNBP1L;EPS8;RASIP1;UNC13B;RIN3;SH3BP4;AP3M1;SGSM2;IQGAP1;CYRIB;GNB2;IFT20;RNF41;ARHGAP1;DOCK4;ARHGDIB;FGD6;YBX3;TRIP11;RAB8A;MAPKAP1;TNFAIP1;CIB1;RCC2;RTKN;MLPH;SPHK2;GNB1;RAB11FIP3;RANBP2;TNPO3;SIKE1;GOLGA5;STRN3;NCKAP1;RRAGD;GCC2;HSP90AA1;TSC2;AMBRA1;ARHGEF2;EHD1;LSM2;RANGAP1;RASA1
prerank,death receptor activity (GO:0005035),-0.49602220077427495,-1.2067390700742795,0.23669724770642203,0.5763279642265856,1.0,5/11,13.88%,TNFRSF1B;TNFRSF11A;FAS;TNFRSF1A;EDA2R
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.35579014520229213,1.2018246944979363,0.1868583162217659,0.577761680488652,1.0,18/55,16.34%,SLC13A3;SLC6A12;SLC16A12;SLC7A2;SLC6A13;SLC22A4;SLC16A14;SLC36A2;SLC38A1;SLC25A10;SLC6A11;SLC38A3;SLC46A1;SLC38A9;SLC38A6;SLC7A3;SLC3A1;SLC16A7
prerank,four-way junction DNA binding (GO:0000400),0.4473329978482827,1.2005010331045998,0.2516703786191537,0.5760629766335913,1.0,6/17,12.33%,GEN1;MEN1;RAD51B;BLM;RAD51C;FANCM
prerank,deubiquitinase activity (GO:0101005),-0.31216790772933123,-1.1995324588361105,0.13333333333333333,0.5907185628742514,1.0,24/88,19.28%,USP53;MINDY2;MINDY1;EIF3F;USP1;USP46;BRCC3;USP7;USP8;OTUD5;USP3;OTUB1;UCHL1;USP5;USP9X;COPS5;PSMD14;USP15;PAN2;UCHL3;TNFAIP3;USP22;USP49;USP4
prerank,ATPase activator activity (GO:0001671),-0.42524976180178514,-1.1989521081412164,0.22181146025878004,0.587725312733312,1.0,7/20,23.63%,DNAJA2;ATP1B1;DNAJA1;TOR1AIP1;TOR1AIP2;ATP1B2;DNAJB1
prerank,Tat protein binding (GO:0030957),-0.5082079008678264,-1.1983225683338112,0.25321100917431194,0.5849891126837234,1.0,6/10,30.42%,ACTB;DNAJA1;SMARCA4;GABARAPL1;NPM1;DLL1
prerank,C-C chemokine receptor activity (GO:0016493),0.4259534602967548,1.1980137822390051,0.22321428571428573,0.5773175399271062,1.0,6/21,13.05%,CCR6;ACKR2;ACKR4;CCR10;CCR9;CXCR4
prerank,protein kinase activator activity (GO:0030295),-0.3326162291993969,-1.1949020690949428,0.17391304347826086,0.5894676811789954,1.0,16/60,17.51%,AFAP1L2;RPLP1;IQGAP1;WNK1;CALM1;RICTOR;FAM20A;RGCC;WNT11;MTCP1;CALM3;ABI1;MADD;CAB39;CDKN1A;AGAP2
prerank,ADP binding (GO:0043531),-0.4087419535787679,-1.1939531111810833,0.22324723247232472,0.5875785741948938,1.0,10/25,18.94%,ME1;ATP5F1D;MIEF1;ATP5F1A;ABCG1;PPP5C;COQ8A;PRKAG1;PGK1;GCLC
prerank,NADP binding (GO:0050661),-0.3796034618410189,-1.1912422402366845,0.2144212523719165,0.5904856952761144,1.0,8/32,16.75%,NOS3;ME1;LBR;DUS2;NNT;DECR1;TM7SF2;SPR
prerank,tau protein binding (GO:0048156),-0.3488714310276864,-1.1908999676019374,0.18267419962335216,0.5871418926852178,1.0,13/40,25.31%,ACTB;HSP90AB1;S100B;DCTN1;TAOK2;PPP5C;APOE;HSP90AA1;PIN1;MAP1A;SMAD2;BRSK2;MARK3
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.26657449427255564,-1.1903318499962978,0.08917197452229299,0.5843714031790433,1.0,71/248,23.55%,DNM3;RAP1A;EEF1A1;MYL6;RHOJ;RAP1B;RASL12;RAB11A;KLC1;EEF2;GBP5;GCH1;RAB8B;GNB2;RAB27A;RAC1;RALB;ARHGDIB;RAB18;GBP7;KRAS;ATL3;HBS1L;RIT1;RAB6B;GPN3;DHX9;CHD1L;RHOT1;ATL2;RHOB;RAB8A;VCP;RHOT2;RAB11B;KIF26A;ENTPD7;RAB24;RAB4A;RAB7A;HRAS;GNB1;GNG5;RAB1A;RRAGD;OPA1;EFTUD2;HSP90AA1;HSPA1A;AGAP2;ATP2B1;ARL2;DNM1;NKIRAS2;PIN1;GNG11;DNM2;ARL8B;GNA11;RAB32;KIF18B;RND2;RRAGA;RAB23;HSPA1B;KIF1C;NRAS;GNGT2;RAP1GAP;RRAGC;RAB43
prerank,histone deacetylase binding (GO:0042826),-0.30671538409208804,-1.1899295969948402,0.15019762845849802,0.5812216147415314,1.0,33/88,26.31%,LEF1;MEF2C;MEF2A;NCOR1;HSP90AB1;HDAC9;HDAC4;TAL1;SFPQ;MTA1;MTA2;HES1;SATB2;MIER2;LCOR;TOP2A;RAD9A;HSP90AA1;HSPA1A;MIER1;SP1;RBBP4;RELA;CHD4;CCND1;HSPA1B;PHF6;NIPBL;YWHAB;TRAF6;ANKRA2;CAMTA2;YWHAE
prerank,protein kinase C binding (GO:0005080),-0.3512378146389486,-1.1879418404328677,0.1941747572815534,0.5818865865391519,1.0,14/43,15.96%,RACK1;CAVIN2;ADCY4;HDAC7;HDAC9;CAVIN3;HSPB1;TRPV4;TIRAP;GRK5;HINT1;TOP2A;YWHAG;DSP
prerank,receptor tyrosine kinase binding (GO:0030971),0.3451304156114152,1.1876230988508893,0.200836820083682,0.5974901922322479,1.0,7/56,4.15%,PIK3R1;ANGPT2;NRG3;NRG1;CBLB;LRP4;STAP1
prerank,translation initiation factor activity (GO:0003743),-0.3635087628566129,-1.184550016862745,0.21165048543689322,0.5866124893071001,1.0,14/36,24.63%,EIF3F;EIF4G3;EIF5B;EIF3D;EIF3I;COPS5;EIF4A1;EIF3K;EIF2B3;EIF5;EIF4A2;EIF1;EIF4G1;EIF4E
prerank,Hsp90 protein binding (GO:0051879),-0.37423252261592754,-1.1840933592460023,0.22043010752688172,0.5835350575444855,1.0,14/33,27.62%,SLC12A2;KDR;RPS3;NR3C1;UNC45B;PPP5C;NOD2;CSNK2A1;PTGES3L;TSC2;STIP1;PPEF2;ERN1;PPID
prerank,copper ion binding (GO:0005507),0.36716872584335536,1.1835860657467343,0.2052313883299799,0.6023489457817257,1.0,8/42,11.17%,PAM;HEPH;P2RX4;MOXD1;LOXL2;LOXL3;ANG;SOD3
prerank,potassium ion leak channel activity (GO:0022841),0.45090585698578384,1.1761450652939978,0.25732217573221755,0.6160407827448158,1.0,1/15,0.16%,KCNK2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.45993913334654773,1.174572992286821,0.2717842323651452,0.6151429300169797,1.0,3/14,12.43%,ALDH4A1;ALDH1L1;MTHFD1
prerank,C-C chemokine binding (GO:0019957),0.41244102234399854,1.1740843228222984,0.2511013215859031,0.6115009191931172,1.0,6/22,13.05%,CCR6;ACKR2;ACKR4;CCR10;CCR9;CXCR4
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.4372921549780384,-1.17403654521529,0.2447418738049713,0.601000795611574,1.0,4/16,13.19%,ANO6;ANO1;TTYH2;ANO2
prerank,intracellular chloride channel activity (GO:0061778),-0.4372921549780384,-1.17403654521529,0.2447418738049713,0.601000795611574,1.0,4/16,13.19%,ANO6;ANO1;TTYH2;ANO2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.39526819047999984,1.1731647110289045,0.2645161290322581,0.6090328126414583,1.0,10/26,18.77%,B3GALT1;B3GALNT1;B3GNT7;CHSY3;B3GALT2;B3GALT5;CHSY1;EXTL2;B3GNT6;CHPF2
prerank,G protein-coupled receptor binding (GO:0001664),0.2931179847928486,1.1715950505688977,0.16885553470919323,0.6079565469095799,1.0,24/132,15.24%,WNT4;GRK3;GPHB5;GNAI1;SFRP1;ZNRF3;RNF43;ADM;PRKN;TAFA5;PACRG;TULP3;RYK;DVL3;CCL25;BICD1;GNA15;UTS2B;GPRC5B;PNOC;GPRASP2;WNT6;CXCL12;WNT5B
prerank,hormone activity (GO:0005179),0.34050716504179807,1.17092001184586,0.2094017094017094,0.6050363862611006,1.0,2/54,1.34%,IGF1;GPHB5
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.3123262268136231,-1.1669114049797686,0.20079522862823063,0.6148051119982259,1.0,21/71,23.05%,PTPRB;PTPRG;PTPN14;PTPRJ;CDC14A;PALD1;PTPRM;PTP4A2;DUSP3;CDC14B;PTPN12;PTPN6;DUSP23;DUSP11;UBASH3B;PTPRK;PTPRO;PTPRU;TIMM50;PTPN22;DUSP4
prerank,glutamate receptor binding (GO:0035254),-0.4239472011901258,-1.1614868341770956,0.2849162011173184,0.6244407736251635,1.0,6/17,19.41%,SHANK3;HIP1;HOMER1;SHISA7;NSF;SHANK1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.4861352806045679,1.160823186611226,0.2793791574279379,0.6242393679741723,1.0,6/10,26.34%,KDM7A;KDM2A;PHF8;KDM4C;KDM2B;KDM4B
prerank,NF-kappaB binding (GO:0051059),-0.39487460213933356,-1.1593099745710165,0.2596685082872928,0.6257895168566975,1.0,12/24,31.46%,NFKBIA;PSMA6;ANXA4;COMMD7;RELA;CDK5RAP3;HIF1AN;BCL10;RNF25;NPM1;COMMD6;HDAC3
prerank,neuropeptide receptor binding (GO:0071855),-0.45011207695261674,-1.1587273914829554,0.2777777777777778,0.6231414721577253,1.0,8/14,45.15%,AGRP;NTS;SHANK1;APLN;NPY;NMU;UCN2;GAL
prerank,myosin II binding (GO:0045159),-0.5030849190591942,-1.1538842549363444,0.3102803738317757,0.6317702432971893,1.0,1/10,0.39%,SHROOM4
prerank,anion channel activity (GO:0005253),-0.3144244592577866,-1.15320565408813,0.20576923076923076,0.629546276574368,1.0,7/61,3.02%,ANO6;SLC26A7;CLIC4;ANO1;LRRC8C;LRRC8D;CLIC1
prerank,U6 snRNA binding (GO:0017070),-0.4458679303997301,-1.152102557449935,0.28810408921933084,0.6284031936127745,1.0,6/14,22.00%,PRPF8;RBM22;DDX39B;LSM2;LSM3;LSM7
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2543652902768341,1.1512884757781074,0.11977186311787072,0.6418692919157645,1.0,62/346,14.65%,RNF220;SH3RF3;HECW2;PDZRN3;MYCBP2;BCOR;PELI2;CBLB;RNF24;TRIM38;RNF145;DTX4;FBXO24;SH3RF1;MDM2;DDB2;ZNRF3;DZIP3;RNF214;TRIP12;RNF43;RNF2;TTC3;RNF138;RNF149;PRKN;HECW1;UBE2O;SMURF2;DTX1;KLHL42;ASB2;FBXO25;RNF181;TRIM27;UBE2E3;CDC23;KCMF1;CUL2;MGRN1;TOPORS;AKTIP;RNF26;UBR3;MIB1;SIAH2;FBXO7;PPIL2;RNF217;GID4;BTRC;RNFT2;RNF146;RNF122;ARIH2;TRIM63;BIRC2;TRAF2;FBXO44;ASB1;UBE2E2;RNF34
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.23678443898894302,1.1506494737750865,0.05631399317406143,0.6385401001482063,1.0,109/831,10.33%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;SALL1;AR;TBX3;GLIS3;MXI1;NR2F2;EPAS1;HLF;NFIA;ZEB1;HIVEP2;TRPS1;RARB;VDR;PRRX1;RBAK;GLI2;TEAD1;ZIC1;TBX18;MITF;PPARA;HOXC4;PRDM5;NFAT5;DLX3;NKX6-1;IKZF4;SMAD3;HOXB3;TFEC;CREB5;STAT5B;ZEB2;ZKSCAN2;HOXC5;GLI3;RUNX3;TBX21;TFCP2;KLF15;SP7;PBX4;TFDP1;SOX21;AEBP1;PKNOX2;ZNF35;HDX;HOXC8;FOSB;PHOX2A;HOXB8;CEBPB;EBF1;ZNF112;TOP1;HES3;ZKSCAN7;HNF4G;BBX;HOXC9;ATF5;ZNF394;NFIX;FOXA2;ZNF296;DMRTA2;SP5;LHX4;DMTF1;CUX1;NFXL1;ZNF697;SOX2;RFX7;SIX4;RARG;RBPJ;ZSCAN21;NSD1;BCL11A;SNAPC3;GLIS1;SOX5;MLXIP;CREB3L4;CREB3;FOXD3;HES5;CTCF;ZBTB45;ATOH8;KCNIP3;GATA3;ZIC4;ZSCAN12;HOXC10;HOXB9;CUX2;SKOR2;HOXC6;PAX1
prerank,ferrous iron binding (GO:0008198),-0.3932034059188005,-1.1496323107782118,0.26515151515151514,0.6305534626112014,1.0,7/21,13.48%,EGLN3;CDO1;FTL;EGLN2;EGLN1;FTH1;FXN
prerank,phospholipase A2 activity (GO:0004623),0.3878001573225271,1.149098928430972,0.26576576576576577,0.6374338246111508,1.0,2/26,2.52%,PLA2G5;PLA2G4A
prerank,kinase activity (GO:0016301),-0.29068992966498275,-1.148478162046942,0.20970873786407768,0.6296420317260216,1.0,30/109,22.90%,ITPKB;NADK2;DGKH;RFK;TRRAP;PRKD3;IPMK;HYKK;CKB;AKT1;SCYL3;NMRK1;CHKA;PIK3C2A;SPHK2;CERKL;IP6K1;PIK3CA;COQ8A;PGK1;CSNK2A1;SEPHS2;DGKZ;PIK3C2B;POMK;NADK;TRIB3;CKMT1A;BCKDK;PIK3CG
prerank,androgen receptor binding (GO:0050681),-0.38624514357160145,-1.1484436488746332,0.27450980392156865,0.625650659465383,1.0,7/25,17.76%,FOXP1;DDX5;ZBTB7A;KDM3A;TRIM68;SMARCA4;KDM1A
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.44525021136221665,-1.1468998690397612,0.27153558052434457,0.625664255903777,1.0,5/14,10.42%,RACK1;NOD1;ATP2A3;MAL;RPS27L
prerank,RNA cap binding (GO:0000339),-0.42783474518581416,-1.145479792848841,0.3063063063063063,0.6255424634601765,1.0,10/16,39.64%,DCPS;EIF3D;EIF4A1;LSM1;NCBP2;EIF4E;CYFIP2;SNUPN;CYFIP1;NCBP1
prerank,voltage-gated potassium channel activity (GO:0005249),0.305406000798472,1.1413264996964847,0.21810699588477367,0.6514210614295574,1.0,21/80,18.45%,KCNK2;KCNT2;KCND2;KCNJ16;KCNJ3;KCND1;KCNJ5;KCNMA1;KCNJ14;KCNS3;KCNH7;KCNQ4;KCNJ6;KCNG2;KCNS1;KCNJ9;KCNN1;KCNG4;KCNC2;KCNH1;KCNH5
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.4165155726746878,-1.1404966809413752,0.3078393881453155,0.635395874916833,1.0,10/18,13.25%,TGFBR2;FERMT2;SMAD7;TGFB1;FKBP1A;TGFB2;SMAD6;TGFB3;ENG;USP15
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.2524781066494627,-1.1399638382674693,0.13846153846153847,0.6327345309381237,1.0,56/254,17.24%,MECOM;LEF1;ELK3;ERG;MEF2C;RREB1;ESR1;MEF2A;KLF4;FOXO1;ELF1;FOXO3;SOX17;ETS1;KLF7;SIX1;PRDM16;NR4A2;ZBTB16;REL;TFCP2L1;PRDM2;PRDM4;ATF4;NR3C1;PLAGL1;NR2C2;YY1;NFATC1;HHEX;SOX18;FOXF2;PRDM15;ZIC3;MYBL1;FOXC2;GABPA;SOX12;E2F3;SOX4;PLAGL2;GRHL1;SATB2;FOXD2;SRF;ETV4;SMAD4;ETV5;NR1H2;RFX5;ZNF76;ZNF319;SP1;KLF6;TCF3;RELA
prerank,Notch binding (GO:0005112),0.4010718001933176,1.1388637385217848,0.29764453961456105,0.6525905432863697,1.0,4/22,6.56%,SNED1;MEGF10;AAK1;DTX1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.36314308000667744,-1.1366396425364589,0.252465483234714,0.6372318653831577,1.0,12/33,18.49%,RNF144B;RPS3;DCUN1D5;RNF125;DCUN1D1;RNF185;TOLLIP;RNF5;UBA2;FOXL2;RNF19A;ZMYM2
prerank,pyridoxal phosphate binding (GO:0030170),0.4136061562285456,1.1346718098034863,0.30701754385964913,0.6584010498545063,1.0,5/20,12.11%,ABAT;GLDC;PLPBP;PDXK;PYGM
prerank,peptide hormone receptor binding (GO:0051428),0.4658177410724179,1.131633313700936,0.3225058004640371,0.6612865076640699,1.0,1/11,1.34%,GPHB5
prerank,RNA stem-loop binding (GO:0035613),0.457745975890984,1.1305425987514761,0.31359649122807015,0.659439741700959,1.0,5/12,13.32%,LARP6;CSDE1;CPEB3;METTL16;MYH10
prerank,phospholipase C activity (GO:0004629),-0.383589730701947,-1.1300397547229593,0.2822429906542056,0.6507676470957456,1.0,4/25,3.46%,PLCE1;EDNRA;PLCG2;PLCB3
prerank,endopeptidase activator activity (GO:0061133),-0.47341283859795913,-1.1288058285744436,0.3327272727272727,0.6499750499001996,1.0,4/10,16.59%,PSENEN;PSMD14;APH1A;VSIR
prerank,ribosome binding (GO:0043022),-0.33265399410979474,-1.1265709289957737,0.24224806201550386,0.6521057264353282,1.0,13/46,21.70%,RACK1;RPSA;EEF2;ERI1;NCLN;NOMO1;FMR1;SEC61B;SRP19;SERBP1;YTHDF1;SRP68;PYM1
prerank,sequence-specific DNA binding (GO:0043565),0.23658029072251416,1.1251137325369334,0.12216404886561955,0.6681353568646086,1.0,81/590,11.35%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;TBX3;NR2F2;EPAS1;HLF;RARB;GLI2;TEAD1;ZIC1;TBX18;PPARA;HOXC4;PRDM5;NFAT5;DLX3;SMAD3;TFEC;CREB5;CREB3L1;ZEB2;BCL2;GLI3;RUNX3;TBX21;TFCP2;KLF15;PBX4;PKNOX2;ZNF35;STN1;HOXC8;FOSB;PHOX2A;HOXB8;CEBPB;KMT2A;BBX;LIN28B;HOXC9;ATF5;PRDM9;NFIX;FOXA2;ZNF296;DMRTA2;MBD2;LHX4;CUX1;CXXC4;SOX2;RFX7;SIX4;RARG;RBPJ;SAFB2;GLIS1;CREB3L4;CREB3;FOXD3;HES5;CXXC1;CTCF;ZBTB45;GATA3;ZIC4;HOXC10;HOXB9;CUX2;FOXR2;SKOR2;PAX1;KDM2A;HNRNPD;AHR;SLTM;GRHL3
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.23294921167978672,1.124878699107532,0.09863945578231292,0.664142916836988,1.0,95/731,10.33%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;SALL1;AR;TBX3;GLIS3;MXI1;NR2F2;HLF;NFIA;ZEB1;HIVEP2;RARB;VDR;PRRX1;GLI2;TEAD1;ZIC1;TBX18;MITF;PPARA;HOXC4;PRDM5;NFAT5;DLX3;NKX6-1;IKZF4;SMAD3;HOXB3;TFEC;CREB5;STAT5B;CREB3L1;ZEB2;ZKSCAN2;HOXC5;GLI3;RUNX3;TBX21;TFCP2;KLF15;SP7;PBX4;SOX21;PKNOX2;HDX;FOSB;CEBPB;EBF1;ZNF112;TOP1;HES3;ZKSCAN7;HNF4G;HOXC9;ZNF394;NFIX;FOXA2;ZNF296;DMRTA2;SP5;DMTF1;ZNF697;SOX2;RFX7;SIX4;RARG;RBPJ;ZSCAN21;NSD1;BCL11A;SNAPC3;GLIS1;SOX5;MLXIP;CREB3L4;CREB3;FOXD3;HES5;CTCF;ZBTB45;ATOH8;KCNIP3;GATA3;ZIC4;ZSCAN12;HOXC10;HOXB9;SKOR2;HOXC6;PAX1
prerank,carbohydrate kinase activity (GO:0019200),-0.46236526277120915,-1.1216730515562967,0.3421516754850088,0.6610297922673172,1.0,6/11,38.75%,HK1;POMK;GNE;FGGY;XYLB;HK3
prerank,MAP kinase phosphatase activity (GO:0033549),-0.4521421463600729,-1.1200408408810112,0.3436960276338515,0.6611684606247628,1.0,7/12,41.41%,DUSP3;DUSP4;DUSP1;DUSP6;DUSP7;DUSP5;DUSP2
prerank,ATPase regulator activity (GO:0060590),-0.3440553433886272,-1.1187688372390219,0.2918287937743191,0.6605630203008617,1.0,14/38,24.42%,FNIP2;DNAJA2;ATP1B1;PFN1;DNAJA1;BAG5;KATNB1;TOR1AIP1;ATP5IF1;TOR1AIP2;ATP1B2;BAG1;DNAJB1;BRSK2
prerank,peptidoglycan binding (GO:0042834),-0.4818024735006438,-1.1182025028619045,0.337037037037037,0.6581927054980947,1.0,4/10,15.24%,NOD1;HK1;PGLYRP1;NOD2
prerank,kinase activator activity (GO:0019209),-0.3575714327626057,-1.1182017663911397,0.2768361581920904,0.6542276891999134,1.0,12/30,27.06%,RPLP1;WNK1;RGCC;WNT11;MADD;CAB39;AGAP2;TPX2;BCL10;SPDYA;RPTOR;TREM2
prerank,antiporter activity (GO:0015297),0.4041361401491394,1.1177493909002412,0.32134831460674157,0.677619695632274,1.0,6/20,15.66%,SLC35D1;SLC35E3;SLC25A10;ATP1A3;SLC35C2;SLC25A30
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3483956401888399,1.1157563162245558,0.2907216494845361,0.678040555965152,1.0,14/34,23.20%,METTL21A;PRDM9;MEN1;SMYD1;SETD7;SMYD3;EHMT2;NSD3;EZH2;KMT5B;VCPKMT;DOT1L;SETD4;CAMKMT
prerank,hexosyltransferase activity (GO:0016758),0.2895129367301256,1.115725050234498,0.2546201232032854,0.673478817740774,1.0,19/101,13.78%,TMTC1;B3GALT1;B3GALNT1;MGAT4C;B3GNT7;ALG5;B3GLCT;TMTC4;FUT4;TMTC3;POGLUT2;FUT9;CHSY3;EXTL1;B3GALT2;POMT2;B3GALT5;GBA2;DPY19L1
prerank,syntaxin binding (GO:0019905),0.3129646531057874,1.114033067110186,0.2787878787878788,0.6732880566408594,1.0,21/61,19.06%,ABCA1;UNC13C;STXBP4;SCFD1;DAPK1;SYT1;CPLX2;SNAP25;GOLGA2;TMED10;STX7;BAIAP3;SYP;STXBP3;SNAP47;SCFD2;TMED9;SYT12;VAMP3;SYT6;SYNPR
prerank,titin binding (GO:0031432),-0.4379286980001441,-1.112626196826532,0.3376146788990826,0.6645929697491245,1.0,4/13,13.89%,CAMK2D;CALM1;CALM3;MYBPC1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.38128874795636825,-1.1117931024143937,0.32170542635658916,0.6627459366980324,1.0,6/22,18.17%,MINDY2;PRPF8;UIMC1;SPRTN;TAB2;TNFAIP3
prerank,nuclear export signal receptor activity (GO:0005049),0.4520726218956703,1.1074656389181006,0.32421052631578945,0.6855465022385567,1.0,4/11,13.48%,RANBP17;XPO4;XPO7;XPO5
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.23015057119729013,1.1071363296225893,0.13051146384479717,0.6817056004328582,1.0,94/732,10.33%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;SALL1;AR;TBX3;GLIS3;MXI1;NR2F2;HLF;NFIA;ZEB1;HIVEP2;RARB;VDR;PRRX1;GLI2;TEAD1;ZIC1;TBX18;MITF;PPARA;HOXC4;PRDM5;NFAT5;DLX3;NKX6-1;IKZF4;SMAD3;HOXB3;TFEC;CREB5;STAT5B;ZEB2;ZKSCAN2;HOXC5;GLI3;RUNX3;TBX21;TFCP2;KLF15;SP7;PBX4;SOX21;PKNOX2;HDX;FOSB;CEBPB;EBF1;ZNF112;TOP1;HES3;ZKSCAN7;HNF4G;HOXC9;ZNF394;NFIX;FOXA2;ZNF296;DMRTA2;SP5;DMTF1;ZNF697;SOX2;RFX7;SIX4;RARG;RBPJ;ZSCAN21;NSD1;BCL11A;SNAPC3;GLIS1;SOX5;MLXIP;CREB3L4;CREB3;FOXD3;HES5;CTCF;ZBTB45;ATOH8;KCNIP3;GATA3;ZIC4;ZSCAN12;HOXC10;HOXB9;SKOR2;HOXC6;PAX1
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.44359662612856615,-1.106519519418894,0.36162361623616235,0.6722413161841996,1.0,6/13,10.91%,PTPRJ;VEGFA;IL1R1;PDGFC;PDGFA;VEGFD
prerank,cholesterol binding (GO:0015485),-0.3257844707771224,-1.105146044818222,0.3108910891089109,0.6716566866267465,1.0,13/47,15.10%,CAV1;PROM1;OSBPL3;CD81;OSBPL1A;STARD3NL;ABCG1;ERLIN2;GRAMD1C;GRAMD1A;STARD5;NPC1;STAR
prerank,cytokine receptor binding (GO:0005126),0.30019988963701844,1.1042338642425675,0.27416173570019725,0.6843034645939584,1.0,17/83,12.72%,TGFBR3;IL34;SMAD3;VEGFB;IL13RA1;IL1RAP;IL4;CD300LF;OSMR;IL18;IL27;CCL25;CNTF;IL6R;TSLP;PIBF1;PRLR
prerank,adenyl ribonucleotide binding (GO:0032559),-0.2424787088009644,-1.1041546879827149,0.18722466960352424,0.6705127756183539,1.0,87/291,23.31%,CDK6;MAP3K5;RPS6KA5;MAP4K3;PEAK1;ME1;NLK;WNK1;PDE4D;ATP1A1;SMC4;HSP90AB1;MAP3K20;PI4K2A;PDE2A;HSPA8;ATP5F1D;MINK1;MIEF1;MTREX;ATP5F1A;ACLY;PRPS2;PFKP;IDE;SRPK1;INSR;DYRK2;NDUFA13;DHX9;HACL1;AKT1;CARS1;CDC42BPB;ABCG1;LMTK2;TRIB1;KCNJ8;PRPS1;PRPS1L1;HSPA5;STK38;PPP5C;STK36;SARS2;PNKP;ACVR1;ABCA2;RRM1;TBCK;TARS1;HSPA4;CAD;UHMK1;NUAK2;COQ8A;CARS2;PRKAG1;STK38L;STK26;PGK1;OAS2;UBA2;HSP90AA1;MYO1F;HSPA1A;MLKL;AGAP2;HSPA9;TAP2;MAP3K6;N4BP2;GCLC;BMPR1B;SNRK;RAPGEF2;MTHFS;HSPA1B;BTK;PYGL;AARS2;PFKL;EIF4G1;BCKDK;MKNK2;NME1;SIK1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.4754614213772639,-1.103421986723093,0.35368043087971274,0.6685292206285104,1.0,4/10,26.51%,CDKN1B;CDKN1A;CDKN2C;CDKN2B
prerank,small GTPase binding (GO:0031267),-0.2591671688564042,-1.1024625075769325,0.22064777327935223,0.6672608540145143,1.0,35/169,15.57%,PLCE1;FGD5;CAV1;EXOC4;EPS8;UNC13B;RIN3;SH3BP4;AP3M1;SGSM2;IQGAP1;CYRIB;IFT20;RNF41;ARHGAP1;DOCK4;ARHGDIB;FGD6;YBX3;TRIP11;RAB8A;MAPKAP1;TNFAIP1;CIB1;RCC2;RTKN;MLPH;SPHK2;RAB11FIP3;RANBP2;TNPO3;SIKE1;GOLGA5;STRN3;NCKAP1
prerank,hyaluronic acid binding (GO:0005540),0.47237897165500553,1.0974591263227553,0.3804347826086957,0.6969091445093388,1.0,1/10,0.21%,CEMIP
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.4311973237610326,-1.0964109689406554,0.34513274336283184,0.6794514419436988,1.0,4/14,14.06%,KCNJ2;KCNQ1;KCNJ8;KCND3
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.4608985508539075,-1.0958348213440379,0.3641025641025641,0.6769318505845451,1.0,2/11,6.56%,LEF1;GATA2
prerank,omega peptidase activity (GO:0008242),-0.28337603535988043,-1.0951635261251453,0.2727272727272727,0.67493989294139,1.0,25/89,21.94%,USP53;USP1;USP46;BRCC3;USP7;USP8;OTUD5;USP3;OTUB1;UCHL1;GGT5;USP5;USP9X;COPS5;PSMD14;USP15;PAN2;UCHL3;TNFAIP3;USP22;USP49;USP4;GGT1;JOSD1;USP38
prerank,phosphatidate phosphatase activity (GO:0008195),0.43347092749837146,1.0943581911094413,0.36253041362530414,0.699966229339163,1.0,6/13,16.56%,PLPP3;PLPPR1;LPIN3;PLPP4;PLPPR5;LPIN1
prerank,growth factor receptor binding (GO:0070851),0.28732300541528333,1.0941554884172933,0.298828125,0.6959022280940622,1.0,19/95,12.84%,AREG;PDGFRA;KL;TNK2;VEGFB;TGFA;IL1RAP;IL4;GLMN;PDGFRB;CD300LF;PDGFD;ERBB4;CNTF;ESM1;IL6R;TSLP;PIBF1;BTC
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.34583493185864345,1.0919839320319171,0.3130081300813008,0.6967785105121438,1.0,11/32,18.47%,BBOX1;KDM7A;JMJD4;PHYH;FTO;KDM2A;PHF8;PHYHD1;ALKBH4;P4HTM;KDM4C
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.4405243094043381,-1.087864448336116,0.3786764705882353,0.6903819479684699,1.0,6/12,22.07%,RACK1;NOD1;ATP2A3;RPS27L;BAD;CASP1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.34349126131094787,1.0867155116125555,0.3453389830508475,0.7056096081322214,1.0,4/38,4.15%,PIK3R1;MAGI2;GRIP1;STAP1
prerank,potassium channel activity (GO:0005267),0.2909013142688233,1.0858920854611909,0.302713987473904,0.7032772443756223,1.0,23/89,20.54%,KCNK2;KCNT2;CCDC51;GRIK5;GRIK2;KCND2;GRIK1;KCND1;KCNMA1;KCNK10;KCNS3;KCNH7;KCNQ4;KCNG2;KCNS1;KCNN1;KCNG4;KCNC2;KCNH1;KCNH5;KCNK13;KCNS2;KCNH4
prerank,cysteine-type peptidase activity (GO:0008234),-0.28687074205917606,-1.0858903237098467,0.29423076923076924,0.6916391935230662,1.0,16/73,13.25%,CAPN2;CTSZ;USP1;USP46;CTSO;CASP7;USP7;CTSC;CASP8;USP8;CTSF;UCHL1;USP5;USP9X;CTSB;USP15
prerank,NADPH binding (GO:0070402),-0.43070407192612903,-1.0856678166567262,0.34385964912280703,0.6884889438999097,1.0,3/13,9.50%,LBR;DUS2;DECR1
prerank,platelet-derived growth factor binding (GO:0048407),0.45334816744409684,1.0831308068301477,0.3516483516483517,0.7055835793604587,1.0,3/11,6.21%,COL1A2;PDGFRA;PDGFRB
prerank,water transmembrane transporter activity (GO:0005372),-0.44755508128805466,-1.0822416511520951,0.36380255941499084,0.6937402971834109,1.0,9/11,55.27%,AQP11;AQP4;AQP1;SLC4A11;AQP9;AQP6;AQP7;SLC5A1;PDPN
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.45120385172988736,-1.0817374401121853,0.3621621621621622,0.6913300470881442,1.0,3/11,21.47%,RPS3;NEIL1;APEX2
prerank,ATP binding (GO:0005524),-0.23960734000070838,-1.07992504823263,0.23788546255506607,0.6923844618455397,1.0,65/266,17.81%,CDK6;MAP3K5;RPS6KA5;MAP4K3;PEAK1;NLK;WNK1;ATP1A1;SMC4;HSP90AB1;MAP3K20;PI4K2A;HSPA8;ATP5F1D;MINK1;MTREX;ATP5F1A;ACLY;PRPS2;PFKP;IDE;SRPK1;INSR;DYRK2;NDUFA13;DHX9;HACL1;AKT1;CARS1;CDC42BPB;ABCG1;LMTK2;TRIB1;KCNJ8;PRPS1;PRPS1L1;HSPA5;STK38;PPP5C;STK36;SARS2;PNKP;ACVR1;ABCA2;RRM1;TBCK;TARS1;HSPA4;CAD;UHMK1;NUAK2;CARS2;PRKAG1;STK38L;STK26;PGK1;OAS2;UBA2;HSP90AA1;MYO1F;HSPA1A;MLKL;AGAP2;HSPA9;TAP2
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.28282123984251506,-1.0782645923147671,0.2848605577689243,0.6928929027191519,1.0,23/83,21.94%,USP53;USP1;USP46;BRCC3;USP7;USP8;OTUD5;USP3;OTUB1;UCHL1;USP5;USP9X;COPS5;PSMD14;USP15;PAN2;UCHL3;TNFAIP3;USP22;USP49;USP4;JOSD1;USP38
prerank,metalloexopeptidase activity (GO:0008235),0.3132738092014059,1.0782417798974488,0.33043478260869563,0.7132778436629406,1.0,12/51,11.50%,AGBL4;MMP16;CPZ;AEBP1;CPA6;CPQ;PEPD;CPXM1;ANPEP;ENPEP;TRHDE;FOLH1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4442712198085009,-1.077759709980158,0.3770197486535009,0.6903367178686106,1.0,2/12,4.08%,SLC6A6;SLC38A5
prerank,filamin binding (GO:0031005),-0.44741522334499695,-1.0753840071471366,0.37251356238698013,0.6927226627825431,1.0,8/11,37.42%,NEBL;TMEM67;RFLNB;MICALL2;RFLNA;FBLIM1;DPYSL4;CEACAM1
prerank,cell adhesion mediator activity (GO:0098631),-0.3697351709203599,-1.0739155583568551,0.3713235294117647,0.6928025669091924,1.0,5/24,5.66%,BSG;ESAM;JAM3;ROBO4;BCAM
prerank,cation channel activity (GO:0005261),-0.2737467571113934,-1.0737470471352806,0.3210633946830266,0.6895780631250868,1.0,11/94,5.17%,PIEZO2;ANO6;KCNK5;ANO1;TRPC3;TRPM7;ABCC9;TRPM6;PIEZO1;ANXA2;PKD1
prerank,protease binding (GO:0002020),0.28293702457267494,1.0709537001793896,0.3025540275049116,0.7273173395782289,1.0,12/99,7.52%,CCBE1;COL1A2;TIMP3;SLC2A13;BCL2;CFLAR;PRKN;SUMO1;SERPINE1;TRIP4;ATP9A;TIMP4
prerank,protein kinase C activity (GO:0004697),-0.4123515588799647,-1.0694487242113624,0.4014466546112116,0.6970633201681742,1.0,4/14,11.76%,PRKCH;PRKCZ;PRKD3;PRKCE
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.3457649614057061,-1.0691111562076505,0.3586337760910816,0.6941566602245245,1.0,7/30,14.05%,SLC39A10;TMEM165;SLC39A8;SLC40A1;SLC39A1;SLC39A11;SLC39A7
prerank,G protein-coupled receptor activity (GO:0004930),0.24795150622942214,1.0690618345501885,0.2811320754716981,0.7278704577775599,1.0,39/239,16.28%,ADGRV1;LGR4;PDGFRL;LPAR1;ADGRB3;GPR88;GPR55;MC5R;P2RY13;GPR174;OPRK1;GRM1;CCR10;PDGFRB;HRH1;GPR171;CALCR;PROKR2;LPAR4;GLP2R;NMBR;GPR173;ADRA1D;GPR161;C3AR1;ADRA1B;CRHR1;GRM4;PAX8;CXCR4;P2RY1;GPR34;DRD2;ADGRL1;HCRTR1;RXFP1;ADRB3;LTB4R2;ADRA1A
prerank,cytokine receptor activity (GO:0004896),0.28760187301651957,1.0685498231905775,0.345703125,0.724613206159278,1.0,12/83,8.73%,IL31RA;CNTFR;LEPR;GHR;IL13RA1;IL1RAP;CCR6;ACKR2;ACKR4;IL1RL2;OSMR;CCR9
prerank,solute:sodium symporter activity (GO:0015370),0.3587683476552166,1.0648800709277915,0.35974304068522484,0.7295191900781715,1.0,5/27,8.07%,SLC17A1;SLC5A3;SLC28A3;SLC20A2;SLC4A7
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.222585587227198,1.0550156443512577,0.281195079086116,0.75065892178937,1.0,77/597,10.48%,TCF7L2;TCF4;ARNT2;ZBTB20;MAF;AR;TBX3;HLF;BCOR;TBL1XR1;RARB;GLI2;TEAD1;ZIC1;MCM3;TBX18;HOXC4;PRDM5;NFAT5;DLX3;SMAD3;TFEC;CREB5;CREB3L1;ORC4;GLI3;RUNX3;TBX21;TFCP2;KLF15;PKNOX2;HOXC8;FOSB;PHOX2A;HOXB8;CEBPB;ZNF513;BBX;LIN28B;HOXC9;ATF5;GABPB1;GABPB2;PRDM9;NFIX;FOXA2;ZNF296;DMRTA2;MBD2;LHX4;DMTF1;CUX1;MEN1;SOX2;RFX7;SIX4;RARG;GLIS1;SOX5;CREB3L4;CREB3;FOXD3;HES5;CTCF;ZBTB45;GATA3;ZIC4;MCM2;HOXC10;HOXB9;MCM9;CUX2;FOXR2;SKOR2;ERBB4;PAX1;ARID5B
prerank,protein kinase inhibitor activity (GO:0004860),-0.31654655099191314,-1.0546876417869027,0.3815789473684211,0.7290419161676647,1.0,16/42,28.12%,RACK1;CDKN1B;TAOK3;DUS2;INKA2;TRIB1;CIB1;CDKN1A;NCK1;YWHAB;CDKN1C;CIT;RPTOR;NPM1;SPRY4;PPP1R1B
prerank,acetyltransferase activity (GO:0016407),0.34933905498791396,1.0520644393130731,0.39828693790149894,0.7539406930563397,1.0,6/31,14.06%,NAT8;SAT1;PAFAH2;KAT8;DBT;EP300
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.3789311603360073,-1.0492546170536268,0.4144981412639405,0.7403935584328724,1.0,16/18,53.53%,HSD17B10;HSD17B2;HSD11B1;HSD17B1;HSD17B7;SRD5A2;HSD3B7;HSD17B8;HSD3B2;DHRS11;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3;RDH5
prerank,organic anion transmembrane transporter activity (GO:0008514),0.26217170426600067,1.0491259826111823,0.3678861788617886,0.7568850529619459,1.0,37/134,16.58%,SLC1A3;SLC13A3;SLC16A12;SLC7A2;SLC6A9;SLC6A13;GJA1;SFXN5;SLC35D1;ABCC2;MFSD12;SLC36A2;SLC22A3;SLC26A1;SLC38A1;SLC7A9;SLC25A13;SLCO5A1;SLC25A42;SLC6A1;SLC1A5;SLC38A3;SLC46A1;SLC35B1;CTNS;SLC38A9;SLC25A15;SLC38A6;OCA2;SLC1A2;SLC7A3;SLC25A24;SLC1A7;SLC3A1;SLC16A7;SLC25A18;SLC6A8
prerank,GTPase regulator activity (GO:0030695),0.24567573096434306,1.048952557210378,0.3157894736842105,0.7528326576214627,1.0,24/212,6.99%,ALDH1A1;NRP1;ERRFI1;ASAP1;ARHGAP28;ARHGAP29;ADGRB3;RIN2;TBC1D4;RABGAP1L;ARHGAP32;RGS20;TNK2;RIMS1;ASAP3;ARHGAP11A;RHOH;RANBP3L;DLC1;ARHGAP22;SRGAP2;ARHGAP24;RGS7;TBC1D2B
prerank,metal ion binding (GO:0046872),0.2243967126482229,1.0439236393270532,0.3234750462107209,0.7614617090358319,1.0,59/477,11.28%,ENPP1;ADCY2;ADGRV1;FBN1;HMGCLL1;CLEC3B;PAM;PLSCR2;FBLN1;SLC8A1;SCUBE1;LRP1;EYA2;KCNIP4;PLA2G5;NRXN1;CDH8;ITPR1;ANXA10;PLA2G4A;GNAI1;RAP2A;DCHS1;CDH18;TNNC1;ATP2A2;AMY1C;AMY1B;AMY1A;MAN1C1;ASTN2;CDH11;ASPH;CDH19;CDH20;CDH7;SYT1;LOXL2;MICU3;GEN1;SLC25A13;PPA1;TRIM27;OTOF;PPA2;SCIN;S100A7A;PDXK;CDK5R1;C2CD5;MCTP2;CDH10;BRSK1;MEX3B;NAALADL1;EML1;CDHR3;SYT13;BAIAP3
prerank,transaminase activity (GO:0008483),0.4355606304988587,1.0433764925879108,0.4146868250539957,0.7583490264914812,1.0,5/11,22.27%,ABAT;BCAT1;BCAT2;GOT1;GOT2
prerank,wide pore channel activity (GO:0022829),0.366252529606066,1.0428278451822797,0.4143763213530655,0.7554214394901353,1.0,2/23,1.64%,GJB6;GJA1
prerank,ephrin receptor binding (GO:0046875),-0.3602359113142503,-1.040911431348921,0.3973384030418251,0.7590132235528941,1.0,15/21,36.39%,CHN1;CRK;SHC1;ANKS1A;EFNB3;EFNB1;PIK3CG;PTPN1;EFNA2;SRC;EFNA4;ABL1;FYN;CBL;EFNA1
prerank,gap junction channel activity (GO:0005243),0.3721412013925596,1.0404049479337896,0.40563991323210413,0.7573802731174856,1.0,2/22,1.64%,GJB6;GJA1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.28059801511032023,-1.0399072938347513,0.37524557956778,0.757924565377018,1.0,17/72,11.22%,STXBP6;KCNJ2;PARD3;VILL;ANXA2;KCNQ1;HIP1R;FLII;JPH2;FZD7;PFN1;HIP1;MAPKAP1;RPH3A;FCHO2;TIRAP;EXOC1
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.3227884239492056,-1.039322104244783,0.41818181818181815,0.7556536411712658,1.0,8/34,15.98%,IQGAP1;CALM1;RICTOR;FAM20A;MTCP1;CALM3;CAB39;CCNK
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.3210370553072718,-1.0391479888583561,0.395910780669145,0.7523312349659655,1.0,18/37,35.01%,SARS1;WARS2;CARS1;LARS2;WARS1;SARS2;TARS1;CARS2;FARS2;IARS1;AARS2;FARSB;GARS1;KARS1;NARS1;IARS2;PARS2;AARS1
prerank,exopeptidase activity (GO:0008238),-0.296613584736204,-1.0389545545076126,0.3776091081593928,0.7490529145790052,1.0,22/50,28.50%,DPP4;FAP;CTSZ;LTA4H;ERAP1;PRCP;CPE;ACE2;DPEP3;DPP8;LNPEP;ACE;RCE1;CNDP2;METAP1D;BLMH;NPEPPS;LAP3;DPP7;NAALAD2;DPP9;CPB1
prerank,hormone receptor binding (GO:0051427),-0.40405351652299515,-1.0378623887756637,0.4191829484902309,0.7484270038602997,1.0,7/14,39.99%,SOCS2;JAK2;ADCYAP1;NCOA6;NPPC;VIP;TYK2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.3977106915297346,1.0368700844378138,0.40358744394618834,0.7620415621365104,1.0,1/15,0.26%,PIK3R1
prerank,SH2 domain binding (GO:0042169),-0.34019250075689117,-1.0359351446690286,0.4153846153846154,0.749899191515958,1.0,14/31,28.20%,AFAP1L2;RACK1;NLK;PTK2;CRK;TRPV4;RUFY1;JAK2;LAT2;CCDC88A;INPPL1;LAX1;SKAP1;LILRB1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.23824413428157726,-1.0358562331955987,0.35876288659793815,0.7463364727830771,1.0,48/188,18.65%,BNC2;MEF2C;FLI1;JUND;KLF4;NCOR1;FOXO3;SOX17;ETS1;VSX1;SIX1;PRDM16;REST;NFYA;RBBP5;SOX13;FOXK1;SMAD6;ATF4;GATA6;HDAC4;TAL1;SOX7;DHX9;YY1;HHEX;SOX18;SFPQ;FOXC2;GABPA;SOX12;KMT2D;SOX4;GRHL1;MTERF3;NR5A2;SMAD4;SOX6;SMARCA2;ETV5;POU2F2;LIN54;SP1;RELA;GLI1;ZNF568;ZBTB48;ARID4B
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.35914884742770536,1.034285396619544,0.4154786150712831,0.7642363027680714,1.0,5/23,6.03%,SH3PXD2B;WDR45B;SNX14;WIPI1;GBF1
prerank,mannosyltransferase activity (GO:0000030),0.3670938679185347,1.0335346601275623,0.42323651452282157,0.7616841765556934,1.0,9/21,22.84%,TMTC1;TMTC4;TMTC3;POMT2;DPY19L1;DPM1;DPY19L4;ALG8;PIGB
prerank,Toll-like receptor binding (GO:0035325),-0.4276538146154899,-1.0316980244304192,0.4358523725834798,0.7533233532934132,1.0,6/11,30.52%,DAB2IP;TOLLIP;TIRAP;TLR6;CD36;TLR1
prerank,TBP-class protein binding (GO:0017025),-0.3551647583375263,-1.030513216015731,0.4359464627151052,0.7528425735593489,1.0,5/21,16.40%,ESR1;HHEX;PSMC5;PSMC1;DRAP1
prerank,nuclear localization sequence binding (GO:0008139),-0.378661701069269,-1.0280603474601733,0.42401500938086306,0.7555137250251971,1.0,8/18,38.01%,NFKBIA;KPNA1;KPNA4;TNPO2;KPNA6;IPO5;NUP214;CABP1
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.3182742293428386,-1.0252672635233915,0.39961759082217974,0.7594023775109878,1.0,14/35,30.73%,FOXP1;NR3C1;H3-3A;POU2F1;SMARCA4;DRAP1;RELA;STAT1;KLF10;TAF1B;PARK7;NPM1;MYC;TAF4
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.29268119552394434,-1.0243537095030892,0.4121212121212121,0.7583020234041721,1.0,20/49,28.80%,MINDY2;MINDY1;PRPF8;BRCC3;UIMC1;VCP;UBXN1;SPRTN;UBL7;RAD18;TAB2;TNFAIP3;BABAM2;ZFAND2B;RAD23A;EPS15;PARP10;UBQLN2;RAD23B;ATRIP
prerank,proton transmembrane transporter activity (GO:0015078),-0.30832082740831707,-1.0201421832228912,0.416015625,0.7655274816221216,1.0,13/39,22.79%,COX4I1;COX6B1;CLCN3;NNT;UQCRQ;COX15;UQCR11;NDUFA4;COX10;UQCRH;NDUFA4L2;CLCN5;COX8A
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.3184126170936523,1.0192112795155623,0.4391304347826087,0.794596596366391,1.0,4/38,5.86%,SERPINE2;SERPINI2;SERPINF1;SERPINE1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.43655130148808635,-1.0187779913041501,0.4377431906614786,0.7654206150805186,1.0,5/10,22.90%,PIK3C2A;PIK3R3;PIK3CA;PIK3C2B;PIK3CG
prerank,mRNA 3'-UTR binding (GO:0003730),0.27720141815507665,1.0180453370185116,0.4269005847953216,0.7929997407947094,1.0,15/79,14.95%,CELF2;RBMS3;RBMS1;DAZAP1;PABPC1L;IGF2BP2;CSDC2;CPEB3;KHSRP;FXR2;PARN;SECISBP2;CPEB1;GEMIN5;RBM24
prerank,flavin adenine dinucleotide binding (GO:0050660),0.2921604187200477,1.0174419067821283,0.4256198347107438,0.7901056027709173,1.0,10/53,11.62%,MICAL3;KDM1B;POR;CYB5R2;PRODH;KMO;CRY1;DDO;MICAL1;SDHA
prerank,CCR chemokine receptor binding (GO:0048020),-0.33327496480607594,-1.0172963621821356,0.4419551934826884,0.7660235085384787,1.0,18/28,49.10%,NES;CCL15;CCL2;NARS1;CCRL2;CCL5;CCL4;CCL14;MSMP;CCL7;CX3CL1;DEFB130A;CCL1;CCL3;CCL11;CCR2;DEFB1;CXCL13
prerank,chemokine receptor activity (GO:0004950),0.3491124003685083,1.0157532210183269,0.42701525054466233,0.7900356923785333,1.0,6/24,13.05%,CCR6;ACKR2;ACKR4;CCR10;CCR9;CXCR4
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3720607265002036,1.0140233910724763,0.41294642857142855,0.7907154256901804,1.0,1/18,0.26%,PIK3R1
prerank,zinc ion binding (GO:0008270),0.22979765043445444,1.0131049307857722,0.4224299065420561,0.7887952006592573,1.0,53/293,13.33%,ENPP1;PAPPA;ADAM33;MYCBP2;PAM;ZEB1;SEC24D;CBLB;RBAK;GLI2;IKZF4;SMAD3;BBOX1;KDM1B;MMP16;MDM2;P2RX4;KDM7A;DUSP12;RNF2;SMPDL3B;MNAT1;KMT2A;PRKN;HDAC10;ANPEP;BAZ1B;SIRT2;ENPEP;CXXC4;NSD1;CTCF;BLM;SLU7;PDXK;CHMP1A;SEC24A;RNF26;SEC23A;KDM2A;NAALADL1;TRHDE;DPP3;ZFYVE1;APIP;CXXC5;ZFP37;CDADC1;PHF8;LITAF;ZNF205;ARIH2;GRIN2A
prerank,sodium channel regulator activity (GO:0017080),0.31514195117565497,1.0129380424272374,0.42943548387096775,0.7848138976069047,1.0,6/37,10.93%,FGF14;SCN3B;GPD1L;FXYD1;FXYD7;FXYD6
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.4292921830926226,-1.0115585352662024,0.45604395604395603,0.7779153231997544,1.0,5/11,29.49%,ANAPC11;RBX1;AMFR;UBE4A;PRPF19
prerank,phosphoric diester hydrolase activity (GO:0008081),0.32142750158856165,1.0096723219554777,0.430327868852459,0.7885179081169301,1.0,4/35,5.68%,ENPP1;PLCL1;PLCXD1;SMPDL3B
prerank,cholesterol transfer activity (GO:0120020),-0.3858774195132121,-1.0093705964854853,0.45229007633587787,0.780181264265727,1.0,5/16,12.46%,PLTP;ABCG1;GRAMD1C;GRAMD1A;STARD5
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.3680001274942314,-1.006649493861074,0.42964352720450283,0.7836184773310523,1.0,6/18,29.54%,RPS6KA3;TNFAIP8;SERPINB9;XIAP;BIRC5;RPS6KA1
prerank,protein tyrosine kinase binding (GO:1990782),-0.2717854325158845,-1.00656823676578,0.42052313883299797,0.780117490138207,1.0,17/71,16.53%,PTPN14;RACK1;GRB14;BMPR2;TJP2;RNF41;NEDD9;DOCK4;CRK;SHC1;PITPNM2;DUSP3;PITPNM3;ACVR1;PITPNM1;PIK3R2;HSP90AA1
prerank,potassium:proton antiporter activity (GO:0015386),-0.42583819285687885,-1.005700285201475,0.45555555555555555,0.7787255677324595,1.0,1/10,0.51%,SLC9A2
prerank,cation transmembrane transporter activity (GO:0008324),0.3003474667283036,1.0049207333060137,0.43186582809224316,0.7965205461956639,1.0,13/48,13.14%,SLC7A2;SLC6A9;MFSD12;SLC36A2;SLC22A3;SLC38A1;SLC41A1;SLC1A5;SLC38A3;SLC38A9;SLC25A15;SLC38A6;OCA2
prerank,microtubule binding (GO:0008017),-0.22651622061962903,-1.0027426584461112,0.3987341772151899,0.7828661924976338,1.0,69/222,27.09%,MTUS1;DNM3;RAB11A;MID2;RPS3;MAP1LC3B;MAP4;RP1;MID1;CHP1;EZR;CEP57;GAPDH;KIF9;KIF1B;KIF23;CEP290;DCTN1;SGIP1;SPEF1;TRPV4;GAS8;FHDC1;KIF16B;KIF26A;RCC2;KATNB1;NDE1;SNPH;MAP1LC3A;FMR1;NDEL1;GAS2L1;OPA1;MAP1B;KRIT1;KIF18A;REEP4;MAPRE2;ARHGEF2;DNM1;MAP1A;KNSTRN;DNM2;KIF13A;KIF18B;TPX2;FMN1;APC2;NEFM;CAMSAP3;RMDN1;KIF1C;CEP44;CLIP1;KIF22;CCDC88A;ARL3;CLIP2;KIF17;HAUS4;RMDN3;CCDC170;KIFC2;CAPN6;RACGAP1;BIRC5;MAP7D3;PEX14
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.43107016832116196,-1.001918529877986,0.4868686868686869,0.7815164064394575,1.0,4/10,23.84%,ANKRD13A;IDE;LAPTM5;FAN1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.32215248658357465,-1.0012424231569517,0.46825396825396826,0.779807826208049,1.0,5/30,11.85%,RPS6KA3;CAST;TNFAIP8;CST3;SERPINB9
prerank,I-SMAD binding (GO:0070411),-0.3953744864486444,-1.001159294335802,0.45454545454545453,0.7764240038441635,1.0,8/13,27.84%,SMAD9;SMAD7;SMAD6;SMURF1;SMAD4;SMAD2;SMAD1;CTNNB1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.40968928784784064,-1.0010515615185296,0.4803001876172608,0.773186346201606,1.0,5/12,19.04%,SLC2A1;MFSD4A;SLC2A8;SLC2A3;SLC2A4
prerank,UDP-glycosyltransferase activity (GO:0008194),0.2768600678792326,1.0000806242071232,0.4444444444444444,0.8048738576362315,1.0,11/70,12.78%,B3GALT1;B3GALNT1;MGAT4C;GXYLT2;B3GNT7;B3GLCT;POGLUT2;CHSY3;EXTL1;B3GALT2;B3GALT5
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.33952514541059076,-0.9993445300284476,0.4567901234567901,0.7741626838066986,1.0,6/22,9.52%,ATP6V0B;ATP2C1;ATP2A3;ATP6V0A2;ATP5F1B;ATP6V0C
prerank,R-SMAD binding (GO:0070412),0.36815857269995556,0.998967234962864,0.4551422319474836,0.803424533358137,1.0,4/18,7.77%,LDLRAD4;SMAD3;PMEPA1;MEN1
prerank,calcium channel regulator activity (GO:0005246),-0.3093007801718885,-0.9988417854799065,0.4788732394366197,0.7717669683464122,1.0,9/37,16.05%,PRKG1;MCUB;CALM1;FKBP1A;REM1;STIM2;CACNB3;SRI;NRXN2
prerank,DNA binding (GO:0003677),0.2069453150472982,0.9968132261952848,0.463898916967509,0.8046454359420229,1.0,113/694,14.56%,TCF7L2;TCF4;RORA;TBX3;NR2F2;EPAS1;HLF;RBMS1;C1D;HIVEP2;DMC1;RARB;VDR;GLI2;TEAD1;MCM3;PPARA;PRDM5;DLX3;SMAD3;ZEB2;BCL2;TBX21;DDB2;TFCP2;MPG;SP7;PBX4;SOX21;ZNF35;STN1;CAMTA1;FOSB;JCHAIN;CEBPB;ZNF292;ZMYM6;RNF138;ZNF513;TOP1;ATF5;TAF6L;KHDRBS1;PRDM9;SETMAR;TOP3A;FOXA2;LHX4;CUX1;ATAD5;CRY1;MEN1;SOX2;RARG;RBPJ;SNAPC3;SAFB2;RAD51B;FUBP1;TIGD4;DNMT1;RBM5;SWSAP1;CTCF;RADX;BLM;POLR2G;GATA3;ZIC4;RPA2;MCM2;TOPORS;MCM9;CUX2;NUP35;ARID5B;GTF3C3;AHR;ANG;SLTM;GRHL3;RAD51C;MCM8;GLYR1;GTF3C2;SNAPC1;PMS2;CXXC5;POGK;SSBP2;GTF3C6;ORC1;DDX60;SURF6;NBN;PAX8;APLP2;SATB1;CENPS;ATF6;PGR;PAX3;MAPT;SPTY2D1;NKX2-1;EP300;CCNT1;SMARCB1;MYBBP1A;BRIP1;GTF3C4;ENDOV;RPA1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.32399648485953464,0.9959994867597332,0.4620253164556962,0.802205304262266,1.0,10/32,13.10%,SLC6A9;SLC43A1;MFSD12;SLC36A2;SLC38A1;SLC7A9;SLC1A5;SLC38A3;SLC38A9;SLC38A6
prerank,thioesterase binding (GO:0031996),-0.4081851136010217,-0.9953909016020308,0.49206349206349204,0.7775222282707313,1.0,4/11,26.60%,RAC1;TRAF1;TRAF6;CDC42
prerank,pre-mRNA binding (GO:0036002),0.3396071690508038,0.9953019395113455,0.4414784394250513,0.7998716631299261,1.0,5/28,9.31%,CELF2;RBM41;RNPC3;CELF4;SLU7
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.3281244680117925,0.9952492887849727,0.45041322314049587,0.7957716261278933,1.0,12/29,19.09%,SLC13A3;ABCC2;SLC26A1;SLC25A10;SLC25A13;SLC1A5;SLC46A1;SLC25A30;SLC25A18;SLC26A4;SLC38A7;SLC13A5
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.39571864653036476,-0.9930564008397638,0.47302158273381295,0.7799197984122254,1.0,2/12,5.75%,BACE2;BACE1
prerank,nuclear import signal receptor activity (GO:0061608),-0.37546877641305654,-0.9925704540395843,0.4690909090909091,0.7776519034004064,1.0,8/15,42.01%,KPNA1;TNPO3;KPNA4;TNPO2;KPNA6;IPO5;KPNA7;IPO9
prerank,retinoic acid receptor binding (GO:0042974),-0.3619323193508993,-0.988905389050291,0.4794007490636704,0.7834331337325349,1.0,4/17,7.15%,ACTN4;NR4A2;TACC1;NRIP1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.36301372055699943,0.9884505967899225,0.4735632183908046,0.8094687867791291,1.0,2/19,1.45%,NRG3;NRG1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.37097481312420405,-0.986511665690555,0.492619926199262,0.7862533860849729,1.0,5/15,13.64%,HS3ST3A1;NDST1;NDST3;HS3ST1;HS3ST3B1
prerank,transition metal ion binding (GO:0046914),0.21665556636619837,0.9860803575214833,0.49454545454545457,0.8114539080083005,1.0,64/397,13.40%,ENPP1;ADCY2;PAPPA;ADAM33;MYCBP2;PAM;ZEB1;AGMO;SEC24D;HEPH;CBLB;RBAK;GLI2;IKZF4;SMAD3;BBOX1;KDM1B;MMP16;MDM2;P2RX4;KDM7A;DUSP12;MOXD1;RNF2;SMPDL3B;MNAT1;KMT2A;PRKN;SCD5;HDAC10;ANPEP;BAZ1B;LOXL2;SIRT2;LOXL3;ENPEP;CXXC4;NSD1;CTCF;BLM;SLU7;PDXK;CHMP1A;SEC24A;SOD2;RNF26;SEC23A;KDM2A;NAALADL1;TRHDE;ANG;SOD3;DPP3;ZFYVE1;APIP;CXXC5;ZFP37;CDADC1;PHF8;LITAF;ZNF205;ARIH2;GRIN2A;MGAT2
prerank,sterol binding (GO:0032934),0.291033375414567,0.9857241696749762,0.4678714859437751,0.8081289802334968,1.0,12/56,13.58%,RORA;ABCA1;OSBPL10;OSBPL8;VDAC2;INSIG2;SCAP;GRAMD1B;SYP;OSBP;SIDT1;ERLIN1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.33672359121591566,-0.9838542417899185,0.4690909090909091,0.7898558438678198,1.0,9/24,23.45%,KCNJ2;ABCC9;KCNJ10;KCNJ8;KCNJ15;KCNK6;ABCC8;KCNJ13;KCNN3
prerank,snoRNA binding (GO:0030515),-0.31317533385233637,-0.9783298983022912,0.47735849056603774,0.8003197145531945,1.0,6/30,12.76%,NOP14;PRKDC;NOP56;DHX37;DKC1;NUDT4
prerank,transcription cis-regulatory region binding (GO:0000976),0.212206253453363,0.9770676543193199,0.552772808586762,0.8257132852344056,1.0,51/406,10.48%,TCF7L2;RORA;ZBTB20;AR;MXI1;EPAS1;BCOR;TBL1XR1;TRPS1;RBAK;TEAD1;TBX18;PRDM5;SMAD3;CREB3L1;GLI3;RUNX3;TBX21;TFCP2;KLF15;TFDP1;AEBP1;ZNF35;HOXC8;PHOX2A;HOXB8;CEBPB;ZNF513;BBX;ATF5;GABPB1;GABPB2;PRDM9;FOXA2;LHX4;DMTF1;CUX1;NFXL1;MEN1;SOX2;SNAPC3;SOX5;MLXIP;CREB3;FOXD3;CTCF;GATA3;HOXC10;CUX2;ERBB4;ARID5B
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.4114034803382876,0.9747224349280169,0.4691075514874142,0.8273289287732464,1.0,3/10,7.36%,CFLAR;CASP3;CASP12
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.3984771477249235,0.9729955510253361,0.47415730337078654,0.8275072275412231,1.0,3/11,7.36%,CFLAR;CASP3;CASP12
prerank,protein heterodimerization activity (GO:0046982),0.23460024838800903,0.9726836091585789,0.5094339622641509,0.8241578994024806,1.0,11/178,4.06%,BMP6;TCF4;ARNT2;ATP1A2;EPAS1;GPHB5;TENM3;ZHX2;DGKD;BCL2;TENM2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.36755057903786137,-0.9726109613063988,0.4864864864864865,0.8114959508296182,1.0,9/16,32.49%,RPS3;CD38;SMUG1;NEIL1;ADPRH;TDG;BST1;OARD1;NEIL3
prerank,DNA-binding transcription factor binding (GO:0140297),-0.2228567152301619,-0.9721686395110477,0.5145413870246085,0.809087964422033,1.0,57/189,21.45%,MEF2C;LMO2;TLE4;PPARD;MEF2A;KLF4;NCOR1;ZBTB7A;PRDM16;HDAC7;HDAC9;WWP2;CTBP1;BHLHE40;PTMA;USF2;TLE3;ATF4;CHCHD2;HSPB1;HCFC1;CBX5;HDAC4;TAL1;DHX9;NFATC1;RB1;TWIST1;HHEX;ZMYND8;DDRGK1;MTA1;MTA2;GABPA;PSMC5;YWHAZ;HES1;MIER2;LDB1;SRF;DDX20;MIER1;SP1;TCF3;RELA;KDM1A;CHD4;STAT1;SKI;ZFPM2;SMAD2;RBL1;TLE2;ZBTB49;HCLS1;TAF9;TLE6
prerank,high voltage-gated calcium channel activity (GO:0008331),0.41455111794155075,0.9719590479058209,0.5126050420168067,0.8218040719499844,1.0,3/10,8.28%,CACNB1;CACNB4;CACNB2
prerank,glucuronosyltransferase activity (GO:0015020),-0.34932028975334983,-0.971865031589318,0.47866419294990725,0.8063567188766572,1.0,1/19,0.72%,CSGALNACT1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.34209646048170533,0.9697129137498822,0.5244444444444445,0.8233711419876014,1.0,4/21,5.80%,PRKACA;AKAP8L;ACBD3;ARFGEF2
prerank,calcium channel inhibitor activity (GO:0019855),-0.4051923769501118,-0.9676141014678742,0.5104364326375711,0.8135685151436258,1.0,3/11,4.20%,MCUB;CALM1;FKBP1A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.2724895193707793,-0.965536112905576,0.5258964143426295,0.8156587258383666,1.0,13/54,17.73%,ACER2;TGM2;HDAC9;HDAC4;PIGL;ASAH2;GLS;ACER3;HINT1;FAAH;MIER2;MIER1;AMDHD2
prerank,transcription coregulator binding (GO:0001221),0.2842034844282843,0.9654408776720342,0.5134575569358178,0.8301967516227398,1.0,14/50,17.21%,RORA;AR;SMAD3;CTCF;CHD6;AHR;EHMT2;PER3;PGR;EZH2;CDK9;THAP7;MTF2;USP11
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.31878610603115215,-0.964589244365838,0.5427435387673957,0.8146336637070687,1.0,6/28,18.78%,DAB2IP;RIPK1;TRAF1;MADD;STAT1;BABAM2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.4148678049462974,-0.9622217243430742,0.5177304964539007,0.8134756128768105,1.0,6/10,41.41%,DUSP4;DUSP1;DUSP6;DUSP7;DUSP5;DUSP2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.4148678049462974,-0.9622217243430742,0.5177304964539007,0.8134756128768105,1.0,6/10,41.41%,DUSP4;DUSP1;DUSP6;DUSP7;DUSP5;DUSP2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.40879633129369475,-0.9586376154983126,0.5196428571428572,0.8188304242578672,1.0,7/10,41.65%,NCF2;CYBB;NOX1;NCF1;NOX3;NCF4;DUOX1
prerank,syntaxin-1 binding (GO:0017075),0.33612859969153436,0.9566135948383242,0.5088105726872246,0.8491265911747833,1.0,10/22,20.20%,UNC13C;DAPK1;SYT1;CPLX2;SNAP25;SYP;STXBP3;VAMP3;SYNPR;STXBP5
prerank,fatty acid synthase activity (GO:0004312),-0.4116618575030171,-0.9557957436269101,0.5271739130434783,0.8226090192496364,1.0,3/10,18.46%,ELOVL7;ELOVL5;ELOVL1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3425959323793045,0.9557755774684739,0.48822269807280516,0.8426770466761915,1.0,4/21,10.58%,CDK8;CDK14;CDKL3;CDK20
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3425959323793045,0.9557755774684739,0.48822269807280516,0.8426770466761915,1.0,4/21,10.58%,CDK8;CDK14;CDKL3;CDK20
prerank,semaphorin receptor binding (GO:0030215),-0.32947903324506567,-0.9551508471894627,0.5317164179104478,0.8209572416348737,1.0,3/23,1.46%,SEMA6A;SEMA3C;SEMA7A
prerank,PDZ domain binding (GO:0030165),0.2757497947165703,0.9515127978735386,0.5174537987679672,0.8495646528535749,1.0,8/61,8.00%,TGFBR3;ARHGAP29;PLEKHA2;GRID2;SLC22A4;PRKN;CXXC4;NLGN1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.3913596547362362,-0.9505579694574009,0.5472061657032755,0.8290184337207936,1.0,6/12,20.07%,CDK6;BRD4;CDK4;CCNK;CDK13;CDK19
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.2867743440113355,-0.9496907748334324,0.5213178294573644,0.8278756294941498,1.0,14/38,23.49%,PARD3;DENND1A;DAB2IP;ZFYVE26;TECPR1;JPH2;HIP1;KIF16B;PHLDA3;PLEKHF1;SNX3;WIPI2;RUBCNL;PLEKHA4
prerank,histone methyltransferase activity (GO:0042054),0.30705586809288304,0.949244451729274,0.5266666666666666,0.8513979300053918,1.0,9/32,15.50%,PRDM9;MEN1;SMYD1;SETD7;SMYD3;EHMT2;NSD3;EZH2;KMT5B
prerank,double-stranded DNA binding (GO:0003690),0.20094153936807452,0.9461191634556491,0.6600719424460432,0.8551783931991784,1.0,62/531,10.33%,TCF4;ARNT2;ZBTB20;MAF;TBX3;HLF;RBMS1;DMC1;RARB;GLI2;TEAD1;ZIC1;TBX18;HOXC4;NFAT5;DLX3;TFEC;CREB5;CREB3L1;GLI3;RUNX3;TBX21;TFCP2;KLF15;PKNOX2;HOXC8;CAMTA1;FOSB;PHOX2A;HOXB8;CEBPB;TOP1;BBX;LIN28B;HOXC9;SETMAR;NFIX;FOXA2;ZNF296;DMRTA2;LHX4;CUX1;CRY1;MEN1;RFX7;SIX4;RARG;RAD51B;GLIS1;CREB3L4;CREB3;FOXD3;HES5;ZBTB45;GATA3;ZIC4;HOXC10;HOXB9;CUX2;FOXR2;SKOR2;PAX1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.31844132886941706,-0.9453675970233597,0.5358490566037736,0.8352045908183634,1.0,8/25,17.22%,ARAP3;HIP1R;AKT1;HIP1;MAPKAP1;KIF16B;PHLDA3;GAB2
prerank,sterol transfer activity (GO:0120015),-0.3577620182472302,-0.9444727979323343,0.5282651072124757,0.8338882401172758,1.0,5/17,12.46%,PLTP;ABCG1;GRAMD1C;GRAMD1A;STARD5
prerank,glucose transmembrane transporter activity (GO:0005355),-0.34505816575139026,-0.9438866564094621,0.5439560439560439,0.8319682948153281,1.0,5/17,19.04%,SLC2A1;MFSD4A;SLC2A8;SLC2A3;SLC2A4
prerank,single-stranded DNA helicase activity (GO:0017116),-0.33537674469278794,-0.9428745558457474,0.5393053016453382,0.8309882293027114,1.0,12/19,36.76%,DHX9;POLQ;HELQ;RFC3;RFC2;MCM5;DSCC1;DNA2;CHTF18;PIF1;HELB;RAD51
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.34010355324125824,-0.9417254355927004,0.518796992481203,0.8304947482085011,1.0,6/20,12.27%,EIF3F;USP7;OTUD5;OTUB1;USP9X;COPS5
prerank,voltage-gated anion channel activity (GO:0008308),-0.36277676213457427,-0.940910685119882,0.5506445672191529,0.8291702309666381,1.0,5/15,15.93%,ANO6;ANO1;CLCN3;GPR89B;GPR89A
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.3872852623019641,0.9398584877637831,0.5465393794749404,0.8669202682304873,1.0,1/12,1.29%,GPR88
prerank,MAP kinase kinase activity (GO:0004708),-0.35625949605021456,-0.936587453475532,0.5482695810564663,0.8364652808204728,1.0,2/15,4.05%,MAP2K5;MAPKAPK3
prerank,leucine zipper domain binding (GO:0043522),0.4160835650425486,0.9362359455747842,0.5192307692307693,0.8716687512140684,1.0,5/10,19.19%,PAWR;PMF1;CRX;DDIT3;AATF
prerank,cGMP binding (GO:0030553),-0.38201436908045827,-0.9361888824295719,0.5586080586080586,0.8340161781699758,1.0,2/11,4.44%,PDE5A;PDE2A
prerank,CXCR chemokine receptor binding (GO:0045236),0.3850467021717807,0.9361463132783217,0.5466666666666666,0.8676998759104168,1.0,4/11,20.23%,PPBP;CXCL1;CXCL12;CXCL10
prerank,symporter activity (GO:0015293),-0.40273628950790163,-0.9350602167660533,0.5526802218114603,0.8332166312536218,1.0,2/10,6.59%,SLC5A6;MFSD2A
prerank,ion gated channel activity (GO:0022839),0.3306872304251131,0.9345044275617228,0.5400410677618069,0.8678214537139376,1.0,4/24,6.66%,KCNT2;ANO7;ANO3;TRPM5
prerank,SUMO binding (GO:0032183),-0.37520345585563286,-0.9328212331710098,0.5432098765432098,0.8351730274390977,1.0,6/13,25.98%,HERC2;RNF111;UBA2;SERBP1;USPL1;TDG
prerank,ATPase binding (GO:0051117),0.2596154593394105,0.9322890993162181,0.5888429752066116,0.8693037517292642,1.0,11/71,10.09%,AR;ATP6V0A4;ABCA1;SLC2A13;ANK2;METTL21A;TMTC4;ANK1;ATXN3;NKD2;ALDOB
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.3917485605520352,-0.9321860137839489,0.5555555555555556,0.8333812375249501,1.0,2/11,13.77%,PRMT8;PRMT3
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.38006206005976806,-0.9314068433844602,0.5346358792184724,0.8319297659660758,1.0,8/12,42.93%,CBR1;NQO1;NQO2;DCXR;DHRS4;NDUFS7;AIFM2;CRYZ
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.2449270531463761,0.9310319701716575,0.564870259481038,0.8682520368631956,1.0,12/91,8.47%,SVIL;FRMPD4;SH3PXD2B;WDR45B;SNX14;WIPI1;GBF1;SNAP91;SYTL2;TULP3;GSDMD;SCIN
prerank,palmitoyltransferase activity (GO:0016409),-0.3018321835370271,-0.9218017284841646,0.6019607843137255,0.8521924405157938,1.0,12/28,31.27%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC5;ZDHHC23;ZDHHC12;ZDHHC17;ZDHHC18;HHAT;ZDHHC3;GOLGA7B;ZDHHC24
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.35010342605210487,-0.9209056436420824,0.579047619047619,0.8508792691297248,1.0,6/15,22.90%,PI4K2A;PIK3C2A;PIK3R3;PIK3CA;PIK3C2B;PIK3CG
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.26010142168839684,-0.9208640433627734,0.6092843326885881,0.8476550835337201,1.0,11/55,11.49%,ITPR2;TRPC3;TRPM7;TMEM165;ATP2C1;ANXA2;PKD1;ATP2A3;TRPV4;ORAI1;ATP2B3
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.21946141794118534,0.920732041374326,0.6384180790960452,0.8893163776706412,1.0,22/173,9.40%,ZBTB20;TBX3;MXI1;ZEB1;TRPS1;TBX18;MITF;PPARA;PRDM5;TFEC;CREB3L1;ZEB2;TBX21;AEBP1;CEBPB;BCL11A;FOXD3;HES5;CTCF;ZBTB45;KCNIP3;GATA3
prerank,O-methyltransferase activity (GO:0008171),0.39936218414081137,0.9203771276845304,0.5403050108932462,0.8860338977503202,1.0,3/10,15.43%,HENMT1;COMT;BCDIN3D
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.27804117123539074,-0.9199735430286724,0.5777351247600768,0.8465461234393958,1.0,9/42,19.03%,CCND3;CCNY;CDKN1B;CCNG2;CCNF;CCNK;CDKN1A;CDKN2C;CCND1
prerank,ribosomal large subunit binding (GO:0043023),-0.3821929096473292,-0.9199439319003389,0.5855379188712522,0.8433289670658682,1.0,5/11,35.72%,NMD3;LTN1;NPM1;RBM3;CPEB2
prerank,protein phosphatase regulator activity (GO:0019888),0.2715446270383933,0.9152062911771313,0.6004273504273504,0.8944984639101775,1.0,3/53,2.77%,RCAN2;PTN;DMPK
prerank,monocarboxylic acid binding (GO:0033293),0.33629488559923176,0.9151106634932888,0.5495689655172413,0.8905246307879578,1.0,1/18,1.09%,NR2F2
prerank,thyroid hormone receptor binding (GO:0046966),-0.2974000685859677,-0.9150304508481695,0.5902527075812274,0.851604184626855,1.0,4/28,7.80%,JMJD1C;NCOR1;TACC1;MED24
prerank,MAP kinase activity (GO:0004707),-0.3575441240850514,-0.9146166110732008,0.5787545787545788,0.8492162960899905,1.0,2/14,2.72%,NLK;MAPK3
prerank,ubiquitin binding (GO:0043130),-0.24707426170386243,-0.91283949535775,0.6398390342052314,0.8500181104971523,1.0,19/73,16.21%,MVB12B;ASCC2;N4BP1;HSPB1;UBE2L6;PLAA;OTUB1;RNF185;UCHL1;TOLLIP;USP5;UBXN1;SPRTN;FAF2;VPS36;TSG101;TOP2A;UCHL3;WDR48
prerank,alkali metal ion binding (GO:0031420),0.3668620243288672,0.9128104469655309,0.5631929046563193,0.8919252277454907,1.0,1/13,0.52%,ATP1A2
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.29356694100786346,-0.9112422249802342,0.6114285714285714,0.8506218332565638,1.0,12/29,34.27%,PTPRJ;GCH1;MAPKAPK3;NFATC1;ACE;CDK5RAP3;DUSP4;DUSP1;DUSP6;DUSP7;MAPK7;ABL1
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.32205768661770073,-0.9092370058089805,0.6170212765957447,0.85206980674666,1.0,5/20,14.05%,SLC39A10;SLC39A8;SLC39A1;SLC39A11;SLC39A7
prerank,P-type ion transporter activity (GO:0015662),-0.3621969895433217,-0.9090762856927519,0.5925233644859813,0.8491795035882433,1.0,7/12,32.26%,ATP2C1;ATP2A3;ATP2B3;ATP2B1;ATP7B;ATP2C2;ATP2A1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.3725724313379092,0.9079933653188634,0.5469107551487414,0.8993726434113595,1.0,5/12,14.36%,PDE7B;PDE3A;PDE3B;PDE4B;PDE4A
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.3934306208003574,-0.9075399998796885,0.5942028985507246,0.8493659069693313,1.0,7/10,27.47%,DPP4;FAP;PRCP;DPP8;DPP7;NAALAD2;DPP9
prerank,calcium-release channel activity (GO:0015278),-0.3357326620953095,-0.9069191157983478,0.5942028985507246,0.8474528216294684,1.0,2/17,3.83%,ITPR2;ITPR3
prerank,chloride channel activity (GO:0005254),0.261690106589455,0.9068819394823668,0.6237623762376238,0.8978006165560541,1.0,17/59,16.79%,ANO7;CLCN2;GABRA2;GABRR3;GLRB;GABRB3;FXYD1;ANO3;GABRR2;CLCN1;GABRA5;CLCN6;ANO5;GLRA3;GABRG1;GABRB1;GABRG3
prerank,histone acetyltransferase binding (GO:0035035),0.32286854896177464,0.9067253899265522,0.567032967032967,0.894123614652805,1.0,5/21,8.34%,EPAS1;GLI3;TRIP4;SIRT2;CITED2
prerank,endopeptidase activity (GO:0004175),0.20435282943956756,0.906659223006528,0.7197696737044146,0.8901644211804791,1.0,29/257,12.01%,ADAMTS6;ADAMTS12;ADAM33;ADAMTS10;TRABD2B;PRTN3;ADAMTS5;RHBDL3;CORIN;SFRP1;MMP16;OMA1;USP37;MMP11;PLG;CASP3;PCSK2;PSMA3;SENP1;PSMA7;USP29;PARL;USP40;ECE2;EEF1AKMT4-ECE2;ADAMTS9;USP47;THOP1;USP25
prerank,amyloid-beta binding (GO:0001540),-0.2346283945749723,-0.9025159201936259,0.6412825651302605,0.8542047979512672,1.0,10/79,7.95%,COL25A1;APBB2;ITM2A;FZD6;FZD4;TGFB2;PFDN5;BACE1;CST3;INSR
prerank,chemokine binding (GO:0019956),0.2949196900149911,0.9012835782537855,0.6093418259023354,0.8990424470157637,1.0,5/30,8.73%,CCR6;ACKR2;ACKR4;CCR10;CCR9
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.36116924648451665,-0.8975852329064294,0.6,0.8615250701604311,1.0,4/12,24.64%,TRAF1;STAT1;BABAM2;TRAF6
prerank,chloride channel inhibitor activity (GO:0019869),-0.38439701369180473,-0.897258784498879,0.5951492537313433,0.8589562448137433,1.0,2/10,6.19%,WNK1;STX1A
prerank,transcription corepressor binding (GO:0001222),0.2990902162361615,0.8961990170939512,0.587991718426501,0.9073866304149085,1.0,8/27,18.41%,RORA;EHMT2;PER3;EZH2;THAP7;MTF2;USP11;PER1
prerank,clathrin adaptor activity (GO:0035615),-0.35167617376440924,-0.8957686983867817,0.6238698010849909,0.8589015997855036,1.0,8/15,31.58%,HIP1R;AP2M1;HIP1;AP2A1;AP2A2;AP1G2;AP1G1;AP2B1
prerank,chemokine activity (GO:0008009),0.2948092705260432,0.8951859291428861,0.6169772256728778,0.9056965320926064,1.0,6/31,16.05%,CXCL16;PPBP;CCL25;CXCL1;CXCL12;CKLF
prerank,alpha-tubulin binding (GO:0043014),0.29592529144434665,0.8947233902430228,0.5873015873015873,0.9027721732517985,1.0,6/31,10.11%,EML4;DLEC1;PACRG;DNAL1;CDK5R1;TBCEL
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.2788376506831808,-0.8937400144928263,0.6029411764705882,0.8602089501294807,1.0,16/33,38.19%,CNOT7;ERI1;DIS3L2;PAN2;DIS3;NOCT;EXOSC9;XRN2;EXD2;ISG20;ANGEL2;DCP2;ANGEL1;PDE12;ERI2;USB1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.2716706717013996,0.8920627875557838,0.6369565217391304,0.9047419051982921,1.0,16/44,16.33%,KMT2A;PRDM9;SETMAR;KMT5C;MEN1;NSD1;SMYD1;CXXC1;SETD7;SMYD3;EHMT2;NSD3;SETD5;EZH2;KMT5B;WDR82
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.2755633981261488,-0.8916228361352045,0.6329787234042553,0.8618762475049899,1.0,14/35,23.86%,QRSL1;DUS2;TRMT9B;GATC;QTRT2;TRDMT1;QTRT1;TRPT1;ELAC1;PTRH2;AARS2;MRPL58;TYW3;GATB
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.21211950846547334,0.8904614410024836,0.7208872458410351,0.9046673940761083,1.0,10/181,2.73%,TCF7L2;ARNT2;LDB2;AR;TBX3;PRRX1;NCOA2;PPARA;SMAD3;TTC8
prerank,GABA receptor binding (GO:0050811),-0.3732179436038436,-0.8876399900528112,0.6220183486238532,0.8673722665370366,1.0,3/11,6.87%,TRAK1;GABARAP;TRAK2
prerank,mRNA binding (GO:0003729),0.20397009511938066,0.8863898498811535,0.7616279069767442,0.9105625834311217,1.0,30/249,10.29%,CELF2;RBFOX1;RBMS3;SAMD4A;NOVA1;RBMS1;ZAR1;DCP1A;LARP6;DAZAP1;PABPC1L;IGF2BP2;CSDC2;DENR;KHDRBS1;ZCCHC13;RBM46;NANOS3;NYNRIN;CELF4;FUBP1;SNIP1;RBM5;SF3B6;CPEB3;PCBP3;DDX6;ESRP1;KHSRP;RIDA
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.35858832403275376,-0.8843935510615284,0.5957066189624329,0.8710813666784079,1.0,7/13,46.69%,ECH1;ECI1;IDI1;EBP;SREBF2;DCT;HSD3B2
prerank,ankyrin binding (GO:0030506),-0.3144789647872788,-0.8792098606060547,0.6497175141242938,0.8791172234286008,1.0,2/19,1.48%,CDH1;SPTBN1
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.25203703460062943,-0.8782760829864955,0.6615678776290631,0.8778282850357678,1.0,15/49,26.09%,ESYT2;ANXA1;ANXA2;DYSF;CPNE8;ANXA4;RPH3A;SYT2;ESYT3;SYT15;CPNE3;ANXA3;PLA2G4F;ANXA8;DOC2B
prerank,phosphoric ester hydrolase activity (GO:0042578),0.25434148392035244,0.8757078260370019,0.6279569892473118,0.931267112286411,1.0,7/49,10.44%,ATP1A2;PLCXD1;DUSP12;PXYLP1;SMPDL3B;HDHD2;LHPP
prerank,RNA polymerase II complex binding (GO:0000993),-0.2768488473429814,-0.8752253689704876,0.6463878326996197,0.8807113046634005,1.0,13/32,34.53%,RPRD1B;ZNF326;BRD4;DHX9;SMYD2;PCIF1;CCAR2;SCAF1;RPRD1A;RTRAF;ESRRB;PCF11;ELOF1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.3388920829526717,0.8738865292375687,0.6260683760683761,0.9313629667723152,1.0,2/15,3.32%,PLA2G4A;SH3PXD2B
prerank,single-stranded RNA binding (GO:0003727),-0.25912491502699364,-0.8732851946616732,0.6647398843930635,0.8817039833376725,1.0,11/43,20.17%,STRBP;IFIH1;CNBP;SNRPC;DHX9;JMJD6;DHX58;FMR1;HNRNPA1;SRA1;RBM7
prerank,carboxypeptidase activity (GO:0004180),0.2775347647136571,0.872465798737993,0.6637168141592921,0.9303901044976968,1.0,8/35,11.50%,AGBL4;CPZ;AEBP1;CPA6;PEPD;CPXM1;NAALADL1;FOLH1
prerank,bHLH transcription factor binding (GO:0043425),0.3213347579225095,0.8712248239316315,0.6268041237113402,0.9290727421878998,1.0,2/19,2.72%,FHL2;SMAD3
prerank,telomeric DNA binding (GO:0042162),-0.27736922495763944,-0.8648314286127451,0.6634241245136187,0.8959229555329774,1.0,15/32,35.72%,HMBOX1;HNRNPA2B1;NCL;UPF3A;KDM1A;ZBTB48;SMG7;SMG1;UPF1;TERF2IP;PIF1;SMG6;RAD50;TERT;PURA
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.3484737754315893,-0.8629191740562344,0.6459074733096085,0.8965773488993237,1.0,4/12,18.13%,H3-3A;POU2F1;RELA;STAT1
prerank,nuclease activity (GO:0004518),0.2506825467976741,0.862806796197552,0.6881496881496881,0.9442450295634143,1.0,8/52,13.71%,ENPP1;SETMAR;EXOG;ANG;RNASE4;REXO5;PARN;ANKLE1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.2940865216742585,-0.8599327237261389,0.6605691056910569,0.899519956502765,1.0,5/22,15.00%,MESD;AP2M1;DNAJA1;APOE;AP2A1
prerank,endoribonuclease activity (GO:0004521),0.27959756308670414,0.8588818518304545,0.6810344827586207,0.9488062926764722,1.0,11/32,22.17%,NYNRIN;EXOG;RIDA;PIWIL2;ENDOV;RCL1;RNASEL;AGO3;AGO1;AGO2;DICER1
prerank,voltage-gated ion channel activity (GO:0005244),0.3359983341840398,0.8568856311451591,0.6334056399132321,0.9491431199561555,1.0,4/14,10.69%,CACNA1E;VDAC2;KCND2;VDAC3
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.35781314019181376,-0.854537116029385,0.6478102189781022,0.9070038494439692,1.0,3/11,14.06%,KCNQ1;KCNJ8;KCND3
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.342157605662495,0.8542410573391712,0.6545842217484008,0.9508390749640382,1.0,6/13,24.64%,FTSJ1;TARBP1;TRMT1L;THUMPD2;TRMT5;THUMPD3
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2411236481663583,0.8518600501986285,0.7233201581027668,0.9518851390407586,1.0,7/60,11.83%,PPM1E;LRRK1;ILKAP;PPM1D;PPM1H;PTEN;TAB1
prerank,methyl-CpG binding (GO:0008327),0.299316314312617,0.8509237877893809,0.6741573033707865,0.9499793455060477,1.0,5/22,13.17%,MBD2;LHX4;CXXC4;CXXC5;ERH
prerank,channel activity (GO:0015267),0.2639484825961473,0.8486659381498642,0.692144373673036,0.9506565307318333,1.0,7/41,13.54%,CHRNA1;STEAP1;BCL2;TRPM5;TRPA1;CHRNA7;CHRNB1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2366386054549319,0.846058141333436,0.734,0.9519428394641497,1.0,18/69,18.57%,PLA2G4A;BAAT;MOGAT3;KAT8;DBT;MOGAT2;ZDHHC2;PLAAT5;EP300;ASPG;MCAT;DGAT2;CERS6;PORCN;CERS4;ZDHHC15;ZDHHC6;GTF2B
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.26205105903980497,-0.845830569034654,0.6969147005444646,0.9209694490023512,1.0,15/34,38.19%,CNOT7;ERI1;DIS3L2;PAN2;DIS3;NOCT;EXOSC9;XRN2;EXD2;ISG20;ANGEL2;ANGEL1;PDE12;ERI2;USB1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.35573148894372036,0.8455287448672424,0.6385809312638581,0.9492597802731729,1.0,1/11,3.33%,CNGB3
prerank,miRNA binding (GO:0035198),0.2764892192529837,0.8441099630747386,0.6836935166994106,0.9482778172812867,1.0,10/30,22.50%,TUT4;AGO4;SOX2;PNPT1;RBM10;AGO3;AGO1;AGO2;ZC3H7B;MATR3
prerank,transferrin receptor binding (GO:1990459),-0.3617982182518248,-0.843065304217242,0.6873857404021938,0.9230262878498322,1.0,6/10,37.29%,CD81;IKBKB;CHUK;SNX2;IKBKG;SNX1
prerank,N-acetyltransferase activity (GO:0008080),0.30680492399297243,0.8417003641193653,0.6681318681318681,0.94952055632833,1.0,2/19,5.52%,NAT8;SAT1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.2795679306236824,-0.8414759348257718,0.7040618955512572,0.9228257266385956,1.0,10/27,24.64%,RNF144B;DCUN1D5;RNF125;DCUN1D1;TOLLIP;FOXL2;RNF19A;ZMYM2;DCUN1D3;TRAF6
prerank,potassium channel regulator activity (GO:0015459),0.24743887659328376,0.8387544470549768,0.7211155378486056,0.9513990912414203,1.0,10/49,16.22%,KCNIP4;DPP10;SLC5A3;SUMO1;KCNIP3;AMIGO1;DPP6;KCNS3;KCNS1;WNK3
prerank,FMN binding (GO:0010181),-0.3503995887812985,-0.8358507501864418,0.6785046728971963,0.9305227573022967,1.0,2/11,7.39%,NOS3;DUS2
prerank,galactosyltransferase activity (GO:0008378),-0.3485789236480077,-0.8347617978931257,0.6924398625429553,0.9293658297440207,1.0,3/11,14.54%,A4GALT;B4GALT4;A3GALT2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.35179102888719377,0.8346413092320532,0.6779661016949152,0.9558894131806712,1.0,2/10,12.45%,ADARB2;CDADC1
prerank,myosin V binding (GO:0031489),-0.31836226165048986,-0.8339500291662042,0.6841155234657039,0.9276830953477659,1.0,4/15,11.21%,RAB11A;RAB6B;RAB8A;RAB11B
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.34966823534986086,-0.8336936901519975,0.6892655367231638,0.9249306265517745,1.0,2/11,12.76%,DCPS;NUDT4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.2815960272186468,-0.8331232442245956,0.7315689981096408,0.9228002328675982,1.0,8/24,24.73%,CERT1;DAB2IP;JPH2;PLEKHF1;SNX3;RUBCNL;GOLPH3;GOLPH3L
prerank,1-phosphatidylinositol binding (GO:0005545),0.3194362584907341,0.8321377195635064,0.6872246696035242,0.9570856775841056,1.0,5/15,16.51%,SNAP91;SCIN;SNX9;ZFYVE1;ZFYVE9
prerank,3'-5' exonuclease activity (GO:0008408),-0.24447561973980614,-0.8312032774000938,0.7504761904761905,0.9231571459157809,1.0,21/45,38.19%,CNOT7;ERI1;RAD1;DIS3L2;REV3L;PAN2;RAD9A;EXD1;DIS3;NOCT;MRE11;EXOSC9;XRN2;EXD2;ISG20;RAD50;ANGEL2;ANGEL1;PDE12;ERI2;USB1
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.2723676187803816,-0.8301124616590946,0.7134935304990758,0.9219526464312755,1.0,10/26,29.74%,PPP1R1A;PABIR1;PPP1R8;LMTK2;BOD1;ARPP19;PPP1R14B;STYXL1;PPP1R1B;MGAT5
prerank,phosphatase inhibitor activity (GO:0019212),0.2987624928187875,0.8269089161144643,0.6817204301075269,0.963197427362471,1.0,1/20,0.69%,PTN
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.31385820484884475,-0.8265113451099616,0.717948717948718,0.9223026549640444,1.0,4/16,9.52%,ATP6V0B;ATP6V0A2;ATP5F1B;ATP6V0C
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.31385820484884475,-0.8265113451099616,0.717948717948718,0.9223026549640444,1.0,4/16,9.52%,ATP6V0B;ATP6V0A2;ATP5F1B;ATP6V0C
prerank,phosphatase activator activity (GO:0019211),0.32785975810399676,0.8258411967359828,0.6787330316742082,0.9614371953013616,1.0,1/14,0.56%,BMP2
prerank,snRNA binding (GO:0017069),-0.24778511011593796,-0.8244077743650029,0.7748091603053435,0.9229391047257022,1.0,14/42,23.27%,PRPF8;SNRPC;SNRPA;RBM22;SNRPD3;LSM11;EFTUD2;DDX39B;LSM2;RBM7;MEPCE;LSM7;LSM10;NCBP2
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.2546261429377509,-0.8225777150044203,0.730188679245283,0.9230348826157209,1.0,7/33,18.03%,RPRD1B;ZNF326;DHX9;MAF1;SMYD2;ERBB2;CCAR2
prerank,endodeoxyribonuclease activity (GO:0004520),-0.29299192563288745,-0.8223353531264168,0.7228464419475655,0.9203491322439865,1.0,9/20,33.06%,RPS3;ERCC1;DCLRE1C;ERCC4;EXO1;DNA2;MRE11;ENDOG;RAD50
prerank,DNA polymerase binding (GO:0070182),-0.29832856104862143,-0.8214799530645677,0.7155797101449275,0.9188548578518639,1.0,7/18,37.43%,HSP90AB1;SMARCA4;HSP90AA1;FANCD2;SMG6;RAD51;LONP1
prerank,tubulin binding (GO:0015631),0.18700892747126124,0.8195986282739969,0.9245283018867925,0.9698027963653287,1.0,56/295,16.05%,GJB6;MTUS2;GJA1;IFT81;KIF13B;TTLL11;EML4;AGBL4;KIF5C;UXT;DLEC1;TTLL9;PRKN;MAP9;ATF5;CEP295NL;MDM1;SAXO2;GPAA1;TUBGCP4;PACRG;UNC5C;DNAL1;KIF7;ALMS1;IFT74;GOLGA2;CAMSAP1;CDK5R1;FSD1;KIF21A;TBCEL;KIF3C;BRSK1;DYNC1I1;EML1;B9D2;KIF3A;MAP10;NAV3;VBP1;MACO1;KIF1A;KIF6;TUBGCP2;MAPT;DLGAP5;CEP57L1;SPAST;MAP6;PAK1;CKAP5;CCDC181;ABRAXAS2;SVBP;DAG1
prerank,retinoid X receptor binding (GO:0046965),0.3465390050271894,0.8190063934555722,0.6770601336302895,0.9669268625267341,1.0,3/11,7.95%,VDR;RARG;NSD1
prerank,kinesin binding (GO:0019894),-0.27156948220710714,-0.8185844762520221,0.7325800376647834,0.9206200393825145,1.0,4/27,14.50%,ACTB;PLEKHM2;KIF1B;SPAG9
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.2793822914760429,-0.8139544105165063,0.748015873015873,0.9258965290894722,1.0,10/24,31.27%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC23;ZDHHC12;ZDHHC17;ZDHHC18;ZDHHC3;GOLGA7B;ZDHHC24
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3079153433574325,0.8125736945106534,0.7027027027027027,0.9753118988311031,1.0,3/17,12.47%,NME3;CMPK1;NOL9
prerank,histone demethylase activity (GO:0032452),-0.2665390874327678,-0.8112698051999685,0.7616387337057728,0.9274260842862769,1.0,6/27,17.76%,JMJD1C;KDM5C;KDM3A;JMJD6;KDM6A;KDM1A
prerank,regulatory RNA binding (GO:0061980),0.25703297312699075,0.8097850951812836,0.76875,0.9764498700470773,1.0,12/38,22.50%,TUT4;AGO4;SOX2;PNPT1;PIWIL2;RBM10;AGO3;AGO1;AGO2;DICER1;ZC3H7B;MATR3
prerank,pyrophosphatase activity (GO:0016462),-0.2286432244657458,-0.8060489315914054,0.8019607843137255,0.9328842315369261,1.0,9/50,12.76%,ENTPD1;PLPP1;DCPS;DHX9;PRUNE1;PRUNE2;ENTPD7;ENTPD6;NUDT4
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.32385205777469306,-0.8031650021535578,0.7140319715808171,0.9346058713138508,1.0,6/12,39.64%,DCPS;NCBP2;EIF4E;CYFIP2;CYFIP1;NCBP1
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.20868527903257747,-0.7986609261564671,0.8884462151394422,0.9386987614175623,1.0,18/85,22.94%,ABHD2;MGLL;NDST3;PNPLA2;PGLS;PLAAT3;PON3;FAAH;LYPLA1;DAGLB;LCAT;GDE1;PTRH2;ABHD8;AARS2;MRPL58;PLA2G4F;ENPP2
prerank,cyclic nucleotide binding (GO:0030551),0.2884504855839375,0.7974242418280719,0.7430406852248393,0.9953833523301848,1.0,8/21,22.32%,RAPGEF4;CNGB3;PDE11A;PDE4B;PDE4A;KCNH1;SLC19A1;PDE10A
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.27163178337312066,-0.797409026036601,0.7813620071684588,0.9376494535681112,1.0,11/22,41.41%,PPM1F;DUSP3;DUSP23;DUSP4;MTMR2;DUSP1;DUSP6;DUSP7;DUSP5;MTMR3;DUSP2
prerank,magnesium ion binding (GO:0000287),-0.19239466971799624,-0.7968442391796389,0.935871743486974,0.9354317680428617,1.0,52/135,35.66%,MAP3K5;NLK;MAP3K20;PI4K2A;PDE2A;PGM1;SRPK1;DYRK2;HACL1;CDC42BPB;ABL2;DIS3L2;STK38;NUAK2;TOP2A;STK38L;STK26;OPA1;XYLT2;UBA2;MAPK12;IDH3A;MAP3K6;GCLC;SNRK;NUDT18;ADPRH;NME1;SIK1;RRAGC;FAN1;BRSK2;PDCD6;TDG;SIK3;ERN1;YDJC;EXD2;PIF1;DCTPP1;PLK1;FIGNL1;FOXK2;SRR;ABL1;DYRK3;THG1L;MAP2K7;MSH6;THTPA;IDH1;OXSR1
prerank,chloride channel regulator activity (GO:0017081),-0.30926274557198374,-0.7940806086394196,0.7628458498023716,0.9367821733582017,1.0,2/14,6.19%,WNK1;STX1A
prerank,carbohydrate:cation symporter activity (GO:0005402),0.3301269104405905,0.7931174142206345,0.7125603864734299,0.9990336721683573,1.0,1/11,2.72%,SLC5A3
prerank,Hsp70 protein binding (GO:0030544),-0.2560989937531768,-0.791903477130141,0.7854330708661418,0.9370963954444053,1.0,12/31,29.63%,RPS3;DNAJC8;DNAJB12;DNAJA1;NOD2;IQCG;DNAJB1;PPEF2;FICD;ERN1;PPID;RNF207
prerank,microtubule minus-end binding (GO:0051011),0.3192298096100578,0.791111577171898,0.7303370786516854,0.9987492067531716,1.0,4/13,16.91%,TUBGCP4;CAMSAP1;TUBGCP2;NUMA1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.3066281130231363,-0.7894089824016225,0.7406716417910447,0.937983966919581,1.0,4/15,20.60%,AGPAT1;ABHD8;AGPAT5;LPCAT2
prerank,iron ion binding (GO:0005506),0.23180068531380396,0.7849301657520347,0.8163265306122449,1.0,1.0,6/48,8.82%,AGMO;HEPH;KDM7A;SCD5;PHYH;FTO
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.21555516174123263,0.7844376011117061,0.8469387755102041,1.0,1.0,6/73,7.65%,LGR4;MC5R;SORCS1;OPRK1;CALCR;GLP2R
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.26209808770990345,0.7835134049160807,0.7758620689655172,1.0,1.0,7/28,18.00%,TNK2;PRKACA;MAPKAPK5;AURKC;PRKCG;MAP2K4;MAPK10
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.24943634075556376,-0.7797542545540533,0.799249530956848,0.9497530912201572,1.0,6/32,19.16%,KCNB1;KCNQ1;KCNC3;KCNA4;KCNA2;KCNB2
prerank,signal sequence binding (GO:0005048),0.2455637310254435,0.779482112868629,0.8029978586723768,1.0,1.0,7/35,17.61%,CEMIP;KDELR3;TOMM70;TIMM22;KDELR2;PEX5L;IPO4
prerank,glutathione transferase activity (GO:0004364),-0.2699446326104856,-0.7789124952238299,0.7699443413729128,0.9480198179692395,1.0,10/23,30.70%,GSTA4;GSTM2;GSTA3;GSTM1;MGST3;GSTK1;GSTM5;GSTO1;MGST2;ALOX5AP
prerank,histone deacetylase activity (GO:0004407),0.29014294936744484,0.7745209196674154,0.7602591792656588,1.0,1.0,6/19,15.91%,HDAC10;SIRT2;MIER3;HDAC8;SIRT6;HDAC1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.3293990332459011,0.7744791267159027,0.723175965665236,1.0,1.0,1/10,3.17%,TATDN1
prerank,GTPase inhibitor activity (GO:0005095),-0.31543646658909186,-0.7740283550660517,0.7355072463768116,0.9521891700470029,1.0,5/13,18.52%,IQGAP1;SLIT2;RTKN;CDC42SE1;ARL2
prerank,tRNA binding (GO:0000049),-0.22776989687126614,-0.7696936642993414,0.8703007518796992,0.9553818408199678,1.0,9/43,17.70%,EEF1A1;SARS1;TRMT9B;CARS1;SARS2;TRMT10C;FARS2;RPUSD4;HSD17B10
prerank,solute:proton symporter activity (GO:0015295),0.28969570856957405,0.7696257069254496,0.7616822429906542,1.0,1.0,4/16,11.94%,SLC2A13;SLC36A2;SLC33A1;CTNS
prerank,fibroblast growth factor binding (GO:0017134),-0.2699707726486461,-0.7691898508449017,0.8011811023622047,0.9530682225293005,1.0,9/21,23.47%,THBS1;RPS19;CEP57;S100A13;FIBP;FGFRL1;ITGB3;API5;FGFR3
prerank,phosphatase activity (GO:0016791),0.2099413663506698,0.7670407505096699,0.8744493392070485,1.0,1.0,29/73,25.72%,ATP1A2;DUSP12;PXYLP1;PLPP3;PLPPR1;HDHD2;LHPP;LPIN3;CILP2;PLPP4;FRA10AC1;PLPPR5;PSPH;LPIN1;OCRL;DUSP28;DUSP26;NT5M;ARMT1;PLPP5;ACP5;PPP1CC;PDXP;DUSP10;BPNT2;SBF1;DUSP15;PLPPR4;DUSP8
prerank,aminopeptidase activity (GO:0004177),-0.25053042098748585,-0.7660211102298503,0.7958015267175572,0.9544712491949009,1.0,10/26,23.47%,LTA4H;ERAP1;MMP14;MMP15;LNPEP;METAP1D;BLMH;NPEPPS;LAP3;MMP17
prerank,lipid phosphatase activity (GO:0042577),0.29744620020178886,0.7657188754359449,0.7511111111111111,1.0,1.0,4/14,16.21%,PLPP3;PLPPR1;PLPPR5;PLPP7
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.30936794003587453,-0.7650613370281633,0.7840290381125227,0.9528903975488512,1.0,3/13,9.09%,SLC7A1;SLC38A5;SLC7A7
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.23374234153789605,-0.7623322950085238,0.8526522593320236,0.9535848937046542,1.0,8/34,19.80%,UBE2Q2;UBE2L6;UBE2G2;UBE2F;UBE2Q1;UBE2G1;UFC1;UBE2B
prerank,RNA polymerase binding (GO:0070063),0.2821615896369722,0.7574804354735342,0.7762863534675615,1.0,1.0,8/18,23.63%,PABPN1;YTHDC2;SCAF8;CCNT1;NEDD4;TCERG1L;BIN1;PKN2
prerank,phospholipase activity (GO:0004620),-0.2036141760625572,-0.7535820934876574,0.9109311740890689,0.9624137800348669,1.0,23/67,35.96%,PLCE1;MGLL;PLCB3;SMPDL3A;PLAAT3;PITPNM3;PLD3;LYPLA1;GDE1;PLA2G4F;ENPP2;NAPEPLD;PLD4;SMPD1;LIPH;PLA2G4B;ABHD6;SMPD2;PLCB2;FAM83B;PLB1;DDHD1;ABHD16A
prerank,motor activity (GO:0003774),0.21473819030361269,0.753465649461894,0.8804123711340206,1.0,1.0,11/60,12.83%,GPR88;KIF13B;KIF5C;DYNC2H1;KIF7;KIF21A;KIF3C;DYNC1I1;KIF3A;KIF1A;KIF6
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.2836510320519712,0.752678943119335,0.7743362831858407,1.0,1.0,9/20,26.25%,MOGAT3;MOGAT2;DGAT2;ABHD5;LCLAT1;PNPLA3;AGPAT4;PLA2G15;LPCAT1
prerank,metalloaminopeptidase activity (GO:0070006),-0.28137552553415834,-0.7460882566332616,0.8102189781021898,0.9693483695070426,1.0,5/16,13.11%,LTA4H;ERAP1;MMP14;MMP15;LNPEP
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.25320438034125053,-0.7430616239067241,0.8654970760233918,0.9701697234461893,1.0,3/27,7.05%,SLC9A2;SLC9B2;SLC4A8
prerank,kinase inhibitor activity (GO:0019210),-0.23632894199917537,-0.7423652877287853,0.8590225563909775,0.9679981729331306,1.0,12/33,28.12%,CDKN1B;TAOK3;DUS2;WARS1;TRIB1;CDKN1A;NCK1;YWHAB;CDKN1C;NPM1;SPRY4;PPP1R1B
prerank,cAMP binding (GO:0030552),-0.30574238444810603,-0.740850699246134,0.7917448405253283,0.966994136726547,1.0,2/11,4.44%,PDE4D;PDE2A
prerank,DNA secondary structure binding (GO:0000217),0.24418033104544326,0.740617678912114,0.8414376321353065,1.0,1.0,8/31,13.77%,KMT2A;GEN1;MEN1;RAD51B;BLM;RAD51C;FANCM;MAPT
prerank,gamma-tubulin binding (GO:0043015),0.2607563744265373,0.7403398615615812,0.7913043478260869,1.0,1.0,6/21,18.22%,TUBGCP4;BRSK1;B9D2;TUBGCP2;PAK1;NDRG1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.2942352153656588,0.7400987654066306,0.771689497716895,1.0,1.0,2/14,9.74%,NME3;CMPK1
prerank,N-acyltransferase activity (GO:0016410),0.23917702450577405,0.7379985464147876,0.8487394957983193,1.0,1.0,7/32,16.91%,NAT8;SAT1;BAAT;PLAAT5;EP300;CERS6;CERS4
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.28765285764269555,0.7371307214885594,0.8223234624145785,1.0,1.0,4/15,8.94%,KMT2A;PRDM9;SETMAR;CXXC1
prerank,WW domain binding (GO:0050699),0.24824825367078684,0.7337336572056085,0.8596881959910914,1.0,1.0,4/26,13.89%,TNK2;PMEPA1;LITAF;TCEAL1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.24096717579414106,-0.7317721964260393,0.857429718875502,0.9752644244221838,1.0,11/29,30.10%,ACER2;GANC;IDUA;ACER3;GUSB;NEU3;CTBS;GANAB;LCT;NEU1;HYAL2
prerank,exonuclease activity (GO:0004527),-0.21609821313951305,-0.7311920840836199,0.8787878787878788,0.9729113202167095,1.0,19/46,30.45%,CNOT7;ERI1;ISG20L2;RAD1;REV3L;DCLRE1C;AEN;RAD9A;EXOSC8;EXD1;APEX2;ENPP2;FAN1;EXO1;MRE11;EXOSC9;XRN2;EXD2;ISG20
prerank,triglyceride lipase activity (GO:0004806),-0.2584973370000675,-0.730755613831298,0.8387681159420289,0.9703348720515625,1.0,5/20,31.79%,PNPLA2;DAGLB;LCAT;LIPH;LIPE
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.29360414386090194,-0.7306472957413908,0.8364661654135338,0.9674601414455041,1.0,2/12,14.75%,CNOT7;PAN2
prerank,pentosyltransferase activity (GO:0016763),0.22883817359277253,0.7295324799176425,0.8716356107660456,1.0,1.0,14/36,24.28%,PARP16;SIRT2;PARP11;PARP3;TIPARP;SIRT6;PARP4;PARP1;PARP8;LACC1;SIRT3;ZC3HAV1;TNKS;SIRT1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.28446755267600066,0.7289468933115584,0.7838983050847458,1.0,1.0,4/14,17.70%,MTMR7;PTEN;MTMR10;MTMR9
prerank,microtubule plus-end binding (GO:0051010),-0.25134898349523127,-0.7214284501423609,0.8801498127340824,0.9755289421157685,1.0,7/20,28.44%,DCTN1;KIF18A;MAPRE2;KNSTRN;CLIP1;CLIP2;DST
prerank,exoribonuclease activity (GO:0004532),-0.28626342375248526,-0.7203607234140592,0.8171428571428572,0.973693716860757,1.0,3/12,28.17%,CNOT7;EXOSC8;EXOSC9
prerank,amino acid binding (GO:0016597),0.23219534858890198,0.7191148762941207,0.8857142857142857,1.0,1.0,8/31,18.02%,GRIN3A;GLDC;GLRB;ASS1;DDAH2;GLRA3;CASR;GRIN2B
prerank,adrenergic receptor binding (GO:0031690),0.2748104808506252,0.7191085935363375,0.8268398268398268,1.0,1.0,4/16,15.81%,MAGI2;APLP1;DLG4;NEDD4
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.29104671182026676,-0.7184217457991838,0.8354203935599285,0.9728616162171071,1.0,2/12,6.70%,JMJD1C;KDM3A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.2922436748834693,0.7145105546700393,0.8021978021978022,1.0,1.0,3/11,17.81%,DDAH2;PADI1;PADI2
prerank,carboxylic acid binding (GO:0031406),-0.21880389669811456,-0.7142749995828879,0.8985239852398524,0.9744383184849812,1.0,19/38,34.75%,NOS3;PSAP;CAD;GCLC;SESN2;HIF1AN;CASTOR2;RTN4R;SESN1;THNSL2;GRIN1;GNMT;NOS2;SRR;NOS1;EPDR1;MAG;GLRA1;SHMT2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.2892793583756837,-0.7139756801477453,0.8516483516483516,0.971807145587245,1.0,5/13,22.90%,PIP5K1B;PIK3C2A;PIK3CA;PIK3C2B;PIK3CG
prerank,chemokine receptor binding (GO:0042379),0.22427788897209944,0.7121987786383316,0.8879837067209776,1.0,1.0,6/35,16.05%,CXCL16;PPBP;CCL25;CXCL1;CXCL12;CKLF
prerank,histone acetyltransferase activity (GO:0004402),-0.226482845905965,-0.7095402048832439,0.892578125,0.9737010826831186,1.0,14/30,35.10%,BAZ1A;EPC1;NAA60;BRCA2;USP22;TAF9;TADA3;CLOCK;TAF10;KAT6B;KAT2A;NAA50;KAT14;CREBBP
prerank,methylated histone binding (GO:0035064),-0.19276948368206165,-0.7058606190665563,0.9397590361445783,0.97453733017349,1.0,8/62,9.29%,RBBP5;ING5;DPF2;MPHOSPH8;CBX5;ZMYND11;SPIN1;ZMYND8
prerank,damaged DNA binding (GO:0003684),-0.20568023066950503,-0.7000605725146984,0.9330708661417323,0.9776711636967029,1.0,10/44,19.24%,RPS3;ERCC1;RAD1;PNKP;DCLRE1C;RAD18;XRCC1;RPA3;POLQ;ERCC4
prerank,methyltransferase activity (GO:0008168),0.21081562650814667,0.6998685608568934,0.9137577002053389,1.0,1.0,12/46,21.25%,FTSJ1;HENMT1;COQ5;DNMT1;COMT;NDUFAF7;BCDIN3D;METTL3;ARMT1;METTL27;DNMT3B;GCSH
prerank,actinin binding (GO:0042805),0.24203805834247957,0.6994896517609228,0.8845315904139434,1.0,1.0,7/21,17.79%,CSRP3;MAGI1;CSRP2;PDLIM5;CSRP1;DAG1;PPARG
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.22577367486349956,0.697877240366649,0.8832271762208068,1.0,1.0,15/33,26.35%,AR;SCAF8;NCOA3;LLPH;GTF2B;RPRD2;AGO1;PAF1;WAC;AGO2;UVSSA;URI1;CTR9;SUPT4H1;ELP4
prerank,manganese ion binding (GO:0030145),0.20896653488433867,0.6967918120208592,0.9227642276422764,1.0,1.0,1/48,0.23%,ADCY2
prerank,carboxy-lyase activity (GO:0016831),-0.2388946137513085,-0.6966902446577716,0.892925430210325,0.9780499061936188,1.0,9/23,45.80%,AMD1;DDC;FAHD1;UXS1;UMPS;PCK2;GAD1;ODC1;AZIN1
prerank,ATP hydrolysis activity (GO:0140603),0.2127975665737832,0.6955774641378895,0.9042769857433809,1.0,1.0,9/41,15.44%,ABCA4;ABCD2;CLPX;SWSAP1;RHOBTB3;SMCHD1;ABCG4;MYO18A;MYO1E
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.27688678122456556,0.6913222242639621,0.8170212765957446,1.0,1.0,3/13,14.45%,ZGRF1;GEN1;ENDOV
prerank,SUMO transferase activity (GO:0019789),0.2640310231055107,0.6898137151649498,0.8509174311926605,1.0,1.0,5/16,17.92%,MDM2;TOPORS;PIAS1;PIAS2;NSMCE2
prerank,microtubule motor activity (GO:0003777),0.20083086701548897,0.6876471723248833,0.9447983014861996,1.0,1.0,9/51,12.83%,KIF13B;KIF5C;KIF7;KIF21A;KIF3C;DYNC1I1;KIF3A;KIF1A;KIF6
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.2627031193355023,0.685772680935475,0.8430493273542601,1.0,1.0,2/16,7.21%,ALOX12;TDO2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.2891462241748145,0.6793540269085141,0.8427947598253275,1.0,1.0,1/10,2.32%,PRKAG2
prerank,sequence-specific mRNA binding (GO:1990825),0.29368132543729464,0.6775619651445915,0.8533916849015317,1.0,1.0,3/10,17.31%,LARP6;RBM24;SHFL
prerank,hydro-lyase activity (GO:0016836),-0.2038711516487843,-0.6766141300324289,0.9447619047619048,0.9934801056569497,1.0,13/41,29.14%,CA4;ECHS1;UROS;ACO1;ECI1;HACD4;ACO2;ALAD;ENO1;PARK7;AUH;CDYL;HACD2
prerank,lipoprotein particle receptor binding (GO:0070325),0.22977002327603335,0.675756658450149,0.9155470249520153,1.0,1.0,10/27,25.15%,LRP1;SYT1;HSP90B1;HSPG2;CRP;LDLRAP1;APBB3;LANCL1;CLTC;RELN
prerank,general transcription initiation factor binding (GO:0140296),-0.2248648043519058,-0.675713385707723,0.9305019305019305,0.9913992909702983,1.0,6/25,17.24%,ESR1;HHEX;PSMC5;PSMC1;DRAP1;RELA
prerank,single-stranded telomeric DNA binding (GO:0043047),0.2878328618232945,0.6734124600906461,0.8487584650112867,1.0,1.0,3/11,14.56%,STN1;RPA2;RPA1
prerank,dynactin binding (GO:0034452),0.27512432021400557,0.6724144973986741,0.8571428571428571,1.0,1.0,7/12,27.57%,BICD1;MAPT;SNX6;BBS4;BICDL1;SNX5;PAFAH1B1
prerank,CoA hydrolase activity (GO:0016289),-0.2549104805404964,-0.6677619937397722,0.902803738317757,0.995146611538827,1.0,10/16,41.02%,ACAA2;ACOT8;ACOT2;HIBCH;ACOT13;ACOT1;ACOT6;ACOT7;ACOT12;ABCD1
prerank,chemoattractant activity (GO:0042056),0.22769454701728614,0.6672556383789285,0.906054279749478,1.0,1.0,3/26,7.78%,GDNF;VEGFB;SCG2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.2496048160001841,0.662768025663318,0.8659574468085106,1.0,1.0,4/16,17.70%,MTMR7;PTEN;MTMR10;MTMR9
prerank,methylation-dependent protein binding (GO:0140034),-0.18344652529166627,-0.6613806413099549,0.971042471042471,0.9974413191421311,1.0,7/57,9.29%,RBBP5;ING5;MPHOSPH8;CBX5;ZMYND11;SPIN1;ZMYND8
prerank,cardiolipin binding (GO:1901612),0.27481326130846295,0.6609308106955324,0.8444444444444444,1.0,1.0,2/10,13.86%,GSDMD;GSDME
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.2224148201880235,0.6590602244763507,0.9344608879492601,1.0,1.0,14/28,28.79%,POP4;ENDOV;DROSHA;RNASEH1;AGO3;AGO2;PRORP;DICER1;MRPL44;EDC3;DBR1;RPP14;POP1;FEN1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.22934588069675088,0.6570269924125397,0.9038854805725971,1.0,1.0,2/21,6.17%,KL;NPTN
prerank,neuropeptide hormone activity (GO:0005184),-0.22763324832468373,-0.6563531079423363,0.9281663516068053,0.9983405969126835,1.0,14/22,53.07%,AGRP;SPX;NPFF;ADCYAP1;NPY;VIP;GAL;PENK;CALCB;UCN;NMB;GRP;NPPA;GHRH
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.23501135451215624,-0.6551894473422377,0.936046511627907,0.9962287813753025,1.0,2/20,5.18%,TJP2;MAGI3
prerank,heme binding (GO:0020037),0.18345712941896378,0.6537170624435997,0.9799599198396793,1.0,1.0,15/65,18.46%,CYP27A1;PTGIS;CYP2A6;PTGES2;TDO2;CYP46A1;CYB5R4;BACH1;HCCS;HEBP1;CYP51A1;CYP26B1;STEAP4;EIF2AK1;PTGS2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.27158771520280595,0.6491312628901112,0.8850325379609545,1.0,1.0,6/11,24.63%,HSPH1;HSPBP1;BAG3;BAG4;GRPEL2;SIL1
prerank,adenyl nucleotide binding (GO:0030554),0.27158771520280595,0.6491312628901112,0.8850325379609545,1.0,1.0,6/11,24.63%,HSPH1;HSPBP1;BAG3;BAG4;GRPEL2;SIL1
prerank,pseudouridine synthase activity (GO:0009982),0.2666391791809649,0.6459346791547541,0.9004065040650406,1.0,1.0,5/13,22.76%,RPUSD2;RPUSD3;PUS7;PUS1;PUS10
prerank,AMP binding (GO:0016208),0.26760565625001215,0.6456725658941747,0.8758314855875832,1.0,1.0,1/11,2.32%,PRKAG2
prerank,serine-type endopeptidase activity (GO:0004252),0.17256096822468306,0.6452521014071457,0.9899396378269618,1.0,1.0,5/80,7.23%,PRTN3;RHBDL3;CORIN;PLG;PCSK2
prerank,endonuclease activity (GO:0004519),0.18874670480022057,0.6421090861122427,0.9611451942740287,1.0,1.0,14/49,22.43%,SETMAR;NYNRIN;EXOG;ANG;PIWIL2;ANKLE1;RCL1;RNASEL;AGO3;AGO1;AGO2;ZRANB3;DICER1;APLF
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.25443272430915,0.6358858514988386,0.8993288590604027,1.0,1.0,5/14,19.72%,KMO;MICAL1;CYB5R4;AIFM1;NOX4
prerank,RNA methyltransferase activity (GO:0008173),0.2357057660917871,0.6347183140735891,0.9065817409766455,0.9991424232582369,1.0,5/19,16.80%,FTSJ1;HENMT1;BCDIN3D;METTL3;METTL8
prerank,serine-type peptidase activity (GO:0008236),-0.1608800604714607,-0.6331238088869715,0.9959595959595959,1.0,1.0,6/96,5.99%,DPP4;F3;TPP1;FAP;PIK3IP1;RHBDD1
prerank,diacylglycerol kinase activity (GO:0004143),-0.26482588958457864,-0.6251063905325916,0.9218472468916519,1.0,1.0,1/11,1.75%,DGKH
prerank,tau-protein kinase activity (GO:0050321),0.22300310506292692,0.6248149692034,0.9157427937915743,1.0,1.0,2/20,10.64%,ROCK2;BRSK1
prerank,5'-3' exonuclease activity (GO:0008409),-0.23928414449257634,-0.6168967049105742,0.9109848484848485,1.0,1.0,6/14,34.73%,DCLRE1C;FAN1;EXO1;MRE11;XRN2;DCP2
prerank,3'-5' DNA helicase activity (GO:0043138),0.22712714305502485,0.6134003610091235,0.939203354297694,1.0,1.0,6/16,22.61%,BLM;MCM2;FANCM;NAV2;FBH1;MCM7
prerank,ubiquitin-specific protease binding (GO:1990381),0.22971381472290164,0.6104686712635631,0.9082774049217002,1.0,1.0,5/19,17.41%,PRKN;SUMO1;PTEN;SART3;SPATA2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.20410401425336006,0.6091584861074847,0.9567099567099567,1.0,1.0,10/27,24.27%,POLR1A;POLR2G;POLR1B;POLR3H;POLR2D;PRIM1;POLR2B;CRCP;POLR3K;MED21
prerank,mannose binding (GO:0005537),0.248165117059489,0.6069078982001013,0.8905908096280087,1.0,1.0,1/12,4.72%,LMAN1L
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.1907106701791658,-0.6058605533897007,0.9766081871345029,1.0,1.0,5/31,14.46%,UBE2Q2;UBE2L6;UBE2G2;UBE2Q1;UBE2G1
prerank,H4 histone acetyltransferase activity (GO:0010485),0.26211474300897186,0.6027560762481912,0.9118279569892473,1.0,1.0,5/10,23.59%,KAT8;EP300;ATF2;MSL3;NAA40
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.24128632638475084,-0.5962224947076343,0.9349442379182156,1.0,1.0,3/13,20.60%,AGPAT1;AGPAT5;LPCAT2
prerank,muscle alpha-actinin binding (GO:0051371),0.22620660834461725,0.5947914508634431,0.9157427937915743,1.0,1.0,7/15,26.77%,PDLIM2;PDLIM5;LDB3;PALLD;PDLIM7;PRICKLE4;SYNPO2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.2542088889401628,-0.5946454097326564,0.916095890410959,1.0,1.0,4/10,31.38%,GALM;RENBP;GALE;GNE
prerank,peptidase inhibitor activity (GO:0030414),0.19113742499652,0.5933289801310806,0.9708333333333333,0.9990868866384989,1.0,2/33,2.58%,AHSG;RECK
prerank,alpha-actinin binding (GO:0051393),0.20252708092321897,0.5914032967525167,0.970917225950783,0.9968785861603027,1.0,7/24,20.49%,PDLIM2;MAGI1;PDLIM5;DAG1;LDB3;PPARG;PALLD
prerank,endopeptidase regulator activity (GO:0061135),0.182153241627598,0.5839631484697952,0.9803063457330415,0.9973219247977732,1.0,5/40,12.42%,AHSG;RECK;PSMF1;PSME3;SPINK1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.19720921854916348,-0.5744020165090363,0.9816849816849816,1.0,1.0,1/24,0.62%,ITPKB
prerank,receptor antagonist activity (GO:0048019),0.2092729062227199,0.5646400047438298,0.9430379746835443,1.0,1.0,1/17,3.28%,DKK3
prerank,5'-3' RNA polymerase activity (GO:0034062),0.18962663932823007,0.5628221881458351,0.9785867237687366,1.0,1.0,10/27,24.27%,POLR1A;POLR2G;POLR1B;POLR3H;POLR2D;TENT2;POLR2B;CRCP;POLR3K;MED21
prerank,vitamin D receptor binding (GO:0042809),-0.21651757493586304,-0.5590171992369309,0.9685185185185186,1.0,1.0,3/14,24.46%,MED24;MED14;MED13
prerank,lysine N-methyltransferase activity (GO:0016278),0.1975320145525372,0.5587983210078237,0.9757575757575757,0.9986446659622346,1.0,3/20,11.54%,METTL21A;SETD7;EHMT2
prerank,lysophospholipase activity (GO:0004622),-0.19892804319885368,-0.5576204228569682,0.974559686888454,1.0,1.0,9/20,38.90%,MGLL;LYPLA1;GDE1;ENPP2;PLA2G4B;PLB1;ABHD16A;LYPLA2;LYPLAL1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",-0.15040623691583266,-0.5526110321312773,1.0,1.0,1.0,9/75,17.70%,ABCC4;ME1;KDSR;IMPDH1;LDHA;ME2;CBR1;SPR;HSD17B10
prerank,telomerase RNA binding (GO:0070034),-0.19416936126738543,-0.548429664524919,0.9685185185185186,1.0,1.0,10/22,34.73%,SNRPD3;DKC1;SMG7;SNRPB;HNRNPC;SMG6;TERT;WRAP53;NOP10;DCP2
prerank,DNA polymerase activity (GO:0034061),-0.19248834011407862,-0.5481753170400693,0.9776536312849162,1.0,1.0,10/22,34.10%,REV3L;POLQ;POLK;POLL;POLE3;CHRAC1;POLB;POLE;TERT;POLA1
prerank,calcium-activated potassium channel activity (GO:0015269),0.23457410080974217,0.5445193163803675,0.9601769911504425,1.0,1.0,11/11,76.56%,KCNMA1;KCNN1;KCNU1;KCNN2;KCNMB3;KCNMB2;PKD2L1;KCNN4;KCNMB4;KCNMB1;KCNN3
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.1671942237811896,-0.5416649848030732,0.9962406015037594,1.0,1.0,12/40,29.02%,PRMT8;CARNMT1;ICMT;LCMT1;MEPCE;NNMT;PEMT;PCMTD2;METTL2A;METTL2B;METTL18;GNMT
prerank,enoyl-CoA hydratase activity (GO:0004300),0.2296197885456665,0.5388429675785926,0.9450800915331807,0.9991274822080963,1.0,1/10,4.91%,ECHDC2
prerank,ribonuclease activity (GO:0004540),-0.15046057351731884,-0.533885504839172,0.99800796812749,1.0,1.0,20/56,35.90%,CNOT7;N4BP1;PPP1R8;NOB1;DIS3L2;SAMHD1;RNASE12;EXOSC8;RNASEK;TSNAX;ERN1;EXOSC9;ENDOG;RPP40;ZC3H12D;SMG6;RNASEH2A;PIWIL4;ENDOU;RNASE7
prerank,mRNA methyltransferase activity (GO:0008174),-0.21599568916854922,-0.5258135787951839,0.973384030418251,1.0,1.0,3/12,20.44%,TRMT10C;PCIF1;TRMT61B
prerank,neuropeptide receptor activity (GO:0008188),0.17652234022497332,0.5252248044949692,0.9809322033898306,1.0,1.0,29/29,82.38%,SORCS1;NPY5R;GRPR;GALR1;OPRM1;TACR3;SORCS3;HCRTR2;TACR1;GPR37;GALR2;SSTR5;GALR3;NPSR1;SSTR4;MCHR1;TACR2;GAL;NPFFR1;NTSR1;NMUR1;SSTR1;NPY2R;GPR143;SORCS2;SSTR2;KISS1R;NMUR2;NPY1R
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.2255508378869177,-0.5240908536636938,0.958029197080292,1.0,1.0,6/10,49.39%,NAA60;NAA80;NAA50;NAA11;NAA25;NAA10
prerank,O-acyltransferase activity (GO:0008374),-0.16981867927552752,-0.52406919441251,0.982824427480916,1.0,1.0,6/30,20.60%,LPCAT3;MBOAT7;MBOAT1;LCAT;PIGW;LPCAT2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.21643831365605254,0.5199130594918717,0.9582417582417583,0.9984588935741454,1.0,2/10,18.34%,DPYSL3;DPYSL2
prerank,N-methyltransferase activity (GO:0008170),0.18275402480121541,0.5169623205140078,0.9736842105263158,0.9960813527006888,1.0,6/20,23.84%,HNMT;DIMT1;TFB1M;METTL15;TRMT1L;RNMT
prerank,tRNA methyltransferase activity (GO:0008175),-0.19428640340944348,-0.511702317453132,0.9824902723735408,1.0,1.0,7/16,32.45%,TRMT9B;TRDMT1;TRMT44;TYW3;METTL2A;METTL2B;TRMT13
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.2103542467907648,0.5091375908998561,0.9690949227373068,0.994884664510774,1.0,3/11,20.81%,SLC25A42;SLC25A24;SLC19A1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.19509801644849592,0.5080867067816386,0.9761904761904762,0.9921164408365272,1.0,2/17,7.15%,BAAT;ACOT11
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.20385077998935852,0.4995379250480993,0.9683972911963883,0.9909331079402003,1.0,3/12,20.81%,SLC25A42;SLC25A24;SLC19A1
prerank,adenylyltransferase activity (GO:0070566),-0.17475045823009064,-0.4900041969284252,0.9922630560928434,1.0,1.0,7/21,29.40%,OAS2;PAPOLG;NMNAT3;FICD;SELENOO;NMNAT2;KARS1
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.17351556474076857,-0.4892673769171252,0.9853479853479854,1.0,1.0,9/21,34.10%,REV3L;POLQ;POLK;POLL;POLE3;CHRAC1;POLB;POLE;POLA1
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.18206128008114547,-0.47609918617072755,0.9889908256880734,1.0,1.0,9/14,49.89%,RPP38;RPP21;TSEN2;RPP40;RPP30;RPP25;ELAC2;TSEN34;POP5
prerank,neuropeptide binding (GO:0042923),0.17448451294927542,0.4741565641405146,0.9955257270693513,0.9923376814437034,1.0,1/18,4.99%,OPRK1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.20021546636296683,-0.44612168755769377,0.9963636363636363,1.0,1.0,2/10,18.17%,OTUD5;TNFAIP3
prerank,ribonuclease P RNA binding (GO:0033204),-0.1865045470381309,-0.445910108875583,0.9964285714285714,1.0,1.0,5/10,43.45%,RPP38;RPP21;RPP40;RPP30;RPP25
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.1761345803778796,-0.41699423843730005,0.9943609022556391,1.0,1.0,11/11,82.40%,NAA60;NAA80;NAA50;NAA11;NAA25;NAA10;NAA30;NAA16;NAA15;NAA40;NAA20
prerank,ribonuclease P activity (GO:0004526),-0.14111636736481037,-0.34466670676545286,1.0,0.9999122633853172,1.0,2/11,19.58%,RPP38;RPP21
